N-CSRS 1 a17-15745_7ncsrs.htm N-CSRS

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM N-CSR

 

CERTIFIED SHAREHOLDER REPORT OF REGISTERED
MANAGEMENT INVESTMENT COMPANIES

 

Investment Company Act file number

811-03692

 

Morgan Stanley Variable Investment Series

(Exact name of registrant as specified in charter)

 

522 Fifth Avenue, New York, New York

 

10036

(Address of principal executive offices)

 

(Zip code)

 

John H. Gernon

522 Fifth Avenue, New York, New York 10036

(Name and address of agent for service)

 

Registrant’s telephone number, including area code:

212-296-0289

 

 

Date of fiscal year end:

December 31,

 

 

Date of reporting period:

June 30, 2017

 

 



 

Item 1 - Report to Shareholders

 



MORGAN STANLEY
VARIABLE INVESTMENT SERIES

Semi-Annual Report

JUNE 30, 2017

The Funds are intended to be a funding vehicle for variable annuity contracts and variable life insurance policies offered by the separate accounts of certain life insurance companies.



Morgan Stanley Variable Investment Series

Table of Contents

Letter to the Shareholders

   

1

   

Fund Performance

   

11

   

Expense Examples

   

12

   

Portfolio of Investments:

 

Limited Duration

   

15

   

Income Plus

   

23

   

European Equity

   

33

   

Multi Cap Growth

   

36

   

Financial Statements:

 

Statements of Assets and Liabilities

   

39

   

Statements of Operations

   

40

   

Statements of Changes in Net Assets

   

42

   

Notes to Financial Statements

   

46

   

Financial Highlights

   

76

   

Investment Advisory Agreement Approval

   

82

   



Morgan Stanley Variable Investment Series

Letter to the Shareholders n June 30, 2017 (unaudited)

Dear Shareholder:

The first half of 2017 delivered positive performance across global equity and fixed income markets. Despite underwhelming U.S. economic and political progress, markets advanced in an environment of strengthening global economic growth, with better-than-expected results in Europe and stability in China, along with low inflation and still-accommodative central banks.

Domestic and International Equity Overview

In the six-month reporting period, U.S. stocks (as measured by the S&P 500 Index) rallied strongly on expectations for stimulative and business-friendly fiscal policy from the new presidential administration. With the Republicans controlling both Congress and the White House, President Trump's promises to cut taxes, increase infrastructure spending and relax regulations were initially anticipated to be enacted wholesale, which sent stocks soaring in the month following the election. However, early policy stumbles and emerging political scandals cast doubt about the ability to pass these reforms. Nevertheless, U.S. stock prices continued to rise and volatility remained relatively low over this reporting period. U.S. companies reported increasing profits, and the economy continued its restrained pace of growth. The Federal Reserve's (Fed) recent interest rate hikes were also perceived as a vote of confidence on the health of the economy.

The European equity market rallied in the first half of 2017, led by cyclical sectors such as technology and industrials (as represented by the MSCI Europe Index). More defensive sectors, such as energy and telecommunications, underperformed the overall MSCI Europe Index. The most recent macro-economic data across the region came in strongly, although the magnitude of improvements somewhat declined toward the end of the period. Political risks also eased, with mainstream candidates winning in the Dutch and French elections during the spring of 2017. Despite political upheaval following Britain's snap election in early June, the U.K. and European Union formally began Brexit negotiations. Additionally, European markets responded positively to signals from the European Central Bank that continued to point toward an accommodative monetary policy stance.

Fixed Income Overview

We could be at a turning point in the market's narrative. While the first half of 2017 was about reflation, looking forward, a unique aspect of the second half stems from central bank polices to remove accommodation, which is creating unknown risk factors. Data in the U.S. continued to cool in the second quarter of 2017, leading to the question of whether the economy had peaked. Nevertheless, these pockets of worries failed to seriously dent market confidence. It was another good quarter for risky assets, with the S&P 500 Index steadily climbing higher and credit spreads grinding lower.



Morgan Stanley Variable Investment Series

Letter to the Shareholders n June 30, 2017 (unaudited) continued

In this environment, U.S. Treasury yields have remained depressed by declining inflation and easy monetary policy in Europe and Japan. High yield and investment grade corporate credit posted gains over the period (as measured by the Bloomberg Barclays U.S. Corporate High Yield Index and Bloomberg Barclays U.S. Corporate Index, respectively), aided by a backdrop of moderate economic growth, strong corporate profits, low inflation, muted market volatility and favorable technicals. In the securitized markets, low interest rate volatility has benefited agency mortgage-backed securities (MBS), although the Fed's ongoing interest rate hikes and its plans for balance sheet reduction could potentially increase volatility for the asset class. Non-agency residential MBS continued to be supported by favorable fundamental conditions in the U.S. housing and mortgage markets. Commercial mortgage-backed securities performance diverged widely depending on collateral composition, as those with greater retail exposure underperformed amid announcements of retail store closings and poor retail earnings.

Limited Duration Portfolio

For the six-month period ended June 30, 2017, Variable Investment Series — Limited Duration Portfolio Class X shares produced a total return of 1.31%, outperforming the Bloomberg Barclays U.S. Government/Credit Index (1-5 Year) (the "Index"),(1) which returned 1.14%. For the same period, the Fund's Class Y shares returned 1.18%. Past performance is no guarantee of future results.

The performance of the Fund's two share classes varies because each has different expenses. The Fund's total returns assume the reinvestment of all distributions but do not reflect the deduction of any charges by your insurance company. Such costs would lower performance.

During calendar year 2016, the Fund received monies related to certain nonrecurring litigation settlements. If these monies were not received, any period returns which include these settlement monies would have been lower. For example, the 2016 fiscal year total return would have been 1.81% for Class X Shares as of December 31, 2016. The return on the other Share Class would also have been similarly impacted. These were one-time settlements, and as a result, the impact on the net asset value and consequently the performance will not likely be repeated in the future. Please call 1-800-548-7786 for additional information.

The Fund's overweight positions in corporate bonds and holdings in the securitized sector were the primary drivers of the outperformance during the period. These securities benefited from both higher yields and relative price appreciation.

(1)  The Bloomberg Barclays U.S. Government/Credit Index (1-5 Year) tracks the performance of U.S. government and corporate obligations, including U.S. government agency and Treasury securities, and corporate and Yankee bonds with maturities of one to five years. The Index is unmanaged and its returns do not include any sales charges or fees. Such costs would lower performance. It is not possible to invest directly in an index.


2



Morgan Stanley Variable Investment Series

Letter to the Shareholders n June 30, 2017 (unaudited) continued

Underweights to non-U.S. government securities detracted slightly from relative performance as these sectors also performed well. We have chosen to be underweight this sector to fund the Fund's overweights in corporate and securitized bonds.

Interest rate positioning also slightly detracted from relative performance. Though short-maturity Treasury yields rose as the Federal Reserve raised the federal funds rate twice during the period, diminished market expectations of future rate increases led to a flattening of the yield curve.

There is no guarantee that any sectors mentioned will continue to perform as discussed above or that securities in such sectors will be held by the Fund in the future.

Income Plus Portfolio

For the six-month period ended June 30, 2017, Variable Investment Series — Income Plus Portfolio Class X shares produced a total return of 4.11%, outperforming the Bloomberg Barclays U.S. Corporate Index (the "Index"),(2) which returned 3.80%. For the same period, the Fund's Class Y shares returned 4.03%. Past performance is no guarantee of future results.

The performance of the Fund's two share classes varies because each has different expenses. The Fund's total returns assume the reinvestment of all distributions but do not reflect the deduction of any charges by your insurance company. Such costs would lower performance.

Despite a challenging macroeconomic environment and increased market volatility, the Fund ended the six-month reporting period with performance above the Index. The biggest contributor to performance was the investment grade segment of the market. Within investment grade, the Fund's positioning in the financials sector most positively impacted performance, driven mainly by the banking sub-sector. The Fund's industrials positioning had a neutral impact on performance overall over the period. Within industrials, energy and transportation positively impacted performance, while technology and capital goods detracted from performance.

The Fund's overweight to the high yield segment of the market was also beneficial to performance, as this asset class performed well during 2017 as yields and spreads declined. Similarly, the Fund's overweight to convertible bonds added to performance given strength in this sector of the market. The Fund's short

(2)  The Bloomberg Barclays U.S. Corporate Index covers U.S. dollar-denominated, investment-grade, fixed rate, taxable securities sold by industrial, utility and financial issuers. It includes publicly issued U.S. corporate and foreign debentures and secured notes that meet specified maturity, liquidity and quality requirements. The Index is unmanaged and its returns do not include any sales charges or fees. Such costs would lower performance. It is not possible to invest directly in an index.


3



Morgan Stanley Variable Investment Series

Letter to the Shareholders n June 30, 2017 (unaudited) continued

duration position (or, less sensitivity to interest rate movements) positively contributed to performance over the period. Treasury yields have increased in the 2- and 3-year part of the yield curve, while declining in the 5-, 7-, 10-, and 30-year part of the curve over the period. Additionally, the use of derivatives, used to offset other exposures in the Fund, had a slight positive impact on slightly from performance over the period.

We have observed that global trends have been depressing U.S. Treasury yields in 2017. Very easy monetary policy by the European Central Bank and Bank of Japan worked to keep yields in these countries low, dragging down U.S. yields. This may be reversing as other central banks begin policy normalization. Though the U.S. economic data weakened recently, data elsewhere in the world remained strong. The market awaits the timing of the Fed's balance sheet reduction and if it will follow through with another rate hike. Other major central banks around the world are also considering raising rates and/or selling assets. The significance is that the second half of 2017 represents the first period since the global financial crisis that major global central banks are making a coordinated move to end excessive policy accommodation.

In investment grade corporates, we entered 2017 expecting competing tensions between fundamentals, valuation and technicals. Beneath the surface, we saw divergences between these factors across financials and non-financials and between the U.S. and Europe. Now, at the halfway point of the year, many of these tensions remain the same. As we weight and sum them, we find ourselves still constructive on the market, with somewhat better (or at least not worse) fundamentals, though facing valuations that are somewhat more expensive. After being very constructive, we are now modestly constructive.

In terms of fundamentals, U.S. banking and other financials remain very strong with high capital levels and improving profitability. We have been concerned about the pace of leveraging of U.S. industrials, though this trend has ameliorated in 2017 given a pause in merger and acquisition activity and share buybacks combined with improving corporate earnings.

The investment grade corporate market continued to perform well in the second quarter of 2017, with yield spreads tightening by 9 basis points, as represented by the Index.(3) On a year-to-date basis, investment-grade spreads are 14 basis points tighter.(2) Spreads are now at the tightest level in nearly three years, returning to post-crisis lows of July 2014.(2)

(3)  Source: Bloomberg Barclays. Data as of June 30, 2017.


4



Morgan Stanley Variable Investment Series

Letter to the Shareholders n June 30, 2017 (unaudited) continued

Some notable news items in the second quarter of 2017 were the U.S. bank stress tests and falling oil prices. All 34 banks passed the Federal Reserve's 2017 stress tests, so no banks need to raise additional capital, as balance sheets remain strong and capital levels remain high. Oil prices trended lower during the second quarter of 2017, although the market viewed this as supply-side driven and therefore sector-specific.

The backdrop for the market remained benign, as volatility, as measured by the VIX volatility index, remains trading in a narrow range and just above historic lows.(2) Financials yield spreads tightened by a similar amount as those of non-financials, as the pace of outperformance in the senior bank space was noticeably slower. Within non-financials, energy was the notable underperformer, as spreads widened in sympathy with softness in oil prices.

In Europe, the debt-equity cycle is much less advanced and the pressure on leverage is much lower. At a macro level, the election of Emmanuel Macron in France during the second quarter of 2017 removes the risk of an anti-euro project government. Macron has been elected on a platform promising structural reform (particularly labor reform), which is pro-growth and viewed as a market positive. Furthermore, reduced uncertainty over bank restructuring and recapitalization helped higher-quality Tier 2 and senior bonds to rally.

In summary, while yield spreads are trading inside long-term median levels, we remain cautiously optimistic about investment grade credit. Technicals remain supportive and fundamentals do not seem to be deteriorating further, though they remain stretched for many non-financials. Financial fundamentals remain strong and continue to improve. Given current valuations, we do not expect a drastic move tighter in spreads; however, we anticipate that spreads will continue to grind tighter if the current backdrop persists. Though we are still looking to take advantage of the current environment of modest, slow spread tightening, we are also open to opportunities to de-risk where appropriate to reflect tighter valuations and less favorable fundamentals.

There is no guarantee that any sectors mentioned will continue to perform as discussed above or that securities in such sectors will be held by the Fund in the future.


5



Morgan Stanley Variable Investment Series

Letter to the Shareholders n June 30, 2017 (unaudited) continued

European Equity Portfolio

For the six-month period ended June 30, 2017, Variable Investment Series — European Equity Portfolio Class X shares produced a total return of 14.95%, underperforming the MSCI Europe Index (the "Index"),(4) which returned 15.36%. For the same period, the Fund's Class Y shares returned 14.77%. Past performance is no guarantee of future results.

Please keep in mind that double-digit returns are highly unusual and cannot be sustained. Investors should also be aware that these returns were primarily achieved during favorable market conditions.

The performance of the Fund's two share classes varies because each has different expenses. The Fund's total returns assume the reinvestment of all distributions but do not reflect the deduction of any charges by your insurance company. Such costs would lower performance.

The main country-level detractors from performance were our stock selection in the U.K., underweight allocation to Spain, and both stock selection and an overweight allocation in Ireland. However, positive relative performance came from our stock selection in Sweden and France, as well as our stock selection in and an overweight allocation to the Netherlands.

On a sector basis, our stock selection in banks, stock selection and overweight allocation in telecommunications, and an underweight allocation in consumer durables and apparel were unfavorable to relative returns. Positive contributors included our stock selection in the capital goods, consumer services and utilities sectors, along with an overweight allocation to household and personal products companies.

The holdings that detracted the most from relative performance included a U.K. oil company, whose share price suffered along with slumping oil prices in the first half of 2017; a U.K. telecommunications company facing concerns about its pension liabilities, falling revenues on the loss of a government contract and speculation of a break-up of the company; a U.K.-based global bank that was hurt by management scandals and regulatory fines; and an Irish building materials company that saw profit-taking in the market because the stock had performed well in 2016 and because a stronger U.S. dollar in 2017 was expected to hurt profitability when its U.S.-based revenues were translated back into euros.

(4)  The Morgan Stanley Capital International (MSCI) Europe Index is a free float-adjusted market capitalization index that is designed to measure developed market equity performance in Europe. The term "free float" represents the portion of shares outstanding that are deemed to be available for purchase in the public equity markets by investors. The performance of the Index is listed in U.S. dollars and assumes reinvestment of net dividends. The Index is unmanaged and its returns do not include any sales charges or fees. Such costs would lower performance. It is not possible to invest directly in an index.


6



Morgan Stanley Variable Investment Series

Letter to the Shareholders n June 30, 2017 (unaudited) continued

In contrast, the top positive contributors to performance were a Swedish truck company with recovering profit margins as well as an improving outlook amid stronger global economic growth; an Anglo-Dutch household and personal products company whose share price rallied following a bid from a competitor (which was later withdrawn); the Fund's lack of exposure to a French oil company, which performed poorly due to falling oil prices; and a holding in a French industrial company that reported strong quarterly earnings results and increased demand for its jets.

We believe that the outlook for European equities remains constructive as we see reduced political risk in Europe following the Dutch and French elections; global economic growth on a more solid footing compared to earlier in the period, due to a stabilization of emerging markets, significant improvements in the eurozone economy and hope of fiscal stimulus by the new U.S. administration; and an accommodative European Central Bank (ECB) stance that will continue for the rest of 2017 and for most of 2018. European economic growth has, in particular, exceeded expectations as we saw strong consumer sentiment, consumer confidence and industrial production data during the reporting period. Improved consumer confidence readings have been supported by a sustained decline in unemployment across the region, including in peripheral Europe. Furthermore, market-friendly results in the recent elections have provided more visibility for companies and they now may be more prone to increase capital expenditures. Additional company investments could extend the life of the economic cycle and support a broader and firmer economy.

As of the end of reporting period, we continue to follow what we consider a well-balanced and diversified approach. The Fund remained overweight technology, telecommunications, health care and consumer staples. The Fund was underweight in materials, utilities, industrials, energy, consumer discretionary and financials.

In these uncertain times, our investment approach remains the same. We continue to seek high-quality companies with high earnings visibility and predictability, stable and strong cash flow, and low levels of debt, trading at attractive valuations.

There is no guarantee that any sectors mentioned will continue to perform as discussed above or that securities in such sectors will be held by the Fund in the future.


7



Morgan Stanley Variable Investment Series

Letter to the Shareholders n June 30, 2017 (unaudited) continued

Multi Cap Growth Portfolio

For the six-month period ended June 30, 2017, Variable Investment Series — Multi Cap Growth Portfolio Class X shares produced a total return of 28.70%, outperforming the Russell 3000® Growth Index (the "Index"),(5) which returned 13.69%. For the same period, the Fund's Class Y shares returned 28.54%. Past performance is no guarantee of future results.

Please keep in mind that double-digit returns are highly unusual and cannot be sustained. Investors should also be aware that these returns were primarily achieved during favorable market conditions.

The performance of the Fund's two share classes varies because each has different expenses. The Fund's total returns assume the reinvestment of all distributions but do not reflect the deduction of any charges by your insurance company. Such costs would lower performance.

The long-term investment horizon and conviction-weighted investment approach embraced by the team since 1998 can result in periods of performance deviation from the benchmark and peers. The Fund outperformed the Index this reporting period primarily due to favorable stock selection and sector allocations.

Stock selection and an overweight allocation in the information technology sector contributed the most to relative outperformance. A provider of proprietary human capital management and financial management enterprise software over the cloud was the sector's largest contributor and the second greatest contributor in the Fund. The company's shares rebounded after a weak fourth quarter on news that the company has signed deals with a number of enterprises.

Stock selection and an overweight allocation in the health care sector also delivered relative gains. A genetic testing and analysis leader was the top contributor in the sector and the third greatest across the Fund. In January 2017, the company reported better-than-expected results, raised its financial outlook, and announced the introduction of a new sequencing system, which helped its share price rally.

The Fund benefited from stock selection in the consumer discretionary sector. An electric car maker was the top contributor both in the sector and across the Fund, due to positive investor sentiment regarding the

(5)  The Russell 3000® Growth Index measures the performance of the broad growth segment of the U.S. equity universe. It includes those Russell 3000® Index companies with higher price-to-book ratios and higher forecasted growth values. The Russell 3000® Index measures the performance of the largest 3000 U.S. companies representing approximately 98% of the investable U.S. equity market. The Index is unmanaged and its returns do not include any sales charges or fees. Such costs would lower performance. It is not possible to invest directly in an index.


8



Morgan Stanley Variable Investment Series

Letter to the Shareholders n June 30, 2017 (unaudited) continued

upcoming launch of its mass market offering, as well as continued progress in the build out of its lithium-ion battery factory. However, relative outperformance was somewhat offset by weak performance from the Fund's holding in a leading coffee roaster and retail chain, which was the largest detractor within the sector and across the Fund. The company's shares pulled back at the end of the reporting period on investor concerns about near-term same-store sales trends.

There were no sector-level relative detractors, while the utilities and materials sectors had a negligible impact on the Fund's relative performance in the reporting period.

There is no guarantee that any sectors mentioned will continue to perform as discussed above or that securities in such sectors will be held by the Fund in the future.

We appreciate your ongoing support of Morgan Stanley Variable Investment Series and look forward to continuing to serve your investment needs.

Very truly yours,

John H. Gernon
President and Principal Executive Officer


9



Morgan Stanley Variable Investment Series

Letter to the Shareholders n June 30, 2017 (unaudited) continued

For More Information About Portfolio Holdings

Each Morgan Stanley fund provides a complete schedule of portfolio holdings in its semiannual and annual reports within 60 days of the end of the fund's second and fourth fiscal quarters. The semiannual reports and the annual reports are filed electronically with the Securities and Exchange Commission (SEC) on Form N-CSRS and Form N-CSR, respectively. Morgan Stanley also delivers the semiannual and annual reports to fund shareholders and makes these reports available on its public web site, www.morganstanley.com/im. Each Morgan Stanley fund also files a complete schedule of portfolio holdings with the SEC for the fund's first and third fiscal quarters on Form N-Q. Morgan Stanley does not deliver the reports for the first and third fiscal quarters to shareholders, nor are the reports posted to the Morgan Stanley public web site. You may, however, obtain the Form N-Q filings (as well as the Form N-CSR and N-CSRS filings) by accessing the SEC's web site, http://www.sec.gov. You may also review and copy them at the SEC's public reference room in Washington, DC. Information on the operation of the SEC's public reference room may be obtained by calling the SEC at (800) SEC-0330. You can also request copies of these materials, upon payment of a duplicating fee, by electronic request at the SEC's e-mail address (publicinfo@sec.gov) or by writing to the SEC's Public Reference Section, Washington, D.C. 20549-1520.

Proxy Voting Policy and Procedures and Proxy Voting Record

You may obtain a copy of the Funds' Proxy Voting Policy and Procedures without charge, upon request, by calling toll free (800) 548-7786 or by visiting the Mutual Fund Center on our web site at www.morganstanley.com/im. It is also available on the SEC's web site at http://www.sec.gov.

You may obtain information regarding how the Funds voted proxies relating to portfolio securities during the most recent twelve-month period ended June 30 without charge by visiting the Mutual Fund Center on our web site at www.morganstanley.com/im. This information is also available on the SEC's web site at http://www.sec.gov.


10




Morgan Stanley Variable Investment Series

Fund Performance n June 30, 2017 (unaudited)

Average Annual Total Returns — Period Ended June 30, 2017(1)   

Class X

 

1 Year

 

5 Years

 

10 Years

  Since
Inception
  Gross Expense
Ratio
  Date of
Inception
 

European Equity

   

16.40

%

   

7.20

%

   

0.59

%

   

7.90

%

   

1.42

%

 

3/1/1991

 

Income Plus

   

3.74

     

4.94

     

6.25

     

6.98

     

0.68

   

3/1/1987

 

Limited Duration

   

2.11

     

1.83

     

0.60

     

1.98

     

0.92

   

5/4/1999

 

Multi Cap Growth

   

30.86

     

17.09

     

10.92

     

11.80

     

0.58

   

3/9/1984

 

Class Y

                         

European Equity

   

16.15

     

6.93

     

0.34

     

2.06

     

1.67

   

6/5/2000

 

Income Plus

   

3.48

     

4.68

     

5.98

     

6.12

     

0.93

   

6/5/2000

 

Limited Duration

   

1.85

     

1.57

     

0.36

     

1.66

     

1.17

   

6/5/2000

 

Multi Cap Growth

   

30.53

     

16.80

     

10.64

     

6.12

     

0.83

   

6/5/2000

 

Performance data quoted represents past performance, which is no guarantee of future results and current performance may be lower or higher than the figures shown. For most recent month-end performance figures, please contact the issuing insurance company or speak with your Financial Advisor. Investment return and principal value will fluctuate. When you sell Fund shares, they may be worth less than their original cost. Total returns do not reflect the deduction of taxes that a shareholder would pay on Fund distributions or the redemption of Fund shares. Performance for Class Y shares will vary from the performance of Class X shares due to differences in expenses. Expenses are as of each Fund's fiscal year end as outlined in the Fund's current prospectus.

(1)  Figure assumes reinvestment of all distributions for the underlying fund based on net asset value (NAV). It does not reflect the deduction of insurance expenses, an annual contract maintenance fee, or surrender charges. If performance information included the effect of these additional charges, the total returns would be lower.


11



Morgan Stanley Variable Investment Series

Expense Examples n June 30, 2017 (unaudited)

As a shareholder of a Fund, you incur two types of costs: (1) insurance company charges; and (2) ongoing costs, which may include advisory fees, administration fees, distribution and services (12b-1) fees, and other Fund expenses. These examples are intended to help you understand your ongoing costs (in dollars) of investing in each Fund and to compare these costs with the ongoing costs of investing in other mutual funds.

These examples are based on an investment of $1,000 invested at the beginning of the period and held for the entire period 01/01/17 – 06/30/17.

Actual Expenses

The first line of the tables on the following page provides information about actual account values and actual expenses. You may use the information in this line, together with the amount you invested, to estimate the expenses that you paid over the period. Simply divide your account value by $1,000 (for example, an $8,600 account value divided by $1,000 = 8.6), then multiply the result by the number in the first line under the heading entitled "Expenses Paid During Period" to estimate the expenses you paid on your account during this period.

Hypothetical Example for Comparison Purposes

The second line of the tables on the following page provides information about hypothetical expenses based on the Fund's actual expense ratio and an assumed rate of return of 5% per year before expenses, which is not the Fund's actual return. The hypothetical account values and expenses may not be used to estimate the actual ending account balance or expenses you paid for the period. You may use this information to compare the ongoing cost of investing in the Fund and other funds. To do so, compare this 5% hypothetical example with the 5% hypothetical examples that appear in the shareholder reports of the other funds.

Please note that the expenses shown in the tables are meant to highlight your ongoing costs only and do not reflect any insurance company charges. Therefore, the second line of the tables is useful in comparing ongoing costs, and will not help you determine the relative total cost of owning different funds. In addition, if these insurance company charges were included, your costs would have been higher.


12



Morgan Stanley Variable Investment Series

Expense Examples n June 30, 2017 (unaudited) continued

Limited Duration

    Beginning
Account Value
  Ending
Account Value
  Expenses Paid
During Period(1)
 
   

01/01/17

 

06/30/17

  01/01/17 –
06/30/17
 

Class X

 
Actual (1.31% return)  

$

1,000.00

   

$

1,013.10

   

$

5.04

   
Hypothetical (5% annual return before expenses)  

$

1,000.00

   

$

1,019.79

   

$

5.06

   

Class Y

 
Actual (1.18% return)  

$

1,000.00

   

$

1,011.80

   

$

6.29

   
Hypothetical (5% annual return before expenses)  

$

1,000.00

   

$

1,018.55

   

$

6.31

   

  (1)  Expenses are equal to the Fund's annualized expense ratios of 1.01% and 1.26% for Class X and Class Y shares, respectively, multiplied by the average account value over the period, multiplied by 181/365 (to reflect the one-half year period).

Income Plus  

    Beginning
Account Value
  Ending
Account Value
  Expenses Paid
During Period(1)
 
   

01/01/17

 

06/30/17

  01/01/17 –
06/30/17
 

Class X

 
Actual (4.11% return)  

$

1,000.00

   

$

1,041.10

   

$

3.54

   
Hypothetical (5% annual return before expenses)  

$

1,000.00

   

$

1,021.32

   

$

3.51

   

Class Y

 
Actual (4.03% return)  

$

1,000.00

   

$

1,040.30

   

$

4.81

   
Hypothetical (5% annual return before expenses)  

$

1,000.00

   

$

1,020.08

   

$

4.76

   

  (1)  Expenses are equal to the Fund's annualized expense ratios of 0.70% and 0.95% for Class X and Class Y shares, respectively, multiplied by the average account value over the period, multiplied by 181/365 (to reflect the one-half year period).


13



Morgan Stanley Variable Investment Series

Expense Examples n June 30, 2017 (unaudited) continued

European Equity

    Beginning
Account Value
  Ending
Account Value
  Expenses Paid
During Period(1)
 
   

01/01/17

 

06/30/17

  01/01/17 –
06/30/17
 

Class X

 
Actual (14.95% return)  

$

1,000.00

   

$

1,149.50

   

$

5.33

   
Hypothetical (5% annual return before expenses)  

$

1,000.00

   

$

1,019.84

   

$

5.01

   

Class Y

 
Actual (14.77% return)  

$

1,000.00

   

$

1,147.70

   

$

6.66

   
Hypothetical (5% annual return before expenses)  

$

1,000.00

   

$

1,018.60

   

$

6.26

   

  (1)  Expenses are equal to the Fund's annualized expense ratios of 1.00% and 1.25%for Class X and Class Y shares, respectively, multiplied by the average account value over the period, multiplied by 181/365 (to reflect the one-half year period). If the Fund had borne all of its expenses, the annualized expense ratios would have been 1.42% and 1.67% for Class X and Class Y shares, respectively.

Multi Cap Growth

    Beginning
Account Value
  Ending
Account Value
  Expenses Paid
During Period(1)
 
   

01/01/17

 

06/30/17

  01/01/17 –
06/30/17
 

Class X

 
Actual (28.70% return)  

$

1,000.00

   

$

1,287.00

   

$

3.23

   
Hypothetical (5% annual return before expenses)  

$

1,000.00

   

$

1,021.97

   

$

2.86

   

Class Y

 
Actual (28.54% return)  

$

1,000.00

   

$

1,285.40

   

$

4.65

   
Hypothetical (5% annual return before expenses)  

$

1,000.00

   

$

1,020.73

   

$

4.11

   

  (1)  Expenses are equal to the Fund's annualized expense ratios of 0.57% and 0.82% for Class X and Class Y shares, respectively, multiplied by the average account value over the period, multiplied by 181/365 (to reflect the one-half year period). If the Fund had borne all of its expenses, the annualized expense ratios would have been 0.58% and 0.83% for Class X and Class Y shares, respectively.


14




Morgan Stanley Variable Investment Series - Limited Duration

Portfolio of Investments n June 30, 2017 (unaudited)

PRINCIPAL
AMOUNT
(000)
 

  COUPON
RATE
  MATURITY
DATE
 

VALUE

 
   

Corporate Bonds (73.5%)

 
   

Basic Materials (1.1%)

 

$

125

   

EI du Pont de Nemours & Co.

   

2.20

%

 

05/01/20

 

$

125,729

   
 

175

   

Goldcorp, Inc. (Canada)

   

2.125

   

03/15/18

   

175,216

   
         

300,945

   
   

Communications (6.9%)

 
 

400

   

AT&T, Inc.

   

2.45

   

06/30/20

   

402,334

   
 

225

   

Baidu, Inc. (China)

   

3.25

   

08/06/18

   

227,863

   
 

200

   

CBS Corp.

   

2.30

   

08/15/19

   

201,406

   
 

150

    Deutsche Telekom International Finance BV
(Germany) (a)
   

2.225

   

01/17/20

   

150,318

   
 

225

   

Orange SA (France)

   

2.75

   

02/06/19

   

227,942

   
 

175

   

Scripps Networks Interactive, Inc.

   

2.75

   

11/15/19

   

177,255

   
 

50

   

Thomson Reuters Corp. (Canada)

   

1.65

   

09/29/17

   

50,014

   
 

175

   

Time Warner Cable LLC

   

6.75

   

07/01/18

   

183,130

   
 

230

   

Verizon Communications, Inc. (a)

   

2.946

   

03/15/22

   

231,851

   
         

1,852,113

   
   

Consumer Discretionary (0.7%)

 
 

200

    Sprint Spectrum Co., LLC/Sprint Spectrum Co.,
II LLC/Sprint Spectrum Co., III LLC (a)
   

3.36

   

03/20/23

   

202,250

   
   

Consumer, Cyclical (5.8%)

 
 

175

   

CVS Health Corp.

   

2.125

   

06/01/21

   

173,027

   
 

100

   

Delta Air Lines, Inc.

   

2.875

   

03/13/20

   

101,373

   
 

200

   

Ford Motor Credit Co., LLC

   

2.681

   

01/09/20

   

201,465

   
 

125

   

Hyundai Capital America (Korea, Republic of) (a)

   

2.00

   

03/19/18

   

125,106

   
 

50

   

Hyundai Capital America (a)

   

2.55

   

04/03/20

   

49,908

   
 

100

   

Hyundai Capital America (Korea, Republic of) (a)

   

2.60

   

03/19/20

   

100,299

   
 

175

   

McDonald's Corp., MTN

   

2.20

   

05/26/20

   

176,262

   
 

240

   

Nissan Motor Acceptance Corp. (Japan) (a)

   

2.65

   

09/26/18

   

242,475

   
 

175

   

Southwest Airlines Co.

   

2.75

   

11/06/19

   

177,824

   
 

200

    Volkswagen Group of America Finance LLC
(Germany) (a)
   

2.40

   

05/22/20

   

200,823

   
         

1,548,562

   
   

Consumer, Non-Cyclical (15.7%)

 
 

140

   

Abbott Laboratories

   

2.35

   

11/22/19

   

141,134

   
 

175

   

AbbVie, Inc.

   

2.50

   

05/14/20

   

177,147

   
 

280

   

Allergan Funding SCS

   

3.00

   

03/12/20

   

286,120

   
 

200

   

Anheuser-Busch InBev Finance, Inc. (Belgium)

   

2.65

   

02/01/21

   

202,850

   
 

150

   

BAT International Finance PLC (United Kingdom) (a)

   

2.75

   

06/15/20

   

152,067

   

See Notes to Financial Statements
15



Morgan Stanley Variable Investment Series - Limited Duration

Portfolio of Investments n June 30, 2017 (unaudited) continued

PRINCIPAL
AMOUNT
(000)
 

  COUPON
RATE
  MATURITY
DATE
 

VALUE

 

$

175

   

Baxalta, Inc.

   

2.875

%

 

06/23/20

 

$

177,916

   
 

200

   

Bayer US Finance LLC (a)

   

2.375

   

10/08/19

   

201,658

   
 

100

   

Becton Dickinson and Co.

   

2.675

   

12/15/19

   

101,284

   
 

175

   

Biogen, Inc.

   

2.90

   

09/15/20

   

178,644

   
 

50

   

Cardinal Health, Inc.

   

1.948

   

06/14/19

   

50,073

   
 

175

   

Celgene Corp.

   

2.875

   

08/15/20

   

179,084

   
 

250

    Cooperatieve Rabobank UA, Series BKTN
(Netherlands)
   

1.375

   

08/09/19

   

247,268

   
 

200

   

Danone SA (France) (a)

   

1.691

   

10/30/19

   

198,515

   
 

175

   

EMD Finance LLC (Germany) (a)

   

2.40

   

03/19/20

   

176,228

   
 

175

   

Gilead Sciences, Inc.

   

2.55

   

09/01/20

   

177,602

   
 

75

   

JM Smucker Co. (The)

   

2.50

   

03/15/20

   

75,829

   
 

150

   

Kroger Co. (The)

   

2.30

   

01/15/19

   

150,660

   
 

50

   

Mead Johnson Nutrition Co.

   

3.00

   

11/15/20

   

51,313

   
 

175

   

Medtronic, Inc.

   

2.50

   

03/15/20

   

177,605

   
 

150

   

Molson Coors Brewing Co.

   

1.45

   

07/15/19

   

148,246

   
 

175

   

Reynolds American, Inc.

   

2.30

   

06/12/18

   

175,802

   
 

300

   

Synchrony Financial

   

3.00

   

08/15/19

   

304,378

   
 

75

    Teva Pharmaceutical Finance Netherlands III BV
(Israel)
   

1.40

   

07/20/18

   

74,843

   
 

250

   

Tyson Foods, Inc.

   

2.65

   

08/15/19

   

253,277

   
 

150

   

UnitedHealth Group, Inc.

   

2.70

   

07/15/20

   

153,223

   
         

4,212,766

   
   

Diversified (0.7%)

 
 

200

    Hutchison Whampoa International 14 Ltd.
(Hong Kong) (a)
   

1.625

   

10/31/17

   

199,642

   
   

Energy (2.3%)

 
 

100

   

BP Capital Markets PLC (United Kingdom)

   

2.315

   

02/13/20

   

100,956

   
 

175

   

Energy Transfer LP

   

2.50

   

06/15/18

   

175,899

   
 

125

   

Enterprise Products Operating LLC

   

2.55

   

10/15/19

   

126,146

   
 

200

   

Kinder Morgan, Inc.

   

3.05

   

12/01/19

   

203,589

   
         

606,590

   
   

Finance (30.0%)

 
 

230

   

ABN Amro Bank N.V. (Netherlands) (a)

   

2.50

   

10/30/18

   

231,927

   
 

150

   

Air Lease Corp.

   

2.125

   

01/15/20

   

149,374

   
 

225

   

American Express Credit Corp., Series G

   

2.25

   

08/15/19

   

227,008

   
 

280

   

Bank of America Corp., MTN

   

2.625

   

10/19/20

   

283,045

   
 

150

   

Bank of New York Mellon Corp. (The), MTN

   

2.45

   

11/27/20

   

151,535

   
 

210

   

BNP Paribas SA, MTN (France)

   

2.70

   

08/20/18

   

212,418

   
 

260

   

BNZ International Funding Ltd. (New Zealand) (a)

   

2.35

   

03/04/19

   

261,270

   

See Notes to Financial Statements
16



Morgan Stanley Variable Investment Series - Limited Duration

Portfolio of Investments n June 30, 2017 (unaudited) continued

PRINCIPAL
AMOUNT
(000)
 

  COUPON
RATE
  MATURITY
DATE
 

VALUE

 

$

275

   

BPCE SA, MTN (France)

   

2.25

%

 

01/27/20

 

$

275,458

   
 

175

   

Capital One Financial Corp.

   

2.45

   

04/24/19

   

176,010

   
 

150

   

Citigroup, Inc.

   

2.45

   

01/10/20

   

150,990

   
 

250

   

Compass Bank

   

1.85

   

09/29/17

   

250,070

   
 

250

   

Credit Agricole SA (France) (a)

   

2.125

   

04/17/18

   

250,736

   
 

250

   

Credit Suisse AG, Series G (Switzerland)

   

2.30

   

05/28/19

   

251,714

   
 

200

   

Danske Bank A/S (Denmark) (a)

   

1.65

   

09/06/19

   

198,200

   
 

225

   

DBS Group Holdings Ltd. (Singapore) (a)

   

2.246

   

07/16/19

   

225,689

   
 

250

   

Discover Bank

   

2.00

   

02/21/18

   

250,346

   
 

175

   

ERP Operating LP

   

2.375

   

07/01/19

   

176,110

   
 

175

   

Goldman Sachs Group, Inc. (The)

   

2.35

   

11/15/21

   

172,823

   
 

220

   

HSBC USA, Inc.

   

2.25

   

06/23/19

   

221,126

   
 

200

   

Intesa Sanpaolo SpA (Italy)

   

3.875

   

01/16/18

   

201,876

   
 

100

   

Jackson National Life Global Funding (a)

   

1.875

   

10/15/18

   

100,198

   
 

100

   

Jackson National Life Global Funding (a)

   

2.20

   

01/30/20

   

100,066

   
 

50

   

JPMorgan Chase & Co., MTN

   

2.295

   

08/15/21

   

49,738

   
 

200

   

LeasePlan Corp. N.V. (Netherlands) (a)

   

2.875

   

01/22/19

   

200,709

   
 

200

   

Lloyds Banking Group PLC (United Kingdom)

   

3.10

   

07/06/21

   

203,343

   
 

201

   

Macquarie Bank Ltd. (Australia) (a)

   

2.60

   

06/24/19

   

202,758

   
 

175

   

Metropolitan Life Global Funding I (See Note 8) (a)

   

2.00

   

04/14/20

   

174,592

   
 

150

   

Metropolitan Life Global Funding I (See Note 8) (a)

   

2.05

   

06/12/20

   

149,913

   
 

230

   

Mizuho Bank Ltd. (Japan) (a)

   

1.85

   

03/21/18

   

230,332

   
 

250

   

National Bank of Canada (Canada)

   

2.15

   

06/12/20

   

249,587

   
 

125

   

New York Life Global Funding (a)

   

1.55

   

11/02/18

   

124,808

   
 

250

   

Principal Life Global Funding II (a)

   

2.15

   

01/10/20

   

250,375

   
 

150

   

Protective Life Global Funding (a)

   

1.722

   

04/15/19

   

149,006

   
 

150

   

Protective Life Global Funding (a)

   

2.70

   

11/25/20

   

151,188

   
 

200

   

QBE Insurance Group Ltd. (Australia) (a)

   

2.40

   

05/01/18

   

200,217

   
 

200

   

Santander Holdings USA, Inc.

   

2.70

   

05/24/19

   

201,565

   
 

250

   

Skandinaviska Enskilda Banken AB (Sweden)

   

2.30

   

03/11/20

   

251,024

   
 

260

   

Sumitomo Mitsui Banking Corp. (Japan)

   

2.45

   

01/10/19

   

262,302

   
 

300

   

UBS AG, MTN (Switzerland)

   

2.375

   

08/14/19

   

302,824

   
 

200

    WEA Finance LLC/Westfield UK & Europe
Finance PLC (a)
   

2.70

   

09/17/19

   

201,756

   
         

8,074,026

   
   

Industrials (3.2%)

 
 

50

   

Harris Corp.

   

2.70

   

04/27/20

   

50,551

   
 

115

   

Ingersoll-Rand Global Holding Co., Ltd.

   

2.875

   

01/15/19

   

116,720

   
 

75

   

Lockheed Martin Corp.

   

2.50

   

11/23/20

   

76,089

   
 

150

   

Rockwell Collins, Inc.

   

1.95

   

07/15/19

   

150,295

   
 

50

   

Ryder System, Inc., MTN

   

2.65

   

03/02/20

   

50,386

   

See Notes to Financial Statements
17



Morgan Stanley Variable Investment Series - Limited Duration

Portfolio of Investments n June 30, 2017 (unaudited) continued

PRINCIPAL
AMOUNT
(000)
 

  COUPON
RATE
  MATURITY
DATE
 

VALUE

 

$

250

    Siemens Financieringsmaatschappij N.V.
(Germany) (a)
   

2.15   

%

 

05/27/20

 

$

251,396

   
 

175

   

Union Pacific Corp.

   

2.25

   

06/19/20

   

176,164

   
         

871,601

   
   

Technology (1.6%)

     
 

125

   

Lam Research Corp.

   

2.80

   

06/15/21

   

126,915

   
 

300

   

TSMC Global Ltd. (Taiwan) (a)

   

1.625

   

04/03/18

   

299,450

   
         

426,365

   
   

Utilities (5.5%)

     
 

275

   

Dominion Energy Gas Holdings LLC

   

2.50

   

12/15/19

   

276,996

   
 

75

   

DTE Energy Co.

   

1.50

   

10/01/19

   

73,918

   
 

100

   

Duke Energy Corp.

   

1.80

   

09/01/21

   

97,715

   
 

225

   

Engie SA (France) (a)

   

1.625

   

10/10/17

   

224,832

   
 

175

   

Eversource Energy

   

1.45

   

05/01/18

   

174,783

   
 

200

   

Origin Energy Finance Ltd. (Australia) (a)

   

3.50

   

10/09/18

   

202,364

   
 

175

   

Sempra Energy

   

2.40

   

03/15/20

   

175,896

   
 

250

   

Southern Co. (The)

   

2.15

   

09/01/19

   

250,238

   
         

1,476,742

   
        Total Corporate Bonds
(Cost $19,644,112)
           

19,771,602

   
   

Asset-Backed Securities (16.2%)

     
 

100

   

AMSR Trust (a)

   

2.609

(b)

 

11/17/33

   

100,734

   
 

98

   

Bayview Opportunity Master Fund IVb Trust (a)

   

3.50

(b)

 

01/28/55

   

100,470

   
 

40

   

CAM Mortgage Trust (a)

   

4.00

   

01/15/56

   

40,578

   
 

100

   

CLUB Credit Trust (a)

   

2.39

   

04/17/23

   

100,106

   
   

Colony American Homes

     
 

120

   

(a)

   

2.359

(b)

 

05/17/31

   

120,615

   
 

100

   

(a)

   

4.009

(b)

 

05/17/31

   

100,950

   
 

82

   

(a)

   

4.42

(b)

 

07/17/31

   

82,230

   
 

73

   

Conn Funding II LP (a)

   

2.73

   

05/15/20

   

73,146

   
 

381

   

Ford Credit Auto Owner Trust (a)

   

2.26

   

11/15/25

   

384,640

   
 

99

   

GCAT LLC (a)

   

3.228

   

05/25/22

   

99,166

   
 

135

   

Golden Credit Card Trust (Canada) (a)

   

1.98

   

04/15/22

   

135,024

   
 

125

   

Green Tree Agency Advance Funding Trust I (a)

   

2.38

   

10/15/48

   

124,639

   
 

206

   

Invitation Homes Trust (a)

   

3.74

(b)

 

08/17/32

   

207,810

   
 

100

   

Mariner Finance Issuance Trust (a)

   

3.62

   

02/20/29

   

100,900

   
 

86

   

Marlette Funding Trust (a)

   

2.827

   

03/15/24

   

86,098

   
   

Nationstar HECM Loan Trust

     
 

40

   

(a)

   

2.239

(b)

 

06/25/26

   

40,139

   

See Notes to Financial Statements
18



Morgan Stanley Variable Investment Series - Limited Duration

Portfolio of Investments n June 30, 2017 (unaudited) continued

PRINCIPAL
AMOUNT
(000)
 

  COUPON
RATE
  MATURITY
DATE
 

VALUE

 

$

23

   

(a)

   

2.883  

%

 

11/25/25

 

$

23,311

   
 

100

   

(a)

   

2.942

   

05/25/27

   

100,034

   
 

37

   

(a)

   

2.981

(b)

 

02/25/26

   

37,349

   
 

50

   

Nissan Auto Lease Trust

   

1.91

   

04/15/20

   

49,953

   
 

139

   

North Carolina State Education Assistance Authority

   

1.956

(b)

 

07/25/25

   

139,426

   
 

103

   

NRZ Excess Spread-Collateralized Notes (a)

   

5.683

   

07/25/21

   

103,301

   
 

100

   

Ocwen Master Advance Receivables Trust (a)

   

2.722

   

08/16/49

   

99,773

   
 

36

   

Panhandle-Plains Higher Education Authority, Inc.

   

2.098

(b)

 

07/01/24

   

36,153

   
 

50

   

PennyMac LLC (a)

   

4.00

   

03/25/55

   

50,221

   
 

89

   

PRPM LLC (a)

   

4.00

   

09/27/21

   

88,718

   
 

57

   

RMAT LLC (a)

   

4.826

   

06/25/35

   

57,222

   
 

103

   

Skopos Auto Receivables Trust (a)

   

5.43

   

12/15/23

   

104,072

   
 

100

   

SPS Servicer Advance Receivables Trust (a)

   

2.53

   

11/16/48

   

99,128

   
 

100

   

Sunset Mortgage Loan Co., LLC (a)

   

3.50

   

06/16/47

   

100,203

   
 

98

   

Towd Point Mortgage Trust (a)

   

2.75

(b)

 

04/25/57

   

99,461

   
   

Verizon Owner Trust

     
 

110

   

(a)

   

1.68

   

05/20/21

   

109,746

   
 

105

   

(a)

   

2.06

   

09/20/21

   

105,433

   
 

97

   

VOLT LIX LLC (a)

   

3.25

   

05/25/47

   

97,584

   
 

94

   

VOLT LV LLC (a)

   

3.50

   

03/25/47

   

93,982

   
 

92

   

VOLT LVI LLC (a)

   

3.50

   

03/25/47

   

92,231

   
 

100

   

VOLT LX LLC (a)

   

3.25

   

04/25/59

   

100,161

   
 

100

   

VOLT LXI LLC (a)

   

3.125

   

06/25/47

   

100,000

   
   

VOLT NPL X LLC

     
 

95

   

(a)

   

3.375

   

10/26/54

   

95,838

   
 

88

   

(a)

   

4.75

   

10/26/54

   

88,822

   
 

100

   

VOLT XIX LLC (a)

   

5.00

   

04/25/55

   

100,601

   
 

100

   

VOLT XXII LLC (a)

   

4.25

   

02/25/55

   

99,967

   
 

198

   

VOLT XXXIII LLC (a)

   

4.25

   

03/25/55

   

198,367

   
        Total Asset-Backed Securities
(Cost $4,339,210)
           

4,368,302

   
   

Mortgages - Other (4.3%)

     
 

61

   

CHL Mortgage Pass-Through Trust

   

5.50

   

05/25/34

   

61,943

   
   

Fannie Mae Connecticut Avenue Securities

     
 

131

         

2.516

(b)

 

04/25/29 - 07/25/29

   

133,078

   
 

56

         

3.416

(b)

 

10/25/28

   

57,027

   
    Freddie Mac Structured Agency Credit Risk
Debt Notes
     
 

93

         

2.116

(b)

 

10/25/27

   

93,545

   
 

90

         

2.466

(b)

 

10/25/28

   

90,439

   
 

126

         

2.966

(b)

 

09/25/28

   

126,851

   

See Notes to Financial Statements
19



Morgan Stanley Variable Investment Series - Limited Duration

Portfolio of Investments n June 30, 2017 (unaudited) continued

PRINCIPAL
AMOUNT
(000)
 

  COUPON
RATE
  MATURITY
DATE
 

VALUE

 

$

62

   

JP Morgan Mortgage Trust

   

3.757

(b)%

 

07/25/35

 

$

61,716

   
 

119

   

Merrill Lynch Mortgage Investors Trust

   

3.076

(b)

 

12/25/34

   

119,926

   
 

279

   

New Residential Mortgage Loan Trust (a)

   

3.75

(b)

 

11/26/35 - 08/25/55

   

288,055

   
 

127

   

Sequoia Mortgage Trust

   

1.832

(b)

 

08/20/34

   

121,061

   
        Total Mortgages - Other
(Cost $1,149,672)
           

1,153,641

   
   

Commercial Mortgage-Backed Securities (2.4%)

     
 

148

   

BLCP Hotel Trust (a)

   

2.109

(b)

 

08/15/29

   

148,059

   
 

109

   

CDGJ Commercial Mortgage Trust (a)

   

2.559

(b)

 

12/15/27

   

109,223

   
 

86

   

Citigroup Commercial Mortgage Trust (a)

   

2.11

   

01/12/30

   

86,603

   
 

94

   

Cosmopolitan Hotel Trust (a)

   

2.559

(b)

 

11/15/33

   

94,810

   
 

100

   

Hudsons Bay Simon JV Trust (a)

   

2.656

(b)

 

08/05/34

   

100,287

   
 

34

    JP Morgan Chase Commercial Mortgage
Securities Trust (a)
   

2.139

(b)

 

07/15/31

   

34,281

   
 

89

   

Velocity Commercial Capital Loan Trust

   

3.016

(b)

 

10/25/46

   

89,973

   
        Total Commercial Mortgage-Backed Securities
(Cost $662,662)
           

663,236

   
   

Sovereign (0.9%)

     
 

245

    Korea Development Bank (The) (Korea, Republic of)
(Cost $242,428)
   

1.50

   

01/22/18

   

244,578

   
   

Collateralized Mortgage Obligations - Agency Collateral Series (0.9%)

     
 

106

   

Federal Home Loan Mortgage Corporation, REMIC

   

7.50

   

09/15/29

   

122,713

   
   

Government National Mortgage Association,

     
       

IO

                     
 

206

             

5.018

(b)

 

03/20/43

   

35,178

   
 

260

             

5.288

(b)

 

05/20/40

   

49,733

   
       

IO PAC

                     
 

333

             

4.938

(b)

 

10/20/41

   

31,997

   
        Total Collateralized Mortgage Obligations - Agency Collateral Series
(Cost $178,954)
           

239,621

   
   

Agency Fixed Rate Mortgages (0.3%)

     
    Federal National Mortgage Association,
Conventional Pools:
     
 

52

             

6.50

   

01/01/32

   

57,630

   
 

23

             

7.00

   

12/01/31 - 06/01/32

   

23,384

   
        Total Agency Fixed Rate Mortgages
(Cost $78,318)
           

81,014

   

See Notes to Financial Statements
20



Morgan Stanley Variable Investment Series - Limited Duration

Portfolio of Investments n June 30, 2017 (unaudited) continued

PRINCIPAL
AMOUNT
(000)
 

  COUPON
RATE
  MATURITY
DATE
 

VALUE

 
   

Short-Term Investments (1.1%)

 
   

U.S. Treasury Security (0.2%)

 

$

51

    U.S. Treasury Bill (c)(d)
(Cost $50,507)
   

1.191

%

 

04/26/18

 

$

50,513

   
NUMBER OF
SHARES (000)
 
 
 
 
 
   

Investment Company (0.9%)

 
    230Morgan Stanley Institutional Liquidity Funds - Government
Portfolio - Institutional Class (See Note 8)
(Cost $229,828)
   

229,828

   
    Total Short-Term Investments
(Cost $280,335)
           

280,341

   
    Total Investments
(Cost $26,575,691) (e)(f)
       

99.6

%

   

26,802,335

   
   

Other Assets in Excess of Liabilities

       

0.4

     

99,753

   
   

Net Assets

       

100.0

%

 

$

26,902,088

   

  IO  Interest Only.

  MTN  Medium Term Note.

  PAC  Planned Amortization Class.

  REMIC  Real Estate Mortgage Investment Conduit.

  (a)  144A security - Certain conditions for public sale may exist. Unless otherwise noted, these securities are deemed to be liquid.

  (b)  Variable/Floating Rate Security - Interest rate changes on these instruments are based on changes in a designated base rate. The rates shown are those in effect on June 30, 2017.

  (c)  Rate shown is the yield to maturity at June 30, 2017.

  (d)  All or a portion of the security was pledged to cover margin requirements for futures contracts.

  (e)  Securities are available for collateral in connection with open futures contracts.

  (f)  At June 30, 2017, the aggregate cost for federal income tax purposes approximates the aggregate cost for book purposes. The aggregate gross unrealized appreciation is $285,084 and the aggregate gross unrealized depreciation is $58,440, resulting in net unrealized appreciation of $226,644.

See Notes to Financial Statements
21



Morgan Stanley Variable Investment Series - Limited Duration

Portfolio of Investments n June 30, 2017 (unaudited) continued

FUTURES CONTRACTS OPEN AT JUNE 30, 2017:

NUMBER OF
CONTRACTS
 

LONG/SHORT

  DESCRIPTION, DELIVERY
MONTH AND YEAR
  UNDERLYING FACE
AMOUNT AT VALUE
  UNREALIZED
DEPRECIATION
 
 

44

   

Long

  U.S. Treasury 5 yr. Note,
Sep-17
 

$

5,184,781

   

$

(11,500

)

 
 

5

   

Long

  U.S. Treasury 2 yr. Note,
Sep-17
   

1,080,547

     

(625

)

 

Total Unrealized Depreciation

 

$

(12,125

)

 

LONG TERM CREDIT ANALYSIS+

AAA

   

12.1

%

 

AA

   

9.5

   

A

   

39.7

   

BBB

   

29.8

   

BB

   

0.0

   

B or Below

   

0.0

   

Not Rated

   

8.9

   
     

100.0

%++

 

+  The ratings shown are based on the Fund's security ratings as determined by Standard & Poor's, Moody's or Fitch, each a Nationally Recognized Statistical Ratings Organization ("NRSRO").

++  Does not include open long futures contracts with an underlying face amount of $6,265,328 with total unrealized depreciation of $12,125.

See Notes to Financial Statements
22



Morgan Stanley Variable Investment Series - Income Plus

Portfolio of Investments n June 30, 2017 (unaudited)

PRINCIPAL
AMOUNT
(000)
 

  COUPON
RATE
  MATURITY
DATE
 

VALUE

 
   

Corporate Bonds (96.4%)

 
   

Basic Materials (4.0%)

 

$

350

   

Air Liquide Finance SA (France) (a)

   

2.25  

%

 

09/27/23

 

$

340,804

   
 

225

   

BHP Billiton Finance USA Ltd. (Australia)

   

5.00

   

09/30/43

   

260,970

   
 

450

   

EI du Pont de Nemours & Co.

   

2.20

   

05/01/20

   

452,627

   
 

390

   

Eldorado Gold Corp. (Canada) (a)

   

6.125

   

12/15/20

   

401,213

   
 

175

   

Goldcorp, Inc. (Canada)

   

5.45

   

06/09/44

   

195,410

   
 

450

   

International Paper Co.

   

3.00

   

02/15/27

   

433,975

   
 

300

   

LyondellBasell Industries N.V.

   

4.625

   

02/26/55

   

295,162

   
 

470

   

NOVA Chemicals Corp. (Canada) (a)

   

5.25

   

08/01/23

   

484,687

   
 

575

   

Sherwin-Williams Co. (The)

   

2.75

   

06/01/22

   

575,312

   
 

315

   

Southern Copper Corp. (Mexico)

   

7.50

   

07/27/35

   

390,958

   
 

220

   

Vale Overseas Ltd. (Brazil)

   

6.875

   

11/21/36

   

237,050

   
         

4,068,168

   
   

Communications (11.8%)

 
 

325

   

21st Century Fox America, Inc.

   

4.75

   

09/15/44

   

343,450

   
 

700

   

Alibaba Group Holding Ltd. (China)

   

2.50

   

11/28/19

   

705,832

   
 

226

   

Altaba, Inc.

   

0.00

(b)

 

12/01/18

   

257,499

   
 

175

   

Amazon.com, Inc.

   

4.95

   

12/05/44

   

207,052

   
 

1,101

   

AT&T, Inc.

   

4.50

   

03/09/48

   

1,034,326

   
 

525

   

Baidu, Inc. (China)

   

2.75

   

06/09/19

   

531,481

   
 

220

   

Baidu, Inc. (China) (c)

   

2.875

   

07/06/22

   

218,940

   
 

200

   

Baidu, Inc. (China)

   

3.25

   

08/06/18

   

202,545

   
 

150

   

CBS Corp.

   

4.90

   

08/15/44

   

158,128

   
 

275

    Charter Communications Operating LLC/
Charter Communications Operating Capital
   

4.908

   

07/23/25

   

297,571

   
 

275

    Charter Communications Operating LLC/
Charter Communications Operating Capital
   

6.484

   

10/23/45

   

331,222

   
 

725

   

Cisco Systems, Inc.

   

1.85

   

09/20/21

   

716,495

   
 

270

   

Comcast Corp.

   

6.40

   

05/15/38

   

359,764

   
 

300

   

Ctrip.com International Ltd. (China) (a)

   

1.25

   

09/15/22

   

324,938

   
 

150

    Deutsche Telekom International Finance BV
(Germany) (a)
   

3.60

   

01/19/27

   

152,914

   
 

200

   

DISH DBS Corp.

   

5.875

   

11/15/24

   

214,144

   
 

425

   

NBC Universal Media LLC

   

5.95

   

04/01/41

   

545,323

   
 

175

   

Netflix, Inc. (a)

   

4.375

   

11/15/26

   

175,000

   
 

900

   

Ooredoo International Finance Ltd. (Qatar) (a)

   

3.25

   

02/21/23

   

889,042

   
 

300

   

Priceline Group, Inc. (The)

   

0.90

   

09/15/21

   

344,250

   
 

250

   

Shutterfly, Inc.

   

0.25

   

05/15/18

   

250,469

   
 

200

   

Sprint Corp.

   

7.125

   

06/15/24

   

223,000

   
 

175

   

Telefonica Emisiones SAU (Spain)

   

4.103

   

03/08/27

   

181,161

   

See Notes to Financial Statements
23



Morgan Stanley Variable Investment Series - Income Plus

Portfolio of Investments n June 30, 2017 (unaudited) continued

PRINCIPAL
AMOUNT
(000)
 

  COUPON
RATE
  MATURITY
DATE
 

VALUE

 

$

330

   

Telefonica Europe BV (Spain)

   

8.25  

%

 

09/15/30

 

$

463,971

   
 

200

   

Telenor East Holding II AS, Series VIP (Norway)

   

0.25

   

09/20/19

   

220,580

   
 

800

   

Time Warner, Inc.

   

3.80

   

02/15/27

   

806,985

   
 

990

   

Verizon Communications, Inc.

   

4.672

   

03/15/55

   

930,784

   
 

100

   

Verizon Communications, Inc.

   

5.012

   

08/21/54

   

99,152

   
 

200

   

Viacom, Inc.

   

5.85

   

09/01/43

   

216,721

   
 

250

   

Viavi Solutions, Inc.

   

0.625

   

08/15/33

   

277,344

   
 

200

   

Vodafone Group PLC (United Kingdom)

   

4.375

   

02/19/43

   

198,255

   
         

11,878,338

   
   

Consumer Discretionary (0.8%)

 
 

825

    Sprint Spectrum Co., LLC/Sprint Spectrum Co.,
II LLC/Sprint Spectrum Co., III LLC (a)
   

3.36

   

03/20/23

   

834,281

   
   

Consumer, Cyclical (7.2%)

 
 

351

   

American Airlines Pass-Through Trust

   

4.00

   

07/15/25

   

367,558

   
 

575

   

BMW US Capital LLC (Germany) (a)

   

2.70

   

04/06/22

   

580,940

   
 

562

    British Airways Pass-Through Trust
(United Kingdom) (a)
   

4.625

   

06/20/24

   

606,134

   
 

150

   

Darden Restaurants, Inc.

   

3.85

   

05/01/27

   

152,710

   
 

100

   

Darden Restaurants, Inc.

   

6.80

   

10/15/37

   

128,123

   
 

475

   

Delta Air Lines, Inc.

   

3.625

   

03/15/22

   

488,144

   
 

325

   

Dollar General Corp.

   

3.25

   

04/15/23

   

331,444

   
 

175

   

Ford Motor Co.

   

4.75

   

01/15/43

   

169,536

   
 

300

   

Ford Motor Credit Co., LLC

   

3.096

   

05/04/23

   

296,795

   
 

300

   

General Motors Co.

   

6.60

   

04/01/36

   

348,555

   
 

168

   

Hanesbrands, Inc. (a)

   

4.875

   

05/15/26

   

171,360

   
 

200

   

Home Depot, Inc.

   

3.35

   

09/15/25

   

207,896

   
 

175

   

Home Depot, Inc.

   

5.875

   

12/16/36

   

228,396

   
 

400

   

Lowe's Cos., Inc.

   

2.50

   

04/15/26

   

384,939

   
 

375

   

Macy's Retail Holdings, Inc.

   

2.875

   

02/15/23

   

344,259

   
 

300

   

McDonald's Corp., MTN

   

4.60

   

05/26/45

   

324,741

   
 

475

   

RH (a)

   

0.00

(b)

 

06/15/19

   

434,625

   
 

125

   

Tesla, Inc.

   

0.25

   

03/01/19

   

143,125

   
 

275

   

Under Armour, Inc.

   

3.25

   

06/15/26

   

258,168

   
 

241

   

United Airlines Pass-Through Trust, Class A

   

4.30

   

08/15/25

   

256,922

   
 

375

    Volkswagen Group of America Finance LLC
(Germany) (a)
   

2.40

   

05/22/20

   

376,543

   
 

125

   

Wal-Mart Stores, Inc.

   

5.25

   

09/01/35

   

152,740

   
 

200

   

Walgreens Boots Alliance, Inc.

   

3.45

   

06/01/26

   

199,957

   
 

350

   

ZF North America Capital, Inc. (Germany) (a)

   

4.50

   

04/29/22

   

368,812

   
         

7,322,422

   

See Notes to Financial Statements
24



Morgan Stanley Variable Investment Series - Income Plus

Portfolio of Investments n June 30, 2017 (unaudited) continued

PRINCIPAL
AMOUNT
(000)
 

  COUPON
RATE
  MATURITY
DATE
 

VALUE

 
   

Consumer, Non-Cyclical (12.9%)

 

$

450

   

Abbott Laboratories

   

3.40  

%

 

11/30/23

 

$

461,301

   
 

175

   

Abbott Laboratories

   

4.90

   

11/30/46

   

193,526

   
 

200

   

AbbVie, Inc.

   

3.20

   

05/14/26

   

198,016

   
 

175

   

AbbVie, Inc.

   

4.70

   

05/14/45

   

186,694

   
 

51

   

Allergan Funding SCS

   

4.75

   

03/15/45

   

55,269

   
 

140

   

Altria Group, Inc.

   

5.375

   

01/31/44

   

169,147

   
 

275

   

Amgen, Inc.

   

2.60

   

08/19/26

   

260,775

   
 

272

   

Amgen, Inc.

   

4.663

   

06/15/51

   

289,341

   
 

400

   

Anheuser-Busch InBev Finance, Inc. (Belgium)

   

3.65

   

02/01/26

   

412,846

   
 

525

   

Anheuser-Busch InBev Finance, Inc. (Belgium)

   

3.70

   

02/01/24

   

550,092

   
 

600

   

Anheuser-Busch InBev Finance, Inc. (Belgium)

   

4.90

   

02/01/46

   

679,894

   
 

325

   

AstraZeneca PLC (United Kingdom)

   

6.45

   

09/15/37

   

438,501

   
 

150

   

Automatic Data Processing, Inc.

   

3.375

   

09/15/25

   

156,052

   
 

125

   

Baxalta, Inc.

   

5.25

   

06/23/45

   

147,049

   
 

225

   

Becton Dickinson and Co.

   

2.894

   

06/06/22

   

225,956

   
 

175

   

Becton Dickinson and Co.

   

4.685

   

12/15/44

   

180,922

   
 

260

    BRF SA (Brazil) (a)    

3.95

   

05/22/23

   

251,953

   
 

250

   

Cencosud SA (Chile) (a)

   

6.625

   

02/12/45

   

273,489

   
 

312

   

EMD Finance LLC (Germany) (a)

   

3.25

   

03/19/25

   

313,614

   
 

275

   

Express Scripts Holding Co.

   

4.50

   

02/25/26

   

291,958

   
 

150

   

Express Scripts Holding Co.

   

4.80

   

07/15/46

   

153,171

   
 

225

   

Gilead Sciences, Inc.

   

4.80

   

04/01/44

   

245,748

   
 

275

   

Grupo Bimbo SAB de CV (Mexico) (a)

   

3.875

   

06/27/24

   

283,848

   
 

250

   

Humana, Inc.

   

3.95

   

03/15/27

   

261,052

   
 

316

   

Illumina, Inc.

   

0.00

(b)

 

06/15/19

   

320,740

   
 

300

   

Kraft Heinz Foods Co.

   

4.375

   

06/01/46

   

294,992

   
 

300

   

Mead Johnson Nutrition Co.

   

3.00

   

11/15/20

   

307,877

   
 

375

   

Medtronic, Inc.

   

4.625

   

03/15/45

   

423,070

   
 

325

   

Novartis Capital Corp. (Switzerland)

   

4.40

   

05/06/44

   

361,467

   
 

350

   

PepsiCo, Inc.

   

3.60

   

03/01/24

   

370,581

   
 

350

   

Pfizer, Inc.

   

3.00

   

12/15/26

   

351,407

   
 

200

   

Philip Morris International, Inc.

   

4.50

   

03/20/42

   

213,232

   
 

400

    Reckitt Benckiser Treasury Services PLC
(United Kingdom) (a)
   

2.375

   

06/24/22

   

397,666

   
 

575

    Teva Pharmaceutical Finance Netherlands III BV
(Israel)
   

3.15

   

10/01/26

   

547,145

   
 

325

   

Thermo Fisher Scientific, Inc.

   

2.95

   

09/19/26

   

316,657

   
 

175

   

Transurban Finance Co., Pty Ltd. (Australia) (a)

   

3.375

   

03/22/27

   

171,265

   
 

300

   

Transurban Finance Co., Pty Ltd. (Australia) (a)

   

4.125

   

02/02/26

   

311,910

   
 

200

   

Tyson Foods, Inc.

   

4.875

   

08/15/34

   

219,454

   

See Notes to Financial Statements
25



Morgan Stanley Variable Investment Series - Income Plus

Portfolio of Investments n June 30, 2017 (unaudited) continued

PRINCIPAL
AMOUNT
(000)
 

  COUPON
RATE
  MATURITY
DATE
 

VALUE

 

$

250

   

UnitedHealth Group, Inc.

   

2.875

%

 

03/15/23

 

$

254,038

   
 

525

   

UnitedHealth Group, Inc.

   

3.75

   

07/15/25

   

553,533

   
 

930

   

WM Wrigley Jr. Co. (a)

   

2.90

   

10/21/19

   

946,027

   
         

13,041,275

   
   

Diversified (0.2%)

     
 

200

   

Alfa SAB de CV (Mexico) (a)

   

5.25

   

03/25/24

   

215,500

   
   

Energy (8.1%)

     
 

250

   

Anadarko Petroleum Corp.

   

6.45

   

09/15/36

   

295,130

   
 

400

   

APT Pipelines Ltd. (Australia) (a)

   

4.20

   

03/23/25

   

413,587

   
 

200

   

BG Energy Capital PLC (United Kingdom) (a)

   

5.125

   

10/15/41

   

223,930

   
 

500

   

BP Capital Markets PLC (United Kingdom)

   

3.119

   

05/04/26

   

496,134

   
 

675

   

Buckeye Partners LP

   

4.15

   

07/01/23

   

694,096

   
 

525

   

Cimarex Energy Co.

   

3.90

   

05/15/27

   

528,925

   
 

450

   

ConocoPhillips Co.

   

4.95

   

03/15/26

   

502,048

   
 

151

   

DCP Midstream Operating LP (a)

   

5.35

   

03/15/20

   

157,795

   
 

425

   

Enable Midstream Partners LP

   

3.90

   

05/15/24

   

422,094

   
 

250

    Endeavor Energy Resources LP/
EER Finance, Inc. (a)
   

7.00

   

08/15/21

   

259,688

   
 

175

   

Enterprise Products Operating LLC

   

5.95

   

02/01/41

   

208,018

   
 

250

   

Exxon Mobil Corp.

   

4.114

   

03/01/46

   

264,396

   
 

100

   

Kinder Morgan Energy Partners LP

   

3.95

   

09/01/22

   

103,434

   
 

250

   

Kinder Morgan, Inc.

   

5.55

   

06/01/45

   

265,887

   
 

300

   

Kinder Morgan, Inc. (a)

   

5.625

   

11/15/23

   

332,367

   
 

325

    MPLX LP    

4.00

   

02/15/25

   

327,730

   
 

25

    MPLX LP    

4.875

   

06/01/25

   

26,552

   
 

150

    MPLX LP    

5.20

   

03/01/47

   

155,068

   
 

100

   

Noble Energy, Inc.

   

5.05

   

11/15/44

   

103,083

   
 

100

   

Phillips 66 Partners LP

   

4.68

   

02/15/45

   

96,150

   
 

325

   

Spectra Energy Capital LLC

   

7.50

   

09/15/38

   

428,054

   
 

450

   

Tesoro Corp. (a)

   

4.75

   

12/15/23

   

487,125

   
 

275

   

TransCanada PipeLines Ltd. (Canada)

   

7.625

   

01/15/39

   

402,380

   
 

475

   

Williams Partners LP/ACMP Finance Corp.

   

4.875

   

05/15/23

   

494,057

   
 

450

   

Woodside Finance Ltd. (Australia) (a)

   

3.70

   

09/15/26

   

443,963

   
         

8,131,691

   
   

Finance (33.9%)

     
 

390

   

ABB Treasury Center USA, Inc. (Switzerland) (a)

   

4.00

   

06/15/21

   

414,383

   
 

600

   

ABN Amro Bank N.V. (Netherlands) (a)

   

4.75

   

07/28/25

   

633,745

   
 

150

    AerCap Ireland Capital DAC/AerCap Global
Aviation Trust (Netherlands)
   

3.50

   

05/26/22

   

154,106

   
 

420

    AerCap Ireland Capital DAC/AerCap Global
Aviation Trust (Netherlands)
   

3.75

   

05/15/19

   

431,588

   

See Notes to Financial Statements
26



Morgan Stanley Variable Investment Series - Income Plus

Portfolio of Investments n June 30, 2017 (unaudited) continued

PRINCIPAL
AMOUNT
(000)
 

  COUPON
RATE
  MATURITY
DATE
 

VALUE

 

$

225

   

Air Lease Corp.

   

2.625  

%

 

07/01/22

 

$

223,265

   
 

250

   

Air Lease Corp.

   

3.375

   

06/01/21

   

256,870

   
 

275

   

Alexandria Real Estate Equities, Inc.

   

3.95

   

01/15/27

   

280,627

   
 

350

   

American Express Credit Corp., MTN

   

3.30

   

05/03/27

   

350,148

   
 

125

   

American International Group, Inc.

   

4.50

   

07/16/44

   

127,604

   
 

375

   

American International Group, Inc.

   

4.875

   

06/01/22

   

411,922

   
 

425

   

Bank of America Corp.

   

4.244

(d)

 

04/24/38

   

442,831

   
 

205

   

Bank of America Corp.

   

7.75

   

05/14/38

   

295,701

   
 

325

   

Bank of America Corp., MTN

   

2.151

   

11/09/20

   

323,788

   
 

150

   

Bank of America Corp., MTN

   

5.00

   

01/21/44

   

170,220

   
 

750

   

Bank of America Corp., Series G

   

3.50

   

04/19/26

   

753,969

   
 

800

   

BBVA Bancomer SA (Mexico) (a)

   

6.50

   

03/10/21

   

885,000

   
 

300

   

BNP Paribas SA (France) (a)

   

3.80

   

01/10/24

   

312,877

   
 

400

   

Boston Properties LP

   

3.65

   

02/01/26

   

405,501

   
 

625

    BPCE SA (France) (a)    

5.15

   

07/21/24

   

668,718

   
 

275

   

Brighthouse Financial, Inc. (a)

   

3.70

   

06/22/27

   

272,220

   
 

450

   

Brixmor Operating Partnership LP

   

4.125

   

06/15/26

   

448,218

   
 

400

   

Brookfield Finance, Inc. (Canada)

   

4.25

   

06/02/26

   

411,573

   
 

625

   

Capital One Financial Corp.

   

3.75

   

03/09/27

   

623,986

   
 

850

   

Citigroup, Inc.

   

4.45

   

09/29/27

   

885,105

   
 

350

   

Citigroup, Inc.

   

8.125

   

07/15/39

   

539,043

   
 

250

   

Credit Suisse Group AG (Switzerland) (a)

   

3.574

   

01/09/23

   

256,450

   
 

625

    Credit Suisse Group Funding Guernsey Ltd.
(Switzerland)
   

4.55

   

04/17/26

   

665,140

   
 

150

   

CubeSmart LP

   

3.125

   

09/01/26

   

142,814

   
 

425

   

Discover Bank

   

7.00

   

04/15/20

   

472,028

   
 

715

   

Discover Financial Services

   

3.85

   

11/21/22

   

733,127

   
 

300

   

Discover Financial Services

   

3.95

   

11/06/24

   

305,114

   
 

300

   

Extra Space Storage LP (a)

   

3.125

   

10/01/35

   

321,188

   
 

450

   

Five Corners Funding Trust (a)

   

4.419

   

11/15/23

   

483,921

   
 

250

   

GE Capital International Funding Co.

   

4.418

   

11/15/35

   

272,620

   
 

375

   

Goldman Sachs Group, Inc. (The)

   

6.25

   

02/01/41

   

490,869

   
 

525

   

Goldman Sachs Group, Inc. (The)

   

6.75

   

10/01/37

   

682,717

   
 

300

   

Goldman Sachs Group, Inc. (The), MTN

   

4.80

   

07/08/44

   

333,449

   
 

250

   

Guardian Life Insurance Co. of America (The) (a)

   

4.85

   

01/24/77

   

265,531

   
 

400

   

Healthcare Trust of America Holdings LP

   

3.70

   

04/15/23

   

408,597

   
 

410

   

HSBC Finance Corp.

   

6.676

   

01/15/21

   

462,422

   
 

525

   

HSBC Holdings PLC (United Kingdom)

   

3.90

   

05/25/26

   

542,515

   
 

325

   

HSBC Holdings PLC (United Kingdom)

   

4.041

(d)

 

03/13/28

   

337,032

   
 

250

   

HSBC Holdings PLC (United Kingdom)

   

4.375

   

11/23/26

   

259,904

   
 

400

   

ING Bank N.V. (Netherlands) (a)

   

5.80

   

09/25/23

   

452,273

   

See Notes to Financial Statements
27



Morgan Stanley Variable Investment Series - Income Plus

Portfolio of Investments n June 30, 2017 (unaudited) continued

PRINCIPAL
AMOUNT
(000)
 

  COUPON
RATE
  MATURITY
DATE
 

VALUE

 

$

200

   

ING Groep N.V. (Netherlands)

   

6.00

(d) %

 

04/16/20(e)

 

$

205,000

   
 

300

   

Intesa Sanpaolo SpA (Italy)

   

3.875

   

01/16/18

   

302,814

   
 

250

   

Intesa Sanpaolo SpA (Italy) (a)

   

5.71

   

01/15/26

   

264,405

   
 

750

   

JPMorgan Chase & Co.

   

3.782

(d)

 

02/01/28

   

767,883

   
 

480

   

JPMorgan Chase & Co.

   

4.95

   

06/01/45

   

536,738

   
 

575

   

LeasePlan Corp. N.V. (Netherlands) (a)

   

2.875

   

01/22/19

   

577,040

   
 

275

   

Lincoln National Corp.

   

7.00

   

06/15/40

   

370,516

   
 

475

   

Lloyds Banking Group PLC (United Kingdom)

   

3.10

   

07/06/21

   

482,940

   
 

125

   

Massachusetts Mutual Life Insurance Co. (a)

   

4.50

   

04/15/65

   

126,810

   
 

500

   

MetLife, Inc. (See Note 8)

   

5.70

   

06/15/35

   

617,428

   
 

500

   

New York Life Global Funding (a)

   

2.90

   

01/17/24

   

505,219

   
 

275

   

Northern Trust Corp.

   

3.375

(d)

 

05/08/32

   

275,224

   
 

750

   

PNC Financial Services Group, Inc. (The)

   

3.15

   

05/19/27

   

747,199

   
 

675

   

Prudential Financial, Inc.

   

5.625

(d)

 

06/15/43

   

742,500

   
 

135

   

Prudential Financial, Inc., MTN

   

6.625

   

12/01/37

   

180,666

   
 

575

   

Realty Income Corp.

   

3.25

   

10/15/22

   

584,336

   
 

575

    Royal Bank of Scotland Group PLC
(United Kingdom)
   

3.875

   

09/12/23

   

587,942

   
 

750

    Santander UK Group Holdings PLC
(United Kingdom)
   

3.571

   

01/10/23

   

767,863

   
 

325

   

Santander UK PLC (United Kingdom) (a)

   

5.00

   

11/07/23

   

349,511

   
 

600

   

Skandinaviska Enskilda Banken AB (Sweden) (a)

   

2.625

   

11/17/20

   

607,619

   
 

250

   

Spirit Realty Capital, Inc.

   

3.75

   

05/15/21

   

248,595

   
 

300

   

Standard Chartered PLC (United Kingdom) (a)

   

2.10

   

08/19/19

   

299,051

   
 

700

   

Swedbank AB (Sweden) (a)

   

2.80

   

03/14/22

   

709,990

   
 

475

   

Synchrony Bank

   

3.00

   

06/15/22

   

473,396

   
 

125

   

TD Ameritrade Holding Corp.

   

3.30

   

04/01/27

   

124,998

   
 

350

   

TD Ameritrade Holding Corp.

   

3.625

   

04/01/25

   

362,512

   
 

475

   

Toronto-Dominion Bank (The) (Canada)

   

3.625

(d)

 

09/15/31

   

472,064

   
 

525

   

UBS Group Funding Switzerland AG (Switzerland) (a)

   

3.491

   

05/23/23

   

537,730

   
 

425

   

Visa, Inc.

   

4.30

   

12/14/45

   

467,299

   
 

325

    WEA Finance LLC/Westfield UK &
Europe Finance PLC (a)
   

3.25

   

10/05/20

   

330,988

   
 

1,800

   

Wells Fargo & Co.

   

3.00

   

10/23/26

   

1,754,876

   
 

250

   

Wells Fargo & Co., MTN

   

4.10

   

06/03/26

   

259,157

   
         

34,251,028

   
   

Industrials (3.4%)

 
 

500

   

Brambles USA, Inc. (Australia) (a)

   

4.125

   

10/23/25

   

513,701

   
 

375

   

Burlington Northern Santa Fe LLC

   

4.55

   

09/01/44

   

416,669

   
 

325

   

CSX Corp.

   

2.60

   

11/01/26

   

314,139

   
 

165

   

Embraer Netherlands Finance BV (Brazil)

   

5.40

   

02/01/27

   

172,631

   

See Notes to Financial Statements
28



Morgan Stanley Variable Investment Series - Income Plus

Portfolio of Investments n June 30, 2017 (unaudited) continued

PRINCIPAL
AMOUNT
(000)
 

  COUPON
RATE
  MATURITY
DATE
 

VALUE

 

$

200

   

Harris Corp.

   

4.854

%

 

04/27/35

 

$

219,646

   
 

510

   

Heathrow Funding Ltd. (United Kingdom) (a)

   

4.875

   

07/15/21

   

549,971

   
 

225

   

Johnson Controls International PLC

   

3.90

   

02/14/26

   

236,001

   
 

425

   

Lockheed Martin Corp.

   

3.55

   

01/15/26

   

441,176

   
 

235

   

MasTec, Inc.

   

4.875

   

03/15/23

   

235,588

   
 

300

    Siemens Financieringsmaatschappij N.V.
(Germany) (a)
   

2.35

   

10/15/26

   

283,601

   
         

3,383,123

   
   

Technology (4.7%)

 
 

250

   

Akamai Technologies, Inc.

   

0.00

(b)

 

02/15/19

   

245,158

   
 

1,150

   

Apple, Inc.

   

2.45

   

08/04/26

   

1,100,975

   
 

400

   

Apple, Inc.

   

3.00

   

06/20/27

   

398,501

   
 

325

   

Applied Materials, Inc.

   

3.30

   

04/01/27

   

330,684

   
 

200

   

Dell International LLC/EMC Corp. (a)

   

8.10

   

07/15/36

   

252,042

   
 

950

   

Microsoft Corp.

   

2.875

   

02/06/24

   

966,299

   
 

350

   

Microsoft Corp.

   

4.45

   

11/03/45

   

390,403

   
 

250

   

Nuance Communications, Inc.

   

1.00

   

12/15/35

   

242,188

   
 

225

   

ON Semiconductor Corp.

   

1.00

   

12/01/20

   

234,563

   
 

550

   

QUALCOMM, Inc.

   

2.60

   

01/30/23

   

548,417

   
         

4,709,230

   
   

Utilities (9.4%)

 
 

400

   

Alabama Power Co.

   

3.75

   

03/01/45

   

396,213

   
 

475

   

Appalachian Power Co.

   

3.40

   

06/01/25

   

488,646

   
 

425

   

Baltimore Gas & Electric Co.

   

2.40

   

08/15/26

   

402,741

   
 

175

   

Black Hills Corp.

   

3.15

   

01/15/27

   

169,552

   
 

250

   

Boston Gas Co. (a)

   

4.487

   

02/15/42

   

267,862

   
 

495

   

CMS Energy Corp.

   

5.05

   

03/15/22

   

545,024

   
 

280

   

CMS Energy Corp.

   

6.25

   

02/01/20

   

308,412

   
 

275

   

Duke Energy Carolinas LLC

   

3.75

   

06/01/45

   

274,244

   
 

275

   

Duke Energy Corp.

   

2.65

   

09/01/26

   

261,701

   
 

550

   

EDP Finance BV (Portugal) (a)

   

3.625

   

07/15/24

   

546,529

   
 

225

   

Enel Finance International N.V. (Italy) (a)

   

6.00

   

10/07/39

   

268,456

   
 

210

   

Enel SpA (Italy) (a)

   

8.75

(d)

 

09/24/73

   

250,425

   
 

300

   

Entergy Arkansas, Inc.

   

3.50

   

04/01/26

   

310,059

   
 

150

   

Entergy Louisiana LLC

   

3.05

   

06/01/31

   

145,080

   
 

700

   

Exelon Generation Co., LLC

   

4.00

   

10/01/20

   

730,865

   
 

300

   

Fortis, Inc., Series WI (Canada)

   

2.10

   

10/04/21

   

294,129

   
 

200

   

GNL Quintero SA (Chile) (a)

   

4.634

   

07/31/29

   

208,000

   
 

450

   

NextEra Energy Capital Holdings, Inc.

   

3.55

   

05/01/27

   

458,072

   
 

275

   

Oncor Electric Delivery Co., LLC

   

2.95

   

04/01/25

   

275,012

   
 

325

   

Origin Energy Finance Ltd. (Australia) (a)

   

3.50

   

10/09/18

   

328,842

   

See Notes to Financial Statements
29



Morgan Stanley Variable Investment Series - Income Plus

Portfolio of Investments n June 30, 2017 (unaudited) continued

PRINCIPAL
AMOUNT
(000)
 

  COUPON
RATE
  MATURITY
DATE
 

VALUE

 

$

590

   

Puget Energy, Inc.

   

6.50

%

 

12/15/20

 

$

660,035

   
 

250

   

South Carolina Electric & Gas Co.

   

4.50

   

06/01/64

   

251,198

   
 

525

   

Trans-Allegheny Interstate Line Co. (a)

   

3.85

   

06/01/25

   

545,334

   
 

396

   

TransAlta Corp. (Canada)

   

4.50

   

11/15/22

   

401,148

   
 

475

   

Virginia Electric & Power Co., Series B

   

4.20

   

05/15/45

   

500,732

   
 

250

   

Xcel Energy, Inc.

   

3.30

   

06/01/25

   

252,629

   
         

9,540,940

   
    Total Corporate Bonds
(Cost $94,280,519)
   

97,375,996

   
   

Sovereign (0.5%)

 
 

550

    Sinopec Group Overseas Development
2015 Ltd. (China) (a)
(Cost $548,460)
   

2.50

   

04/28/20

   

552,963

   
   

Asset-Backed Security (0.1%)

 
 

98

    CVS Pass-Through Trust (a)
(Cost $97,686)
   

8.353

   

07/10/31

   

126,230

   
   

Short-Term Investments (2.5%)

 
   

U.S. Treasury Security (0.9%)

 
 

889

    U.S. Treasury Bill (f)(g)
(Cost $880,413)
   

1.191

   

04/26/18

   

880,512

   
NUMBER OF
SHARES (000)
 
 
 
 
 
   

Investment Company (1.6%)

 
    1,662Morgan Stanley Institutional Liquidity Funds - Government
Portfolio - Institutional Class (See Note 8)
(Cost $1,661,891)
   

1,661,891

   
    Total Short-Term Investments
(Cost $2,542,304)
   

2,542,403

   
        Total Investments
(Cost $97,468,969) (h)(i)
       

99.5

%

   

100,597,592

   
       

Other Assets in Excess of Liabilities

       

0.5

     

460,743

   
       

Net Assets

       

100.0

%

 

$

101,058,335

   

  MTN  Medium Term Note.

  (a)  144A security - Certain conditions for public sale may exist. Unless otherwise noted, these securities are deemed to be liquid.

  (b)  Capital appreciation bond.

See Notes to Financial Statements
30



Morgan Stanley Variable Investment Series - Income Plus

Portfolio of Investments n June 30, 2017 (unaudited) continued

  (c)  When-issued security.

  (d)  Variable/Floating Rate Security - Interest rate changes on these instruments are based on changes in a designated base rate. The rates shown are those in effect on June 30, 2017.

  (e)  Perpetual - One or more securities do not have a predetermined maturity date. Rates for these securities are fixed for a period of time, after which they revert to a floating rate. Interest rates in effect are as of June 30, 2017.

  (f)  Rate shown is the yield to maturity at June 30, 2017.

  (g)  All or a portion of the security was pledged to cover margin requirements for futures contracts and swap agreements.

  (h)  Securities are available for collateral in connection with purchase of when-issued securities, open futures contracts and swap agreements.

  (i)  At June 30, 2017, the aggregate cost for federal income tax purposes approximates the aggregate cost for book purposes. The aggregate gross unrealized appreciation is $3,787,865 and the aggregate gross unrealized depreciation is $659,242, resulting in net unrealized appreciation of $3,128,623.

FUTURES CONTRACTS OPEN AT JUNE 30, 2017:

NUMBER OF
CONTRACTS
 

LONG/SHORT

  DESCRIPTION, DELIVERY
MONTH AND YEAR
  UNDERLYING FACE
AMOUNT AT VALUE
  UNREALIZED
APPRECIATION
(DEPRECIATION)
 
 

76

   

Long

  U.S. Treasury 2 yr. Note,
Sep-17
 

$

16,424,313

   

$

(25,094

)

 
 

20

   

Long

  U.S. Treasury 30 yr. Bond,
Sep-17
   

3,073,750

     

25,156

   
 

10

   

Long

  U.S. Treasury Ultra Bond,
Sep-17
   

1,658,750

     

28,484

   
 

17

   

Short

  U.S. Treasury 5 yr. Note,
Sep-17
   

(2,003,211

)

   

8,391

   
 

29

   

Short

  U.S. Treasury 10 yr. Ultra Long Bond,
Sep-17
   

(3,909,563

)

   

8,220

   
 

32

   

Short

  U.S. Treasury 10 yr. Note,
Sep-17
   

(4,017,000

)

   

9,031

   

Net Unrealized Appreciation

 

$

54,188

   

See Notes to Financial Statements
31



Morgan Stanley Variable Investment Series - Income Plus

Portfolio of Investments n June 30, 2017 (unaudited) continued

CREDIT DEFAULT SWAP AGREEMENTS OPEN AT JUNE 30, 2017:

SWAP
COUNTERPARTY &
REFERENCE
OBLIGATION
  BUY/SELL
PROTECTION
  NOTIONAL
AMOUNT
(000)
  INTEREST
RATE
  TERMINATION
DATE
  UNREALIZED
DEPRECIATION
  UPFRONT
PAYMENTS
PAID
(RECEIVED)
 

VALUE

  CREDIT
RATING OF
REFERENCE
OBLIGATION†
 
Barclays Bank PLC
Quest Diagnostics, Inc.
 

Buy

 

$

845

     

1.00

%

 

3/20/19

 

$

(29,867

)

 

$

16,217

   

$

(13,650

)

 

BBB+

 
Morgan Stanley &
Co., LLC* 
CDX.NA.HY.27
 

Buy

   

2,054

     

5.00

   

12/20/21

   

(71,682

)

   

(85,582

)

   

(157,264

)

 

NR

 
Total Credit Default
Swaps
     

$

2,899

           

$

(101,549

)

 

$

(69,365

)

 

$

(170,914

)

     

INTEREST RATE SWAP AGREEMENT OPEN AT JUNE 30, 2017:

SWAP COUNTERPARTY

  NOTIONAL
AMOUNT
(000)
  FLOATING RATE
INDEX
  PAY/RECEIVE
FLOATING RATE
 

FIXED RATE

  TERMINATION
DATE
  UNREALIZED
DEPRECIATION
 
Morgan Stanley &
Co., LLC*
   

5,897

      3 Month LIBOR    

Receive

   

2.48

%

 

12/21/26

 

$

(110,977

)

 

  LIBOR    London Interbank Offered Rate.

  NR    Not rated.

  †    Credit rating as issued by Standard & Poor's.

  *    Cleared swap agreement, the broker is Morgan Stanley & Co., LLC.

LONG TERM CREDIT ANALYSIS+

AAA

   

3.0

%

 

AA

   

9.4

   

A

   

44.1

   

BBB

   

37.2

   

BB

   

1.7

   

B or Below

   

1.2

   

Not Rated

   

3.4

   
     

100.0

%++

 

+  The ratings shown are based on the Fund's security ratings as determined by Standard & Poor's, Moody's or Fitch, each a Nationally Recognized Statistical Ratings Organization ("NRSRO").

++  Does not include open long/short futures contracts with an underlying face amount of $31,086,587 with net unrealized appreciation of $54,188. Does not include open swap agreements with total unrealized depreciation of $212,526.

See Notes to Financial Statements
32




Morgan Stanley Variable Investment Series - European Equity

Portfolio of Investments n June 30, 2017 (unaudited)

NUMBER OF
SHARES
 

 

VALUE

 
    Common Stocks (98.1%)
Denmark (2.4%)
 
   

Pharmaceuticals

 
 

17,417

   

Novo Nordisk A/S, Series B

 

$

745,868

   
   

France (16.6%)

 
   

Aerospace & Defense

 
 

10,607

   

Airbus SE

   

872,264

   
   

Banks

 
 

13,201

   

BNP Paribas SA

   

950,788

   
   

Electrical Equipment

 
 

10,348

   

Schneider Electric SE

   

795,062

   
   

Hotels, Restaurants & Leisure

 
 

13,393

   

Accor SA

   

627,857

   
   

Insurance

 
 

28,049

   

AXA SA

   

767,266

   
   

Media

 
 

8,353

   

Publicis Groupe SA

   

623,082

   
   

Multi-Utilities

 
 

32,927

   

Suez

   

609,807

   
       

Total France

   

5,246,126

   
   

Germany (16.6%)

 
   

Auto Components

 
 

2,330

   

Continental AG

   

502,835

   
   

Automobiles

 
 

8,054

   

Daimler AG (Registered)

   

582,933

   
   

Chemicals

 
 

7,247

   

Symrise AG

   

513,349

   
    Health Care Providers &
Services
 
 

9,521

   

Fresenius SE & Co., KGaA

   

816,233

   
   

Industrial Conglomerates

 
 

7,198

   

Siemens AG (Registered)

   

989,421

   
   

Pharmaceuticals

 
 

6,762

   

Bayer AG (Registered)

   

874,268

   
   

Software

 
 

9,114

   

SAP SE

   

951,954

   
       

Total Germany

   

5,230,993

   
NUMBER OF
SHARES
 

 

VALUE

 
   

Ireland (1.9%)

 
   

Construction Materials

 
 

17,231

   

CRH PLC

 

$

609,600

   
   

Italy (1.5%)

 
   

Capital Markets

 
 

23,622

   

Azimut Holding SpA (a)

   

473,496

   
   

Netherlands (11.9%)

 
   

Banks

 
 

49,586

   

ING Groep N.V.

   

855,183

   
    Diversified Telecommunication
Services
 
 

177,008

   

Koninklijke KPN N.V.

   

566,277

   
   

Personal Products

 
 

15,027

   

Unilever N.V. CVA

   

829,320

   
   

Professional Services

 
 

35,792

   

RELX N.V.

   

735,837

   
    Semiconductors &
Semiconductor Equipment
 
 

5,919

   

ASML Holding N.V.

   

771,360

   
       

Total Netherlands

   

3,757,977

   
   

Spain (1.0%)

 
   

Information Technology Services

 
 

5,279

    Amadeus IT Group SA,
Class A
   

315,639

   
   

Sweden (2.0%)

 
   

Machinery

 
 

36,765

   

Volvo AB, Class B

   

626,664

   
   

Switzerland (15.8%)

 
   

Food Products

 
 

18,297

   

Nestle SA (Registered)

   

1,592,329

   
   

Insurance

 
 

2,530

   

Zurich Insurance Group AG

   

736,389

   
   

Pharmaceuticals

 
 

13,468

   

Novartis AG (Registered)

   

1,120,812

   
 

4,400

    Roche Holding AG
(Genusschein)
   

1,120,534

   
     

2,241,346

   

See Notes to Financial Statements
33



Morgan Stanley Variable Investment Series - European Equity

Portfolio of Investments n June 30, 2017 (unaudited) continued

NUMBER OF
SHARES
 

 

VALUE

 
    Textiles, Apparel & Luxury
Goods
 
 

1,151

   

Swatch Group AG (The)

 

$

425,038

   
       

Total Switzerland

   

4,995,102

   
   

United Kingdom (28.4%)

 
   

Banks

 
 

220,329

   

Barclays PLC

   

581,827

   
 

685,192

   

Lloyds Banking Group PLC

   

590,341

   
     

1,172,168

   
    Diversified Telecommunication
Services
 
 

111,598

   

BT Group PLC

   

428,421

   
    Equity Real Estate Investment
Trusts (REITs)
 
 

42,644

    Great Portland Estates
PLC REIT
   

331,584

   
   

Household Products

 
 

8,883

   

Reckitt Benckiser Group PLC

   

900,582

   
   

Insurance

 
 

44,267

   

Prudential PLC

   

1,015,314

   
   

Oil, Gas & Consumable Fuels

 
 

158,591

   

BP

PL

C

   

914,634

   
 

35,027

    Royal Dutch Shell PLC,
Class A
   

928,385

   
     

1,843,019

   
   

Pharmaceuticals

 
 

32,966

   

GlaxoSmithKline PLC

   

702,227

   
   

Tobacco

 
 

15,892

   

British American Tobacco PLC

   

1,083,361

   
 

15,302

   

Imperial Brands PLC

   

687,289

   
     

1,770,650

   
    Wireless Telecommunication
Services
 
 

286,191

   

Vodafone Group PLC

   

811,662

   
       

Total United Kingdom

   

8,975,627

   
        Total Common Stocks
(Cost $22,311,214)
   

30,977,092

   
NUMBER OF
SHARES
(000)
 

 

VALUE

 
    Short-Term Investments (1.6%)
Securities held as Collateral
on Loaned Securities
 
   

Investment Company (1.2%)

 
 

389

    Morgan Stanley Institutional
Liquidity Funds - Treasury
Securities Portfolio -
Institutional Class
(See Note 8)
 

$

388,667

   
PRINCIPAL
AMOUNT
(000)
 

 

 
   

Repurchase Agreements (0.4%)

 

$

47

    Barclays Capital, Inc.
(1.08%, dated 06/30/17, due
07/03/17; proceeds
$47,128; fully collateralized
by U.S. Government
obligations; 2.13% - 2.75%
due 06/30/22 - 08/15/42;
valued at $48,066)
   

47,124

   
 

43

    HSBC Securities USA, Inc.
(1.06%, dated 06/30/17, due
07/03/17; proceeds
$43,135; fully collateralized
by a U.S. Government agency
security; 5.00% due
06/01/47; valued at
$44,008)
   

43,131

   

See Notes to Financial Statements
34



Morgan Stanley Variable Investment Series - European Equity

Portfolio of Investments n June 30, 2017 (unaudited) continued

PRINCIPAL
AMOUNT
(000)
 

 

VALUE

 

$

31

    HSBC Securities USA, Inc.
(1.07%, dated 06/30/17, due
07/03/17; proceeds
$30,811; fully collateralized
by a U.S. Government
agency security; 5.00% due
06/01/47; valued at
$31,437)
 

$

30,808

   
     

121,063

   
    Total Short-Term
Investments
(Cost $509,730)
   

509,730

   
Total Investments
(Cost $22,820,944) (b)
   

99.7

%

   

31,486,822

   
Other Assets in Excess of
Liabilities
   

0.3

     

80,049

   

Net Assets

   

100.0

%

 

$

31,566,871

   

Country assignments and aggregations are based generally on third party vendor classifications and information, and may be different from the assignments and aggregations under the policies set forth in the Fund's prospectus and/or statement of additional information relating to geographic classifications.

CVA  Certificaten Van Aandelen.

REIT  Real Estate Investment Trust.

  (a)  All or a portion of this security was on loan at June 30, 2017.

  (b)  At June 30, 2017, the aggregate cost for federal income tax purposes approximates the aggregate cost for book purposes. The aggregate gross unrealized appreciation is $10,051,239 and the aggregate gross unrealized depreciation is $1,385,361, resulting in net unrealized appreciation of $8,665,878.

SUMMARY OF INVESTMENTS
INDUSTRY
 

VALUE

  PERCENT OF
TOTAL
INVESTMENTS
 

Pharmaceuticals

 

$

4,563,709

     

14.7

%

 

Banks

   

2,978,139

     

9.6

   

Insurance

   

2,518,969

     

8.1

   
Oil, Gas & Consumable
Fuels
   

1,843,019

     

6.0

   

Tobacco

   

1,770,650

     

5.7

   

Food Products

   

1,592,329

     

5.1

   
Diversified
Telecommunication
Services
   

994,698

     

3.2

   

Industrial Conglomerates

   

989,421

     

3.2

   

Software

   

951,954

     

3.1

   

Household Products

   

900,582

     

2.9

   

Aerospace & Defense

   

872,264

     

2.8

   

Personal Products

   

829,320

     

2.7

   
Health Care Providers &
Services
   

816,233

     

2.6

   
Wireless Telecommunication
Services
   

811,662

     

2.6

   

Electrical Equipment

   

795,062

     

2.6

   
Semiconductors &
Semiconductor
Equipment
   

771,360

     

2.5

   

Professional Services

   

735,837

     

2.4

   
Hotels, Restaurants &
Leisure
   

627,857

     

2.0

   

Machinery

   

626,664

     

2.0

   

Media

   

623,082

     

2.0

   

Multi-Utilities

   

609,807

     

2.0

   

Construction Materials

   

609,600

     

2.0

   

Automobiles

   

582,933

     

1.9

   

Chemicals

   

513,349

     

1.7

   

Auto Components

   

502,835

     

1.6

   

Capital Markets

   

473,496

     

1.5

   
Textiles, Apparel & Luxury
Goods
   

425,038

     

1.4

   
Equity Real Estate
Investment Trusts (REITs)
   

331,584

     

1.1

   
Information Technology
Services
   

315,639

     

1.0

   
   

$

30,977,092

+

   

100.0

%

 

+  Does not reflect the value of securities held as collateral on loaned securities.

See Notes to Financial Statements
35



Morgan Stanley Variable Investment Series - Multi Cap Growth

Portfolio of Investments n June 30, 2017 (unaudited)

NUMBER OF
SHARES
 

 

VALUE

 
   

Common Stocks (92.2%)

 
   

Automobiles (1.5%)

 
 

10,079

   

Tesla, Inc. (a)(b)

 

$

3,644,667

   
   

Biotechnology (1.2%)

 
 

17,980

    Alnylam Pharmaceuticals,
Inc. (b)
   

1,434,085

   
 

26,609

   

Intrexon Corp. (a)(b)

   

641,011

   
 

24,595

   

Juno Therapeutics, Inc. (a)(b)

   

735,144

   
     

2,810,240

   
    Health Care Equipment &
Supplies (4.9%)
 
 

12,682

   

Intuitive Surgical, Inc. (b)

   

11,862,362

   
    Health Care
Technology (12.2%)
 
 

116,337

   

athenahealth, Inc. (b)

   

16,351,165

   
 

213,566

    Veeva Systems, Inc.,
Class A (b)
   

13,093,732

   
     

29,444,897

   
    Hotels, Restaurants &
Leisure (8.3%)
 
 

231,282

    Shake Shack, Inc.,
Class A (a)(b)
   

8,067,116

   
 

203,459

   

Starbucks Corp.

   

11,863,695

   
     

19,930,811

   
    Information Technology
Services (7.2%)
 
 

88,644

   

Mastercard, Inc., Class A

   

10,765,814

   
 

71,522

   

Visa, Inc., Class A

   

6,707,333

   
     

17,473,147

   
    Internet & Direct Marketing
Retail (13.6%)
 
 

21,265

   

Amazon.com, Inc. (b)

   

20,584,520

   
 

6,458

   

Priceline Group, Inc. (The) (b)

   

12,079,818

   
     

32,664,338

   
    Internet Software &
Services (20.3%)
 
 

31,886

    Alibaba Group Holding Ltd.
ADR (China) (b)
   

4,492,737

   
NUMBER OF
SHARES
 

 

VALUE

 
 

16,335

   

Alphabet, Inc., Class C (b)

 

$

14,844,104

   
 

137,120

   

Facebook, Inc., Class A (b)

   

20,702,378

   
 

114,200

    Tencent Holdings Ltd.
(China) (c)
   

4,083,874

   
 

272,699

   

Twitter, Inc. (b)

   

4,873,131

   
     

48,996,224

   
    Life Sciences Tools &
Services (4.9%)
 
 

67,992

   

Illumina, Inc. (b)

   

11,797,972

   
    Semiconductors &
Semiconductor
Equipment (3.2%)
 
 

53,377

   

NVIDIA Corp.

   

7,716,179

   
   

Software (14.9%)

 
 

136,265

   

Salesforce.com, Inc. (b)

   

11,800,549

   
 

112,646

   

ServiceNow, Inc. (b)

   

11,940,476

   
 

46,158

   

Snap, Inc., Class A (a)(b)

   

820,228

   
 

116,865

   

Workday, Inc., Class A (b)

   

11,335,905

   
     

35,897,158

   
        Total Common Stocks
(Cost $121,834,508)
   

222,237,995

   
   

Preferred Stocks (4.8%)

 
    Electronic Equipment,
Instruments &
Components (0.2%)
 
 

18,954

    Magic Leap, Series C (b)(d)(e)(f)
(acquisition cost - $436,567;
acquired 12/22/15)
   

471,955

   
    Hotels, Restaurants &
Leisure (0.6%)
 
 

114,561

    Blue Bottle Coffee, Inc.,
Series B (b)(d)(e)(f)
(acquisition cost - $1,657,606;
acquired 01/24/14)
   

1,489,293

   

See Notes to Financial Statements
36



Morgan Stanley Variable Investment Series - Multi Cap Growth

Portfolio of Investments n June 30, 2017 (unaudited) continued

NUMBER OF
SHARES
 

 

VALUE

 
    Internet & Direct Marketing
Retail (2.8%)
 
 

42,717

    Airbnb, Inc., Series D (b)(d)(e)(f)
(acquisition cost - $1,739,139;
acquired 04/16/14)
 

$

4,600,621

   
 

50,711

    Uber Technologies,
Series G (b)(d)(e)(f)
(acquisition cost - $2,473,289;
acquired 12/03/15)
   

2,091,321

   
     

6,691,942

   
    Life Sciences Tools &
Services (1.0%)
 
 

627,809

    10X Genomics, Inc.,
Series B (b)(d)(e)(f)
(acquisition cost - $2,052,935;
acquired 12/19/14)
   

2,517,514

   
   

Software (0.2%)

 
 

141,612

    Lookout, Inc.,
Series F (b)(d)(e)(f)
(acquisition cost - $1,617,648;
acquired 06/17/14)
   

433,333

   
        Total Preferred Stocks
(Cost $9,977,184)
   

11,604,037

   
NOTIONAL
AMOUNT
(000)
 

 

 
   

Call Option Purchased (0.0%)

 
   

Foreign Currency Option

 
 

36,450

    USD/CNY November 2017
@ CNY $7.40, Royal Bank of
Scotland
(Cost $122,384)
   

22,526

   
NUMBER OF
SHARES
(000)
 
 

VALUE

 
    Short-Term Investments (4.0%)
Securities held as Collateral
on Loaned Securities (1.1%)
 
   

Investment Company (0.8%)

 
 

1,937

    Morgan Stanley Institutional
Liquidity Funds - Treasury
Securities Portfolio -
Institutional Class
(See Note 8)
 

$

1,937,435

   
PRINCIPAL
AMOUNT
(000)
 

 

 
   

Repurchase Agreements (0.3%)

 

$

235

    Barclays Capital, Inc.
(1.08%, dated 06/30/17,
due 07/03/17; proceeds
$234,924; fully collateralized
by U.S. Government
obligations; 2.13% - 2.75%
due 06/30/22 - 08/15/42;
valued at $239,603)
   

234,903

   
 

215

    HSBC Securities USA, Inc.
(1.06%, dated 06/30/17,
due 07/03/17; proceeds
$215,019; fully collateralized
by a U.S. Government agency
security; 5.00% due 06/01/47;
valued at $219,373)
   

215,000

   
 

154

    HSBC Securities USA, Inc.
(1.07%, dated 06/30/17,
due 07/03/17; proceeds
$153,585; fully collateralized
by a U.S. Government agency
security; 5.00% due 06/01/47;
valued at $156,707)
   

153,571

   
     

603,474

   
        Total Securities held as
Collateral on Loaned
Securities
(Cost $2,540,909)
   

2,540,909

   

See Notes to Financial Statements
37



Morgan Stanley Variable Investment Series - Multi Cap Growth

Portfolio of Investments n June 30, 2017 (unaudited) continued

NUMBER OF
SHARES
(000)
 

 

VALUE
 
   

Investment Company (2.9%)

     
 

7,041

    Morgan Stanley Institutional
Liquidity Funds - Treasury
Securities Portfolio -
Institutional Class
(See Note 8)
(Cost $7,041,272)
 

$

7,041,272

   
    Total Short-Term
Investments
(Cost $9,582,181)
   

9,582,181

   
Total Investments
(Cost $141,516,257) (g)
   

101.0

%

   

243,446,739

   
Liabilities in Excess of
Other Assets
   

(1.0

)

   

(2,321,958

)

 

Net Assets

   

100.0

%

 

$

241,124,781

   

ADR  American Depositary Receipt.

  (a)  All or a portion of this security was on loan at June 30, 2017.

  (b)  Non-income producing security.

  (c)  Security trades on the Hong Kong exchange.

  (d)  At June 30, 2017, the Fund held fair valued securities valued at $11,604,037, representing 4.8% of net assets. These securities have been fair valued as determined in good faith under procedures established by and under the general supervision of the Trust's Trustees.

  (e)  Illiquid security.

  (f)  Security cannot be offered for public resale without first being registered under the Securities Act of 1933 and related rules ("restricted security"). Acquisition date represents the day on which an enforceable right to acquire such security is obtained and is presented along with related cost in the security description. The Fund has registration rights for certain restricted securities. Any costs related to such registration are borne by the issuer. The aggregate value of restricted securities (excluding 144A holdings) at June 30, 2017, amounts to $11,604,037 and represents 4.8% of net assets.

  (g)  At June 30, 2017, the aggregate cost for federal income tax purposes approximates the aggregate cost for book purposes. The aggregate gross unrealized appreciation is $109,298,012 and the aggregate gross unrealized depreciation is $7,367,530, resulting in net unrealized appreciation of $101,930,482.

Currency Abbreviations:

CNY  Chinese Yuan Renminbi.

USD  United States Dollar.

SUMMARY OF INVESTMENTS
INDUSTRY
 

VALUE

  PERCENT OF
TOTAL
INVESTMENTS
 
Internet Software &
Services
 

$

48,996,224

     

20.3

%

 
Internet & Direct Marketing
Retail
   

39,356,280

     

16.3

   

Software

   

36,330,491

     

15.1

   

Health Care Technology

   

29,444,897

     

12.2

   
Hotels, Restaurants &
Leisure
   

21,420,104

     

8.9

   
Information Technology
Services
   

17,473,147

     

7.3

   
Life Sciences Tools &
Services
   

14,315,486

     

6.0

   
Health Care Equipment &
Supplies
   

11,862,362

     

4.9

   
Semiconductors &
Semiconductor
Equipment
   

7,716,179

     

3.2

   

Investment Company

   

7,041,272

     

2.9

   

Automobiles

   

3,644,667

     

1.5

   

Biotechnology

   

2,810,240

     

1.2

   
Electronic Equipment,
Instruments &
Components
   

471,955

     

0.2

   

Other

   

22,526

     

0.0

   
   

$

240,905,830

+

   

100.0

%

 

+  Does not reflect the value of securities held as collateral on loaned securities.

See Notes to Financial Statements
38




Morgan Stanley Variable Investment Series

Financial Statements

Statement of Assets and Liabilities
June 30, 2017 (unaudited)

    Limited
Duration
  Income
Plus
  European
Equity
  Multi Cap
Growth
 

Assets:

 

Investments in securities, at value*

 

$

26,248,002

   

$

98,318,273

   

$

31,098,155

(1)

 

$

234,468,032

(1)

 

Investment in affiliate, at value**

   

554,333

     

2,279,319

     

388,667

     

8,978,707

   

Total investments in securities, at value

   

26,802,335

     

100,597,592

     

31,486,822

     

243,446,739

   

Cash

   

95,638

     

79

     

     

   

Receivable for:

 

Interest

   

135,902

     

921,136

     

     

   

Investments sold

   

     

98,565

     

441,935

     

512,746

   

Foreign withholding taxes reclaimed

   

     

1,636

     

140,752

     

   

Dividends

   

     

     

59,126

     

   

Shares of beneficial interest sold

   

21,069

     

     

     

   

Premium paid on open swap agreements

   

     

16,217

     

     

   

Variation margin on open swap agreements

   

     

13,558

     

     

   

Interest and dividends from affiliates

   

1,055

     

2,304

     

105

     

4,455

   

Prepaid expenses and other assets

   

9,941

     

24,338

     

13,676

     

28,002

   

Total Assets

   

27,065,940

     

101,675,425

     

32,142,416

     

243,991,942

   

Liabilities:

 

Collateral on securities loaned, at value

   

     

     

509,730

     

2,540,909

   

Unrealized depreciation on open swap agreements

   

     

29,867

     

     

   

Payable to bank

   

     

     

1,821

     

   

Payable for:

 

Investments purchased

   

95,611

     

377,684

     

296

     

   

Shares of beneficial interest redeemed

   

15

     

92,652

     

3,613

     

158,257

   

Advisory fee

   

6,629

     

35,097

     

12,525

     

83,372

   

Administration fee

   

1,777

     

6,725

     

2,107

     

16,253

   

Distribution fee (Class Y Shares)

   

4,374

     

10,452

     

1,311

     

10,649

   

Trustees' fees

   

1,202

     

4,537

     

1,269

     

9,624

   

Variation margin on open futures contracts

   

8,033

     

1,423

     

     

   

Transfer agent fees

   

255

     

269

     

260

     

274

   

Accrued expenses and other payables

   

45,956

     

58,384

     

42,613

     

47,823

   

Total Liabilities

   

163,852

     

617,090

     

575,545

     

2,867,161

   

Net Assets

 

$

26,902,088

   

$

101,058,335

   

$

31,566,871

   

$

241,124,781

   

Composition of Net Assets:

 

Paid-in-capital

 

$

34,897,636

   

$

92,193,760

   

$

29,248,682

   

$

97,710,200

   

Net unrealized appreciation (depreciation)

   

214,519

     

2,970,285

     

8,668,169

     

101,930,482

   

Accumulated undistributed net investment income (net investment loss)

   

738,902

     

5,113,354

     

1,486,420

     

(450,259

)

 

Accumulated net realized gain (loss)

   

(8,948,969

)

   

780,936

     

(7,836,400

)

   

41,934,358

   

Net Assets

 

$

26,902,088

   

$

101,058,335

   

$

31,566,871

   

$

241,124,781

   
* Cost  

$

26,021,636

   

$

95,192,958

   

$

22,432,277

   

$

132,537,550

   
** Affiliated Cost  

$

554,055

   

$

2,276,011

   

$

388,667

   

$

8,978,707

   

Class X Shares:

 

Net Assets

 

$

5,727,224

   

$

51,158,076

   

$

25,274,768

   

$

190,767,682

   
Shares Outstanding (unlimited shares authorized, $0.01 par value)    

740,183

     

4,391,167

     

1,441,817

     

3,648,212

   

Net Asset Value Per Share

 

$

7.74

   

$

11.65

   

$

17.53

   

$

52.29

   

Class Y Shares:

 

Net Assets

 

$

21,174,864

   

$

49,900,259

   

$

6,292,103

   

$

50,357,099

   
Shares Outstanding (unlimited shares authorized, $0.01 par value)    

2,743,802

     

4,298,393

     

360,019

     

993,110

   

Net Asset Value Per Share

 

$

7.72

   

$

11.61

   

$

17.48

   

$

50.71

   

(1)  Including securities loaned at value of $478,592 and $6,111,909.

See Notes to Financial Statements
39



Morgan Stanley Variable Investment Series

Financial Statements continued

Statement of Operations
For the six months ended June 30, 2017 (unaudited)

    Limited
Duration
  Income
Plus
  European
Equity
  Multi Cap
Growth
 

Net Investment Income:

 

Income

 

Interest

 

$

352,815

   

$

1,994,516

   

$

   

$

   

Dividends†

   

     

     

760,969

     

165,683

   

Income from securities loaned - net

   

     

     

4,807

     

95,038

   

Interest and dividends from affiliates (Note 8)

   

3,509

     

17,636

     

641

     

15,178

   

Total Income

   

356,324

     

2,012,152

     

766,417

     

275,899

   

†Net of foreign withholding taxes

   

     

     

92,053

     

   

Expenses

 

Advisory fee (Note 4)

   

40,989

     

215,804

     

131,863

     

477,974

   

Professional fees

   

54,471

     

54,792

     

45,612

     

49,373

   

Distribution fee (Class Y shares) (Note 5)

   

27,000

     

64,109

     

7,545

     

59,975

   

Administration fee (Note 4)

   

10,930

     

41,105

     

12,125

     

91,043

   

Custodian fees

   

5,603

     

10,553

     

11,005

     

7,421

   

Shareholder reports and notices

   

3,979

     

8,742

     

4,036

     

15,357

   

Trustees' fees and expenses

   

1,688

     

1,682

     

1,695

     

3,778

   

Transfer agent fees and expenses (Note 6)

   

1,744

     

1,773

     

1,763

     

1,804

   

Other

   

18,359

     

26,302

     

7,377

     

12,240

   

Total Expenses

   

164,763

     

424,862

     

223,021

     

718,965

   

Less: amounts waived (Note 4)

   

     

     

(63,910

)

   

(10,265

)

 

Less: rebate from Morgan Stanley affiliated cash sweep (Note 8)

   

(201

)

   

(924

)

   

(221

)

   

(4,604

)

 

Net Expenses

   

164,562

     

423,938

     

158,890

     

704,096

   

Net Investment Income (Loss)

   

191,762

     

1,588,214

     

607,527

     

(428,197

)

 

Realized and Unrealized Gain (Loss):

 

Realized Gain (Loss) on:

 

Investments

   

14,564

     

1,136,587

     

744,120

     

19,229,848

   

Investments in affiliates (Note 8)

   

(417

)

   

     

     

   

Futures contracts

   

46,092

     

15,776

     

     

   

Swap agreements

   

     

(138,450

)

   

     

   

Foreign currency translation

   

     

     

5,123

     

(13

)

 

Net Realized Gain

   

60,239

     

1,013,913

     

749,243

     

19,229,835

   

Change in Unrealized Appreciation (Depreciation) on:

 

Investments

   

72,162

     

1,518,416

     

2,874,205

     

37,770,556

   

Investments in affiliates (Note 8)

   

2,249

     

28,052

     

     

   

Futures contracts

   

(7,875

)

   

38,180

     

     

   

Swap agreements

   

     

(66,845

)

   

     

   

Foreign currency translation

   

     

     

10,426

     

   

Net Change in Unrealized Appreciation (Depreciation)

   

66,536

     

1,517,803

     

2,884,631

     

37,770,556

   

Net Gain

   

126,775

     

2,531,716

     

3,633,874

     

57,000,391

   

Net Increase

 

$

318,537

   

$

4,119,930

   

$

4,241,401

   

$

56,572,194

   

See Notes to Financial Statements
40



(This page has been intentionally left blank.)



Morgan Stanley Variable Investment Series

Financial Statements continued

Statements of Changes in Net Assets

   

Limited Duration

 

Income Plus

 
    For The Six
Months Ended
June 30, 2017
  For The Year
Ended
December 31, 2016
  For The Six
Months Ended
June 30, 2017
  For The Year
Ended
December 31, 2016
 
   

(unaudited)

     

(unaudited)

     

Increase (Decrease) in Net Assets:

 

Operations:

 

Net investment income (loss)

 

$

191,762

   

$

470,243

   

$

1,588,214

   

$

3,950,097

   

Net realized gain (loss)

   

60,239

     

718,166

     

1,013,913

     

(184,262

)

 

Net change in unrealized appreciation (depreciation)

   

66,536

     

281,564

     

1,517,803

     

3,769,020

   

Net Increase (Decrease)

   

318,537

     

1,469,973

     

4,119,930

     

7,534,855

   

Dividends and Distributions to Shareholders from:

 

Net investment income

 

Class X shares

   

     

(98,769

)

   

     

(2,195,894

)

 

Class Y shares

   

     

(286,780

)

   

     

(1,968,336

)

 

Net realized gain

 

Class X shares

   

     

     

     

(1,365,988

)

 

Class Y shares

   

     

     

     

(1,324,001

)

 

Total Dividends and Distributions

   

     

(385,549

)

   

     

(6,854,219

)

 

Net increase (decrease) from transactions in shares of beneficial interest

   

(1,463,233

)

   

(4,255,775

)

   

(9,196,044

)

   

(9,093,992

)

 

Net Increase (Decrease)

   

(1,144,696

)

   

(3,171,351

)

   

(5,076,114

)

   

(8,413,356

)

 

Net Assets:

 

Beginning of period

   

28,046,784

     

31,218,135

     

106,134,449

     

114,547,805

   

End of Period

 

$

26,902,088

   

$

28,046,784

   

$

101,058,335

   

$

106,134,449

   

Accumulated Undistributed Net Investment Income (Loss)

 

$

738,902

   

$

547,140

   

$

5,113,354

   

$

3,525,140

   

See Notes to Financial Statements
42



   

European Equity

 

Multi Cap Growth

 
    For The Six
Months Ended
June 30, 2017
  For The Year
Ended
December 31, 2016
  For The Six
Months Ended
June 30, 2017
  For The Year
Ended
December 31, 2016
 
   

(unaudited)

     

(unaudited)

     

Increase (Decrease) in Net Assets:

 

Operations:

 

Net investment income (loss)

 

$

607,527

   

$

909,644

   

$

(428,197

)

 

$

(108,661

)

 

Net realized gain (loss)

   

749,243

     

24,461

     

19,229,835

     

22,946,720

   

Net change in unrealized appreciation (depreciation)

   

2,884,631

     

(1,898,801

)

   

37,770,556

     

(31,186,518

)

 

Net Increase (Decrease)

   

4,241,401

     

(964,696

)

   

56,572,194

     

(8,348,459

)

 

Dividends and Distributions to Shareholders from:

 

Net investment income

 

Class X shares

   

     

(747,146

)

   

     

   

Class Y shares

   

     

(157,314

)

   

     

   

Net realized gain

 

Class X shares

   

     

     

     

(27,887,923

)

 

Class Y shares

   

     

     

     

(7,755,377

)

 

Total Dividends and Distributions

   

     

(904,460

)

   

     

(35,643,300

)

 

Net increase (decrease) from transactions in shares of beneficial interest

   

(1,965,132

)

   

(3,964,224

)

   

(18,585,243

)

   

6,930,617

   

Net Increase (Decrease)

   

2,276,269

     

(5,833,380

)

   

37,986,951

     

(37,061,142

)

 

Net Assets:

 

Beginning of period

   

29,290,602

     

35,123,982

     

203,137,830

     

240,198,972

   

End of Period

 

$

31,566,871

   

$

29,290,602

   

$

241,124,781

   

$

203,137,830

   

Accumulated Undistributed Net Investment Income (Loss)

 

$

1,486,420

   

$

878,893

   

$

(450,259

)

 

$

(22,062

)

 


43



Morgan Stanley Variable Investment Series

Financial Statements continued

Statements of Changes in Net Assets continued
Summary of Transactions in Shares of Beneficial Interest

   

Limited Duration

 

Income Plus

 
    For The Six
Months Ended
June 30, 2017
  For The Year
Ended
December 31, 2016
  For The Six
Months Ended
June 30, 2017
  For The Year
Ended
December 31, 2016
 
   

(unaudited)

     

(unaudited)

     

Class X Shares

 

Shares

 

Sold

   

16,126

     

25,123

     

44,578

     

60,941

   

Reinvestment of dividends and distributions

   

     

13,030

     

     

317,176

   

Redeemed

   

(52,649

)

   

(179,486

)

   

(438,546

)

   

(759,941

)

 

Net Increase (Decrease) - Class X

   

(36,523

)

   

(141,333

)

   

(393,968

)

   

(381,824

)

 

Amount

 

Sold

 

$

124,417

   

$

190,388

   

$

510,629

   

$

699,340

   

Reinvestment of dividends and distributions

   

     

98,769

     

     

3,561,882

   

Redeemed

   

(404,594

)

   

(1,359,299

)

   

(4,985,624

)

   

(8,655,005

)

 

Net Increase (Decrease) - Class X

 

$

(280,177

)

 

$

(1,070,142

)

 

$

(4,474,995

)

 

$

(4,393,783

)

 

Class Y Shares

 

Shares

 

Sold

   

46,211

     

65,366

     

34,236

     

151,270

   

Reinvestment of dividends and distributions

   

     

37,834

     

     

293,435

   

Redeemed

   

(199,994

)

   

(524,599

)

   

(447,458

)

   

(858,057

)

 

Net Increase (Decrease) - Class Y

   

(153,783

)

   

(421,399

)

   

(413,222

)

   

(413,352

)

 

Amount

 

Sold

 

$

353,667

   

$

495,273

   

$

387,997

   

$

1,718,702

   

Reinvestment of dividends and distributions

   

     

286,780

     

     

3,292,337

   

Redeemed

   

(1,536,723

)

   

(3,967,686

)

   

(5,109,046

)

   

(9,711,248

)

 

Net Increase (Decrease) - Class Y

 

$

(1,183,056

)

 

$

(3,185,633

)

 

$

(4,721,049

)

 

$

(4,700,209

)

 

See Notes to Financial Statements
44



   

European Equity

 

Multi Cap Growth

 
    For The Six
Months Ended
June 30, 2017
  For The Year
Ended
December 31, 2016
  For The Six
Months Ended
June 30, 2017
  For The Year
Ended
December 31, 2016
 
   

(unaudited)

     

(unaudited)

     

Class X Shares

 

Shares

 

Sold

   

5,577

     

37,160

     

5,918

     

28,421

   

Reinvestment of dividends and distributions

   

     

49,611

     

     

697,896

   

Redeemed

   

(102,818

)

   

(306,282

)

   

(301,076

)

   

(520,195

)

 

Net Increase (Decrease) - Class X

   

(97,241

)

   

(219,511

)

   

(295,158

)

   

206,122

   

Amount

 

Sold

 

$

93,978

   

$

572,744

   

$

285,366

   

$

1,331,784

   

Reinvestment of dividends and distributions

   

     

747,146

     

     

27,887,923

   

Redeemed

   

(1,693,620

)

   

(4,676,503

)

   

(14,432,088

)

   

(22,959,763

)

 

Net Increase (Decrease) - Class X

 

$

(1,599,642

)

 

$

(3,356,613

)

 

$

(14,146,722

)

 

$

6,259,944

   

Class Y Shares

 

Shares

 

Sold

   

1,733

     

4,655

     

5,535

     

15,945

   

Reinvestment of dividends and distributions

   

     

10,453

     

     

199,624

   

Redeemed

   

(23,947

)

   

(54,254

)

   

(100,084

)

   

(180,778

)

 

Net Increase (Decrease) - Class Y

   

(22,214

)

   

(39,146

)

   

(94,549

)

   

34,791

   

Amount

 

Sold

 

$

30,386

   

$

69,645

   

$

238,964

   

$

689,556

   

Reinvestment of dividends and distributions

   

     

157,314

     

     

7,755,377

   

Redeemed

   

(395,876

)

   

(834,570

)

   

(4,677,485

)

   

(7,774,260

)

 

Net Increase (Decrease) - Class Y

 

$

(365,490

)

 

$

(607,611

)

 

$

(4,438,521

)

 

$

670,673

   


45




Morgan Stanley Variable Investment Series

Notes to Financial Statements n June 30, 2017 (unaudited)

1. Organization and Accounting Policies

Morgan Stanley Variable Investment Series (the "Trust") is registered under the Investment Company Act of 1940, as amended (the "Act"), as an open-end management investment company. The Trust is offered exclusively to life insurance companies in connection with particular life insurance and/or annuity contracts they offer. The Trust applies investment company accounting and reporting guidance.

The Trust, organized on February 25, 1983 as a Massachusetts business trust, consists of four funds ("Funds") which commenced operations as follows:

FUND

  COMMENCEMENT OF
OPERATIONS
 

FUND

  COMMENCEMENT OF
OPERATIONS
 

Limited Duration

 

May 4, 1999

 

European Equity

 

March 1, 1991

 

Income Plus

 

March 1, 1987

 

Multi Cap Growth

 

March 9, 1984

 

Each Fund is classified as diversified. On June 5, 2000, the Trust commenced offering one additional class of shares (Class Y shares). Each Fund currently offers two share classes — Class X shares and Class Y shares. The two classes are identical except that Class Y shares incur distribution expenses. Class X shares are generally available to holders of contracts offered before May 1, 2000. Class Y shares are available to holders of contracts offered on or after June 5, 2000.

The investment objectives of each Fund are as follows:

FUND  

INVESTMENT OBJECTIVE

 
Limited Duration  

Seeks to provide a high level of current income, consistent with the preservation of capital.

 
Income Plus  

Seeks, as its primary objective, to provide a high level of current income by investing primarily in U.S. government securities and other fixed-income securities. As a secondary objective, the Fund seeks capital appreciation but only when consistent with its primary objective.

 
European Equity  

Seeks to maximize the capital appreciation of its investments.

 
Multi Cap Growth  

Seeks, as its primary objective, growth of capital through investments in common stocks of companies believed by the "Adviser" Morgan Stanley Investment Management Inc. to have potential for superior growth. As a secondary objective, the Fund seeks income but only when consistent with its primary objective.

 


46



Morgan Stanley Variable Investment Series

Notes to Financial Statements n June 30, 2017 (unaudited) continued

The following is a summary of significant accounting policies:

A. Valuation of Investments — (1) An equity portfolio security listed or traded on an exchange is valued at its latest reported sales price (or at the exchange official closing price if such exchange reports an official closing price), and if there were no sales on a given day and if there is no official exchange closing price for that day, the security is valued at the mean between the last reported bid and asked prices if such bid and asked prices are available on the relevant exchanges; (2) all other equity portfolio securities for which over-the-counter ("OTC") market quotations are readily available are valued at the latest reported sales price (or at the market official closing price if such market reports an official closing price), and if there was no trading in the security on a given day and if there is no official closing price from relevant markets for that day, the security is valued at the mean between the last reported bid and asked prices if such bid and asked prices are available on the relevant markets. Listed equity securities not traded on the valuation date with no reported bid and asked prices available on the exchange are valued at the mean between the current bid and asked prices obtained from one or more reputable brokers or dealers. An unlisted equity security that does not trade on the valuation date and for which bid and asked prices from the relevant markets are unavailable is valued at the mean between the current bid and asked prices obtained from one or more reputable brokers or dealers. In cases where a security is traded on more than one exchange, the security is valued on the exchange designated as the primary market; (3) futures are valued at the settlement price on the exchange on which they trade or, if a settlement price is unavailable, at the last sale price on the exchange; (4) listed options are valued at the last reported sales price on the exchange on which they are listed (or at the exchange official closing price if such exchange reports an official closing price). If an official closing price or last reported sales price is unavailable, the listed option should be fair valued at the mean between its latest bid and ask prices. Unlisted options are valued at the mean between their latest bid and ask prices from a broker/dealer or valued by a pricing service/vendor; (5) OTC swaps may be valued by an outside pricing service approved by the Trust's Board of Trustees (the "Trustees") or quotes from a broker or dealer. Swaps cleared on a clearinghouse or exchange may be valued using the closing price provided by the clearinghouse or exchange; (6) quotations of foreign portfolio securities, other assets and liabilities and forward contracts stated in foreign currency are translated into U.S. dollar equivalents at the prevailing market rates prior to the close of the New York Stock Exchange ("NYSE"); (7) certain portfolio securities may be valued by an outside pricing service/vendor approved by the Trustees. The pricing service/vendor may employ a pricing model that takes into account, among other things, bids, yield spreads, and/or other market data and specific security characteristics. Alternatively, if a valuation is not available from an outside pricing service/vendor, and the security trades on an exchange, the security may be valued at its latest


47



Morgan Stanley Variable Investment Series

Notes to Financial Statements n June 30, 2017 (unaudited) continued

reported sale price (or at the exchange official closing price if such exchange reports an official closing price), prior to the time when assets are valued. If there are no sales on a given day and if there is no official exchange closing price for that day, the security is valued at the mean between the last reported bid and asked prices if such bid and asked prices are available in the relevant exchanges; (8) when market quotations are not readily available, including circumstances under which the Adviser or Morgan Stanley Investment Management Limited (the "Sub-Adviser"), a wholly-owned subsidiary of Morgan Stanley, determine that the closing price, last sale price or the mean between the last reported bid and asked prices are not reflective of a security's market value, portfolio securities are valued at their fair value as determined in good faith under procedures established by and under the general supervision of the Trustees. Occasionally, developments affecting the closing prices of securities and other assets may occur between the times at which valuations of such securities are determined (that is, close of the foreign market on which the securities trade) and the close of business on the NYSE. If developments occur during such periods that are expected to materially affect the value of such securities, such valuations may be adjusted to reflect the estimated fair value of such securities as of the close of the NYSE, as determined in good faith by the Trustees or by the Adviser using a pricing service and/or procedures approved by the Trustees; and (9) investments in mutual funds, including the Morgan Stanley Institutional Liquidity Funds, are valued at the net asset value ("NAV") as of the close of each business day.

The Trustees have responsibility for determining in good faith the fair value of the investments, and the Trustees may appoint others, such as the Trust's Adviser or a valuation committee, to assist the Trustees in determining fair value and to make the actual calculations pursuant to the fair valuation methodologies previously approved by the Trustees. Under procedures approved by the Trustees, the Trust's Adviser has formed a Valuation Committee whose members are approved by the Trustees. The Valuation Committee provides administration and oversight of the Trust's valuation policies and procedures, which are reviewed at least annually by the Trustees. These procedures allow the Trust to utilize independent pricing services, quotations from securities and financial instrument dealers, and other market sources to determine fair value.

The Trust has procedures to determine the fair value of securities and other financial instruments for which market prices are not readily available. Under these procedures, the Valuation Committee convenes on a regular and ad hoc basis to review such securities and considers a number of factors, including valuation methodologies and significant unobservable valuation inputs, when arriving at fair value. The Valuation Committee may employ a market-based approach which may use related or comparable assets or liabilities, recent transactions, market multiples, book values and other relevant information for the investment to determine the fair value of the investment. An income-based valuation approach may also be used in which


48



Morgan Stanley Variable Investment Series

Notes to Financial Statements n June 30, 2017 (unaudited) continued

the anticipated future cash flows of the investment are discounted to calculate fair value. Discounts may also be applied due to the nature or duration of any restrictions on the disposition of the investments. Due to the inherent uncertainty of valuations of such investments, the fair values may differ significantly from the values that would have been used had an active market existed. The Valuation Committee employs various methods for calibrating these valuation approaches including a regular review of valuation methodologies, key inputs and assumptions, transactional back-testing or disposition analysis, and reviews of any related market activity.

B. Accounting for Investments — Security transactions are accounted for on the trade date (date the order to buy or sell is executed). Realized gains and losses on security transactions are determined by the identified cost method. Dividend income and other distributions are recorded on the ex-dividend date, except for certain dividends on foreign securities which are recorded as soon as the Trust is informed after the ex-dividend date. Interest income is accrued daily as earned except where collection is not expected. Discounts are accreted and premiums are amortized over the life of the respective securities and are included in interest income.

C. Repurchase Agreements — Certain Funds may enter into repurchase agreements under which the Fund lends cash and takes possession of securities with an agreement that the counterparty will repurchase such securities. In connection with transactions in repurchase agreements, a bank as custodian for the Fund takes possession of the underlying securities which are held as collateral, with a market value at least equal to the amount of the repurchase transaction, including principal and accrued interest. To the extent that any repurchase transaction exceeds one business day, the value of the collateral is marked-to-market on a daily basis to determine that the value of the collateral does not decrease below the repurchase price plus accrued interest as earned. If such a decrease occurs, additional collateral will be requested and, when received, will be added to the account to maintain full collateralization. In the event of default on the obligation to repurchase, the Fund has the right to liquidate the collateral and apply the proceeds in satisfaction of the obligation. In the event of default or bankruptcy by the counterparty to the agreement, realization of the collateral proceeds may be subject to cost and delays. The Fund, along with other affiliated investment companies, may utilize a joint trading account for the purpose of entering into repurchase agreements.

D. Multiple Class Allocations — Investment income, expenses (other than distribution fees), and realized and unrealized gains and losses are allocated to each class of shares based upon the relative net asset value on the date such items are recognized. Distribution fees are charged directly to the respective class.


49



Morgan Stanley Variable Investment Series

Notes to Financial Statements n June 30, 2017 (unaudited) continued

E. Foreign Currency Translation and Foreign Investments — The books and records of the Funds are maintained in U.S. dollars. Foreign currency amounts are translated into U.S. dollars as follows:

—  investments, other assets and liabilities at the prevailing rate of exchange on the valuation date;

—  investment transactions and investment income at the prevailing rates of exchange on the dates of  such transactions.

Although the net assets of the Funds are presented at the foreign exchange rates and market values at the close of the period, the Funds do not isolate that portion of the results of operations arising as a result of changes in the foreign exchange rates from the fluctuations arising from changes in the market prices of securities held at period end. Similarly, the Funds do not isolate the effect of changes in foreign exchange rates from the fluctuations arising from changes in the market prices of securities sold during the period. Accordingly, realized and unrealized foreign currency gains (losses) on investments in securities are included in the reported net realized and unrealized gains (losses) on investment transactions and balances. However, pursuant to U.S. Federal income tax regulations, gains and losses from certain foreign currency transactions and the foreign currency portion of gains and losses realized on sales and maturities of foreign denominated debt securities are treated as ordinary income for U.S. Federal income tax purposes.

Net realized gains (losses) on foreign currency transactions represent net foreign exchange gains (losses) from foreign currency forward exchange contracts, disposition of foreign currencies, currency gains (losses) realized between the trade and settlement dates on securities transactions, and the difference between the amount of investment income and foreign withholding taxes recorded on the Funds' books and the U.S. dollar equivalent amounts actually received or paid. Net unrealized currency gains (losses) from valuing foreign currency denominated assets and liabilities at period end exchange rates are reflected as a component of unrealized appreciation (depreciation) in the Statements of Assets and Liabilities. The change in unrealized currency gains (losses) on foreign currency translations for the period is reflected in the Statements of Operations.

F. Restricted Securities — Certain Funds may invest in unregistered or otherwise restricted securities. The term "restricted securities" refers to securities that are unregistered or are held by control persons of the issuer and securities that are subject to contractual restrictions on their resale. As a result, restricted securities may be more difficult to value and the Fund may have difficulty disposing of such assets either in a timely manner or for a reasonable price. In order to dispose of an unregistered security, the Fund, where it has contractual rights to do so, may have to cause such security to be registered. A considerable period may elapse between the time the decision is made to sell the security and the time the security is registered so that


50



Morgan Stanley Variable Investment Series

Notes to Financial Statements n June 30, 2017 (unaudited) continued

the Fund can sell it. Contractual restrictions on the resale of securities vary in length and scope and are generally the result of a negotiation between the issuer and the acquirer of the securities. The Fund would, in either case, bear market risks during that period. Restricted securities, if any, are identified in the Portfolio of Investments.

G. When-Issued/Delayed Delivery Securities — Certain Funds may purchase or sell when-issued and delayed delivery securities. Securities purchased on a when-issued or delayed delivery basis are purchased for delivery beyond the normal settlement date at a stated price, and no income accrues to the Fund on such securities prior to delivery date. Payment and delivery for when-issued and delayed delivery securities can take place a month or more after the date of the transaction. When a Fund enters into a purchase transaction on a when-issued or delayed delivery basis, securities are available for collateral in an amount at least equal in value to a Fund's commitments to purchase such securities. Purchasing securities on a when-issued or delayed delivery basis may involve a risk that the market price at the time of delivery may be lower than the agreed upon purchase price, in which case there could be an unrealized loss at the time of delivery. Purchasing investments on a when-issued or delayed delivery basis may be considered a form of leverage which may increase the impact that gains (losses) may have on a Fund.

H. Securities Lending — Certain Funds may lend securities to qualified financial institutions, such as broker-dealers, to earn additional income. Any increase or decrease in the fair value of the securities loaned that might occur and any interest earned or dividends declared on those securities during the term of the loan would remain in the Fund. The Fund receives cash or securities as collateral in an amount equal to or exceeding 100% of the current fair value of the loaned securities. The collateral is marked-to-market daily by State Street Bank and Trust Company ("State Street"), the securities lending agent, to ensure that a minimum of 100% collateral coverage is maintained.

Based on pre-established guidelines, the securities lending agent invests any cash collateral that is received in an affiliated money market portfolio and repurchase agreements. Securities lending income is generated from the earnings on the invested collateral and borrowing fees, less any rebates owed to the borrowers and compensation to the lending agent, and is recorded as "Income from Securities Loaned — Net" in the Fund's Statement of Operations.

A Fund has the right under the lending agreement to recover the securities from the borrower on demand.


51



Morgan Stanley Variable Investment Series

Notes to Financial Statements n June 30, 2017 (unaudited) continued

The following table presents financial instruments that are subject to enforceable netting arrangements as of June 30, 2017.

   

GROSS AMOUNTS NOT OFFSET IN THE STATEMENTS OF ASSETS AND LIABILITIES

 

FUND

  GROSS ASSET AMOUNTS
PRESENTED IN STATEMENTS
OF ASSETS AND LIABILITIES
  FINANCIAL
INSTRUMENT
  COLLATERAL
RECEIVED
  NET AMOUNT
(NOT LESS THAN 0)
 

European Equity

 

$

478,592

(a)

 

$

   

$

(478,592

)(b)(d)

 

$

0

   

Multi Cap Growth

   

6,111,909

(a)

   

     

(6,111,909

)(c)(d)

   

0

   

(a)  Represents market value of loaned securities at period end.

(b)  The Fund received cash collateral of $509,730, which was subsequently invested in Repurchase Agreements and Morgan Stanley Institutional Liquidity Funds as reported in the Portfolio of Investments.

(c)  The Fund received cash collateral of $2,540,909, which was subsequently invested in Repurchase Agreements and Morgan Stanley Institutional Liquidity Funds as reported in the Portfolio of Investments. In addition, the Fund received non-cash collateral of $3,709,072 in the form of U.S. Government obligations, which the Fund cannot sell or repledge, and accordingly are not reflected in the Portfolio of Investment.

(d)  The actual collateral received is greater than the amount shown here due to overcollateralization.

FASB Accounting Standards Update No. 2014-11 ("ASU No. 2014-11"), "Transfers & Servicing (Topic 860): Repurchase-to-Maturity Transactions, Repurchase Financings, and Disclosures", is intended to provide increased transparency about the types of collateral pledged in securities lending transactions and other similar transactions that are accounted for as secured borrowing.

The following tables display a breakdown of transactions accounted for as secured borrowings, the gross obligations by class of collateral pledged, and the remaining contractual maturity of those transactions as of June 30, 2017.

   

REMAINING CONTRACTUAL MATURITY OF THE AGREEMENTS

 

FUND

  OVERNIGHT AND
CONTINUOUS
 

<30 DAYS

  BETWEEN
30 & 90 DAYS
 

>90 DAYS

 

TOTAL

 

European Equity

 

Securities Lending Transactions

 

Common Stocks

 

$

509,730

   

$

   

$

   

$

   

$

509,730

   

Total Borrowings

 

$

509,730

   

$

   

$

   

$

   

$

509,730

   

Gross amount of recognized liabilities for securities lending transactions

 

$

509,730

   


52



Morgan Stanley Variable Investment Series

Notes to Financial Statements n June 30, 2017 (unaudited) continued

   

REMAINING CONTRACTUAL MATURITY OF THE AGREEMENTS

 

FUND

  OVERNIGHT AND
CONTINUOUS
 

<30 DAYS

  BETWEEN
30 & 90 DAYS
 

>90 DAYS

 

TOTAL

 

Multi Cap Growth

 

Securities Lending Transactions

 

Common Stocks

 

$

2,540,909

   

$

   

$

   

$

   

$

2,540,909

   

Total Borrowings

 

$

2,540,909

   

$

   

$

   

$

   

$

2,540,909

   

Gross amount of recognized liabilities for securities lending transactions

 

$

2,540,909

   

I. Dividends and Distributions to Shareholders — Dividends and distributions to shareholders are recorded on the ex-dividend date. Dividends from net investment income, if any, are declared and paid annually. Net realized capital gains, if any, are distributed at least annually.

J. Expenses — Direct expenses are charged to the respective Fund and general Trust expenses are allocated on the basis of relative net assets or equally among the Funds.

K. Use of Estimates — The preparation of financial statements in accordance with generally accepted accounting principles in the United States ("GAAP") requires management to make estimates and assumptions that affect the reported amounts and disclosures. Actual results could differ from those estimates.

L. Indemnifications — The Trust enters into contracts that contain a variety of indemnifications. The Trust's maximum exposure under these arrangements is unknown. However, the Trust has not had prior claims or losses pursuant to these contracts and expects the risk of loss to be remote.

2. Fair Valuation Measurements

Financial Accounting Standards Board ("FASB") Accounting Standards CodificationTM ("ASC") 820, "Fair Value Measurement" ("ASC 820"), defines fair value as the value that the Fund would receive to sell an investment or pay to transfer a liability in a timely transaction with an independent buyer in the principal market, or in the absence of a principal market, the most advantageous market for the investment or liability. ASC 820 establishes a three-tier hierarchy to distinguish between (1) inputs that reflect the assumptions market participants would use in valuing an asset or liability developed based on market data obtained from sources independent of the reporting entity (observable inputs); and (2) inputs that reflect the reporting entity's own assumptions about the assumptions market participants would use in valuing an asset or liability developed based on the best information available in the circumstances (unobservable inputs) and to establish classification of fair value measurements for disclosure purposes. Various inputs are used in


53



Morgan Stanley Variable Investment Series

Notes to Financial Statements n June 30, 2017 (unaudited) continued

determining the value of the Fund's investments. The inputs are summarized in the three broad levels listed below.

•  Level 1 — unadjusted quoted prices in active markets for identical investments

•  Level 2 — other significant observable inputs (including quoted prices for similar investments, interest rates, prepayment speeds, credit risk, etc.)

•  Level 3 — significant unobservable inputs including the Fund's own assumptions in determining the fair value of investments. Factors considered in making this determination may include, but are not limited to, information obtained by contacting the issuer, analysts, or the appropriate stock exchange (for exchange-traded securities), analysis of the issuer's financial statements or other available documents and, if necessary, available information concerning other securities in similar circumstances

The inputs or methodology used for valuing securities are not necessarily an indication of the risk associated with investing in those securities and the determination of the significance of a particular input to the fair value measurement in its entirety requires judgment and considers factors specific to each security.

The following is a summary of the inputs used to value each Fund's investments as of June 30, 2017.

Investment Type

  Level 1
Unadjusted
Quoted Prices
  Level 2
Other
Significant
Observable
Inputs
  Level 3
Significant
Unobservable
Inputs
 

Total

 

Limited Duration

 

Assets:

 

Fixed Income Securities

 

Corporate Bonds

 

$

   

$

19,771,602

   

$

   

$

19,771,602

   

Asset-Backed Securities

   

     

4,368,302

     

     

4,368,302

   

Mortgages — Other

   

     

1,153,641

     

     

1,153,641

   

Commercial Mortgage-Backed Securities

   

     

663,236

     

     

663,236

   

Sovereign

   

     

244,578

     

     

244,578

   
Collateralized Mortgage Obligations —
Agency Collateral Series
   

     

239,621

     

     

239,621

   

Agency Fixed Rate Mortgages

   

     

81,014

     

     

81,014

   

Total Fixed Income Securities

   

     

26,521,994

     

     

26,521,994

   


54



Morgan Stanley Variable Investment Series

Notes to Financial Statements n June 30, 2017 (unaudited) continued

Investment Type

  Level 1
Unadjusted
Quoted Prices
  Level 2
Other
Significant
Observable
Inputs
  Level 3
Significant
Unobservable
Inputs
 

Total

 

Short-Term Investments

 

U.S. Treasury Security

 

$

   

$

50,513

   

$

   

$

50,513

   

Investment Company

   

229,828

     

     

     

229,828

   

Total Short-Term Investments

   

229,828

     

50,513

     

     

280,341

   

Total Assets

   

229,828

     

26,572,507

     

     

26,802,335

   

Liabilities:

 

Futures Contracts

   

(12,125

)

   

     

     

(12,125

)

 

Total

 

$

217,703

   

$

26,572,507

   

$

   

$

26,790,210

   

Income Plus

 

Assets:

 

Fixed Income Securities

 

Corporate Bonds

 

$

   

$

97,375,996

   

$

   

$

97,375,996

   

Sovereign

   

     

552,963

     

     

552,963

   

Asset-Backed Security

   

     

126,230

     

     

126,230

   

Total Fixed Income Securities

   

     

98,055,189

     

     

98,055,189

   

Short-Term Investments

 

U.S. Treasury Security

   

     

880,512

     

     

880,512

   

Investment Company

   

1,661,891

     

     

     

1,661,891

   

Total Short-Term Investments

   

1,661,891

     

880,512

     

     

2,542,403

   

Futures Contracts

   

79,282

     

     

     

79,282

   

Total Assets

   

1,741,173

     

98,935,701

     

     

100,676,874

   

Liabilities:

 

Futures Contract

   

(25,094

)

   

     

     

(25,094

)

 

Credit Default Swap Agreements

   

     

(101,549

)

   

     

(101,549

)

 

Interest Rate Swap Agreement

   

     

(110,977

)

   

     

(110,977

)

 

Total Liabilities

   

(25,094

)

   

(212,526

)

   

     

(237,620

)

 

Total

 

$

1,716,079

   

$

98,723,175

   

$

   

$

100,439,254

   


55



Morgan Stanley Variable Investment Series

Notes to Financial Statements n June 30, 2017 (unaudited) continued

Investment Type

  Level 1
Unadjusted
Quoted Prices
  Level 2
Other
Significant
Observable
Inputs
  Level 3
Significant
Unobservable
Inputs
 

Total

 

European Equity

 

Assets:

 

Common Stocks

 
Aerospace & Defense  

$

872,264

   

$

   

$

   

$

872,264

   

Auto Components

   

502,835

     

     

     

502,835

   

Automobiles

   

582,933

     

     

     

582,933

   

Banks

   

2,978,139

     

     

     

2,978,139

   

Capital Markets

   

473,496

     

     

     

473,496

   

Chemicals

   

513,349

     

     

     

513,349

   

Construction Materials

   

609,600

     

     

     

609,600

   

Diversified Telecommunication Services

   

994,698

     

     

     

994,698

   

Electrical Equipment

   

795,062

     

     

     

795,062

   

Equity Real Estate Investment Trusts (REITs)

   

331,584

     

     

     

331,584

   

Food Products

   

1,592,329

     

     

     

1,592,329

   
Health Care Providers & Services    

816,233

     

     

     

816,233

   
Hotels, Restaurants & Leisure    

627,857

     

     

     

627,857

   

Household Products

   

900,582

     

     

     

900,582

   

Industrial Conglomerates

   

989,421

     

     

     

989,421

   

Information Technology Services

   

315,639

     

     

     

315,639

   

Insurance

   

2,518,969

     

     

     

2,518,969

   

Machinery

   

626,664

     

     

     

626,664

   

Media

   

623,082

     

     

     

623,082

   

Multi-Utilities

   

609,807

     

     

     

609,807

   
Oil, Gas & Consumable Fuels    

1,843,019

     

     

     

1,843,019

   

Personal Products

   

829,320

     

     

     

829,320

   

Pharmaceuticals

   

4,563,709

     

     

     

4,563,709

   

Professional Services

   

735,837

     

     

     

735,837

   
Semiconductors & Semiconductor Equipment    

771,360

     

     

     

771,360

   

Software

   

951,954

     

     

     

951,954

   
Textiles, Apparel & Luxury Goods    

425,038

     

     

     

425,038

   

Tobacco

   

1,770,650

     

     

     

1,770,650

   

Wireless Telecommunication Services

   

811,662

     

     

     

811,662

   

Total Common Stocks

   

30,977,092

     

     

     

30,977,092

   


56



Morgan Stanley Variable Investment Series

Notes to Financial Statements n June 30, 2017 (unaudited) continued

Investment Type

  Level 1
Unadjusted
Quoted Prices
  Level 2
Other
Significant
Observable
Inputs
  Level 3
Significant
Unobservable
Inputs
 

Total

 

Short-Term Investments

 

Investment Company

 

$

388,667

   

$

   

$

   

$

388,667

   

Repurchase Agreements

   

     

121,063

     

     

121,063

   

Total Short-Term Investments

   

388,667

     

121,063

     

     

509,730

   

Total Assets

 

$

31,365,759

   

$

121,063

   

$

   

$

31,486,822

   

Multi Cap Growth

 

Assets:

 

Common Stocks

 

Automobiles

 

$

3,644,667

   

$

   

$

   

$

3,644,667

   

Biotechnology

   

2,810,240

     

     

     

2,810,240

   
Health Care Equipment & Supplies    

11,862,362

     

     

     

11,862,362

   

Health Care Technology

   

29,444,897

     

     

     

29,444,897

   
Hotels, Restaurants & Leisure    

19,930,811

     

     

     

19,930,811

   

Information Technology Services

   

17,473,147

     

     

     

17,473,147

   
Internet & Direct Marketing Retail    

32,664,338

     

     

     

32,664,338

   
Internet Software & Services    

48,996,224

     

     

     

48,996,224

   
Life Sciences Tools & Services    

11,797,972

     

     

     

11,797,972

   
Semiconductors & Semiconductor Equipment    

7,716,179

     

     

     

7,716,179

   

Software

   

35,897,158

     

     

     

35,897,158

   

Total Common Stocks

   

222,237,995

     

     

     

222,237,995

   

Preferred Stocks

   

     

     

11,604,037

     

11,604,037

   

Call Option Purchased

   

     

22,526

     

     

22,526

   

Short-Term Investments

 

Investment Company

   

8,978,707

     

     

     

8,978,707

   

Repurchase Agreements

   

     

603,474

     

     

603,474

   

Total Short-Term Investments

   

8,978,707

     

603,474

     

     

9,582,181

   

Total Assets

 

$

231,216,702

   

$

626,000

   

$

11,604,037

   

$

243,446,739

   

Transfers between investment levels may occur as the markets fluctuate and/or the availability of data used in an investment's valuation changes. The Trust recognizes transfers between the levels as of the end of the period. As of June 30, 2017, the Trust did not have any investments transfer between investment levels.


57



Morgan Stanley Variable Investment Series

Notes to Financial Statements n June 30, 2017 (unaudited) continued

Following is a reconciliation of investments in which significant unobservable inputs (Level 3) were used in determining fair value:

   

Multi Cap Growth

 
   

Preferred Stocks

 

Beginning Balance

 

$

12,235,135

   

Purchases

   

   

Sales

   

   

Amortization of discount

   

   

Transfers in

   

   

Transfers out

   

   

Corporate actions

   

   

Change in unrealized appreciation (depreciation)

   

(631,098

)

 

Realized gains (losses)

   

   

Ending Balance

 

$

11,604,037

   
Net change in unrealized appreciation
(depreciation) from investments still held
as of June 30, 2017
 

$

(631,098

)

 

The following table presents additional information about valuation techniques and inputs used for investments that are measured at fair value and categorized within Level 3 as of June 30, 2017. Various valuation techniques were used in the valuation of certain investments and weighted based on the level of significance.

Multi Cap Growth

    Fair Value at
June 30,
2017
 

Valuation Technique

 

Unobservable Input

 

Range

  Selected
Value
  Impact
to
Valuation
from an
Increase
in Input
 
Electronic Equipment,
Instuments & Components
 

Preferred Stock

 

$

471,955

   

Discounted Cash Flow

  Weighted Average
Cost of Capital
   

25.0

%

   

27.0

%

   

26.0

%

 

Decrease

 
            Perpetual Growth
Rate
   

3.0

%

   

4.0

%

   

3.5

%

 

Increase

 
        Market Comparable
Companies
  Enterprise Value/
Revenue
   

12.0

x

   

20.8

x

   

12.0

x

 

Increase

 
            Discount for Lack
of Marketability
   

20.0

%

   

20.0

%

   

20.0

%

 

Decrease

 


58



Morgan Stanley Variable Investment Series

Notes to Financial Statements n June 30, 2017 (unaudited) continued

    Fair Value at
June 30,
2017
 

Valuation Technique

 

Unobservable Input

 

Range

  Selected
Value
  Impact
to
Valuation
from an
Increase
in Input
 
Hotels, Restaurants &
Leisure
 

Preferred Stock

 

$

1,489,293

   

Discounted Cash Flow

  Weighted Average
Cost of Capital
   

20.0

%

   

22.0

%

   

21.0

%

 

Decrease

 
            Perpetual Growth
Rate
   

2.5

%

   

3.5

%

   

3.0

%

 

Increase

 
        Market Comparable
Companies
  Enterprise Value/
Revenue
   

2.2

x

   

5.7

x

   

2.5

x

 

Increase

 
            Discount for Lack
of Marketability
   

20.0

%

   

20.0

%

   

20.0

%

 

Decrease

 
Internet & Direct
Marketing Retail
 

Preferred Stocks

 

$

4,600,621

   

Discounted Cash Flow

  Weighted Average
Cost of Capital
   

15.5

%

   

17.5

%

   

16.5

%

 

Decrease

 
            Perpetual Growth
Rate
   

3.0

%

   

4.0

%

   

3.5

%

 

Increase

 
        Market Comparable
Companies
  Enterprise Value/
Revenue
   

9.7

x

   

15.5

x

   

9.7

x

 

Increase

 
            Discount for Lack
of Marketability
   

20.0

%

   

20.0

%

   

20.0

%

 

Decrease

 
   

$

2,091,321

   

Discounted Cash Flow

  Weighted Average
Cost of Capital
   

17.0

%

   

19.0

%

   

18.0

%

 

Decrease

 
            Perpetual Growth
Rate
   

3.0

%

   

4.0

%

   

3.5

%

 

Increase

 
        Market Comparable
Companies
  Enterprise Value/
Revenue
   

2.1

x

   

8.3

x

   

2.2

x

 

Increase

 
            Discount for Lack
of Marketability
   

20.0

%

   

20.0

%

   

20.0

%

 

Decrease

 


59



Morgan Stanley Variable Investment Series

Notes to Financial Statements n June 30, 2017 (unaudited) continued

    Fair Value at
June 30,
2017
 

Valuation Technique

 

Unobservable Input

 

Range

  Selected
Value
  Impact
to
Valuation
from an
Increase
in Input
 
Life Sciences Tools &
Services
 

Preferred Stock

 

$

2,517,514

   

Discounted Cash Flow

  Weighted Average
Cost of Capital
   

25.5

%

   

27.5

%

   

26.5

%

 

Decrease

 
            Perpetual Growth
Rate
   

3.0

%

   

4.0

%

   

3.5

%

 

Increase

 
        Market Comparable
Companies
  Enterprise Value/
Revenue
   

2.4

x

   

3.3

x

   

3.2

x

 

Increase

 
            Discount for Lack
of Marketability
   

20.0

%

   

20.0

%

   

20.0

%

 

Decrease

 

Software

 

Preferred Stock

 

$

433,333

   

Discounted Cash Flow

  Weighted Average
Cost of Capital
   

19.0

%

   

21.0

%

   

20.0

%

 

Decrease

 
            Perpetual Growth
Rate
   

3.0

%

   

4.0

%

   

3.5

%

 

Increase

 
        Market Comparable
Companies
  Enterprise Value/
Revenue
   

4.8

x

   

6.6

x

   

5.0

x

 

Increase

 
            Discount for Lack
of Marketability
   

20.0

%

   

20.0

%

   

20.0

%

 

Decrease

 

3. Derivatives

Certain Funds may, but are not required to, use derivative instruments for a variety of purposes, including hedging, risk management, portfolio management or to earn income. Derivatives are financial instruments whose value is based, in part, on the value of an underlying asset, interest rate, index or financial instrument. Prevailing interest rates and volatility levels, among other things, also affect the value of derivative instruments. A derivative instrument often has risks similar to its underlying asset and may have additional risks, including imperfect correlation between the value of the derivative and the underlying asset, risks of default by the counterparty to certain transactions, magnification of losses incurred due to changes in the market value of the securities, instruments, indices or interest rates to which the derivative instrument relates, risks that the transactions may not be liquid and risks arising from margin requirements. The use of derivatives involves risks that are different from, and possibly greater than, the risks associated with other portfolio investments. Derivatives may involve the use of highly specialized instruments that require


60



Morgan Stanley Variable Investment Series

Notes to Financial Statements n June 30, 2017 (unaudited) continued

investment techniques and risk analyses different from those associated with other portfolio investments. All of a Fund's holdings, including derivative instruments, are marked-to-market each day with the change in value reflected in unrealized appreciation (depreciation). Upon disposition, a realized gain or loss is recognized.

Certain derivative transactions may give rise to a form of leverage. Leverage magnifies the potential for gain and risk of loss. Leverage associated with derivative transactions may cause a Fund to liquidate portfolio positions when it may not be advantageous to do so to satisfy its obligations or to meet earmarking or segregation requirements, pursuant to applicable Securities and Exchange Commission ("SEC") rules and regulations, or may cause a Fund to be more volatile than if the Fund had not been leveraged. Although the Adviser and/or Sub-Adviser seek to use derivatives to further the Fund's investment objectives, there is no assurance that the use of derivatives will achieve this result.

Following is a description of the derivative instruments and techniques that a Fund used during the period and their associated risks:

Options — With respect to options, certain Funds are subject to equity risk, interest rate risk and foreign currency exchange risk in the normal course of pursuing its investment objectives. If a Fund buys an option, it buys a legal contract giving it the right to buy or sell a specific amount of the underlying instrument or foreign currency, or futures contract on the underlying instrument or foreign currency, at an agreed-upon price during a period of time or on a specified date typically in exchange for a premium paid by a Fund. A Fund may purchase and/or sell put and call options. Purchasing call options tends to increase a Fund's exposure to the underlying (or similar) instrument. Purchasing put options tends to decrease a Fund's exposure to the underlying (or similar) instrument. When entering into purchased option contracts, a Fund bears the risk of interest or exchange rates or securities prices moving unexpectedly, in which case, a Fund may not achieve the anticipated benefits of the purchased option contracts; however the risk of loss is limited to the premium paid. Purchased options are reported as part of "Total Investments in Securities" in the Statements of Assets and Liabilities. Premium paid for purchasing options which expired are treated as realized losses. If a Fund sells an option, it sells to another party the right to buy from or sell to a Fund a specific amount of the underlying instrument or foreign currency, or futures contract on the underlying instrument or foreign currency, at an agreed upon price during a period of time or on a specified date typically in exchange for a premium received by a Fund. When options are purchased OTC, a Fund bears the risk that the counterparty that wrote the option will be unable or unwilling to perform its obligations under the option contract. Options may also be illiquid and a Fund may have difficulty closing out its position. A decision as to whether, when and how to use options involves the exercise of skill and judgment


61



Morgan Stanley Variable Investment Series

Notes to Financial Statements n June 30, 2017 (unaudited) continued

and even a well-conceived option transaction may be unsuccessful because of market behavior or unexpected events. The prices of options can be highly volatile and the use of options can lower total returns.

Futures — A futures contract is a standardized, exchange-traded agreement to buy or sell a specific quantity of an underlying asset, reference rate or index at a specific price at a specific future time. The value of a futures contract tends to increase and decrease in tandem with the value of the underlying instrument. Depending on the terms of the particular contract, futures contracts are settled through either physical delivery of the underlying instrument on the settlement date or by payment of a cash settlement amount on the settlement date. During the period the futures contract is open, payments are received from or made to the broker based upon changes in the value of the contract (the variation margin). A decision as to whether, when and how to use futures contracts involves the exercise of skill and judgment and even a well-conceived futures transaction may be unsuccessful because of market behavior or unexpected events. In addition to the derivatives risks discussed above, the prices of futures contracts can be highly volatile, using futures contracts can lower total return, and the potential loss from futures contracts can exceed a Fund's initial investment in such contracts. No assurance can be given that a liquid market will exist for any particular futures contract at any particular time. There is also the risk of loss by a Fund of margin deposits in the event of bankruptcy of a broker with which a Fund has open positions in the futures contract.

Swaps — A Fund may enter into OTC swap contracts or cleared swap transactions. A swap contract is an agreement between two parties pursuant to which the parties exchange payments at specified dates on the basis of a specified notional amount, with the payments calculated by reference to specified securities, indices, reference rates, currencies or other instruments. Typically swap agreements provide that when the period payment dates for both parties are the same, the payments are made on a net basis (i.e., the two payment streams are netted out, with only the net amount paid by one party to the other). A Fund's obligations or rights under a swap contract entered into on a net basis will generally be equal only to the net amount to be paid or received under the agreement, based on the relative values of the positions held by each party. Cleared swap transactions help reduce counterparty credit risk. In a cleared swap, a Fund's ultimate counterparty is a clearinghouse rather than a swap dealer, bank or other financial institution. OTC swap agreements are not entered into or traded on exchanges and often there is no central clearing or guaranty function for OTC swaps. These OTC swaps are often subject to credit risk or the risk of default or non-performance by the counterparty. Both OTC and cleared swaps could result in losses if interest rates, foreign currency exchange rates or other factors are not correctly anticipated by a Fund or if the reference index, security or investments do not perform as expected. During the period swap agreements are open, payments are received from or made to the clearinghouse or counterparty based upon changes in the value of the


62



Morgan Stanley Variable Investment Series

Notes to Financial Statements n June 30, 2017 (unaudited) continued

contract (variation margin). The Dodd-Frank Wall Street Reform and Consumer Protection Act and related regulatory developments require the clearing and exchange-trading of certain standardized swap transactions. Mandatory exchange-trading and clearing is occurring on a phased-in basis.

A Fund's use of swaps during the period included those based on the credit of an underlying security commonly referred to as credit default swaps. A Fund may be either the buyer or seller in a credit default swap. As the buyer in a credit default swap, a Fund would pay to the counterparty the periodic stream of payments. If no default occurs, a Fund would receive no benefit from the contract. As the seller in a credit default swap, a Fund would receive the stream of payments but would be subject to exposure on the notional amount of the swap, which it would be required to pay in the event of default. The use of credit default swaps could result in losses to a Fund if the Adviser fails to correctly evaluate the creditworthiness of the issuer of the referenced debt obligation.

If the Fund is a seller of protection and a credit event occurs, as defined under the terms of that particular swap agreement, the Fund will either (i) pay to the buyer of protection an amount equal to the notional amount of the swap agreement and take delivery of the referenced obligation, other deliverable obligations or underlying securities comprising the referenced index or (ii) pay a net settlement amount in the form of cash or securities equal to the notional amount of the swap agreement less the recovery value of the referenced obligation or underlying securities comprising the referenced index. If the Fund is a buyer of protection and a credit event occurs, as defined under the terms of that particular swap agreement, the Fund will either (i) receive from the seller of protection an amount equal to the notional amount of the swap agreement and deliver the referenced obligation, other deliverable obligations or underlying securities comprising the referenced index or (ii) receive a net settlement amount in the form of cash or securities equal to the notional amount of the swap agreement less the recovery value of the referenced obligation or underlying securities comprising the referenced index. Recovery values are estimated by market makers considering either industry standard recovery rates or entity specific factors and considerations until a credit event occurs. If a credit event has occurred, the recovery value is determined by a facilitated auction whereby a minimum number of allowable broker bids, together with a specified valuation method, are used to calculate the settlement value. The Fund's maximum risk of loss from counterparty risk, either as the protection seller or as the protection buyer, is the fair value of the swap agreement.

The current credit rating of each individual issuer is listed in the table following the Fund of Investments and serves as an indicator of the current status of the payment/performance risk of the credit derivative. Alternatively, for credit default swaps on an index of credits, the quoted market prices and current values serve as an indicator of the current status of the payment/performance risk of the credit derivative.


63



Morgan Stanley Variable Investment Series

Notes to Financial Statements n June 30, 2017 (unaudited) continued

Generally, lower credit ratings and increasing market values, in absolute terms, represent a deterioration of the credit and a greater likelihood of an adverse credit event of the issuer.

When a Fund has an unrealized loss on a swap agreement, the Fund has instructed the custodian to pledge cash or liquid securities as collateral with a value approximately equal to the amount of the unrealized loss. Collateral pledges are monitored and subsequently adjusted if and when the swap valuations fluctuate. If applicable, cash collateral is included with "Due from (to) Broker" in the Statements of Assets and Liabilities.

Upfront payments received or paid by a Fund will be reflected as an asset or liability, respectively, in the Statements of Assets and Liabilities.

FASB ASC 815, "Derivatives and Hedging" ("ASC 815"), is intended to improve financial reporting about derivative instruments by requiring enhanced disclosures to enable investors to better understand how and why a Fund uses derivative instruments, how these derivative instruments are accounted for and their effects on a Fund's financial position and results of operations.

The following table sets forth the fair value of each Fund's derivative contracts by primary risk exposure as of June 30, 2017.

FUND

  PRIMARY RISK
EXPOSURE
  ASSET DERIVATIVES
STATEMENTS OF
ASSETS AND
LIABILITIES LOCATION
 

FAIR VALUE

  LIABILITY DERIVATIVES
STATEMENTS OF
ASSETS AND
LIABILITIES LOCATION
 

FAIR VALUE

 
Limited Duration
  Interest Rate
Risk
  Variation margin on
open futures contracts
 

$

    Variation margin on
open futures contract
 

$

(12,125

)(e)

 
 

Income Plus

    Interest Rate
Risk
  Variation margin on
open futures contracts
 

$

79,282

(e)

  Variation margin on
open futures contract
 

$

(25,094

)(e)

 
        Credit Risk
 
  Variation margin on
open swap agreements
   

    Variation margin on
open swap agreement
   

(71,682

)(e)

 
            Unrealized appreciation on
open swap agreements
   

    Unrealized depreciation on
open swap agreement
   

(29,867

)

 
        Interest Rate
Risk
  Variation margin on
open swap agreements
   

    Variation margin on
open swap agreement
   

(110,977

)(e)   
               

$

79,282

       

$

(237,620

)

 
 

Multi Cap Growth

    Currency
Risk
  Investments, at Value
(Option Purchased)
 

$

22,526

(f)

 
 
         

(e)  Includes cumulative appreciation (depreciation) as reported in the Portfolio of Investments. Only current day's net variation margin is reported within the Statements of Assets and Liabilities.

(f)  Amounts are included in Investments in securities in the Statements of Assets and Liabilities.


64



Morgan Stanley Variable Investment Series

Notes to Financial Statements n June 30, 2017 (unaudited) continued

The following tables set forth by primary risk exposure of each Fund's realized gains (losses) and change in unrealized appreciation (depreciation) by type of derivative contract for the six months ended June 30, 2017 in accordance with ASC 815.

   

AMOUNT OF REALIZED GAIN (LOSS) ON DERIVATIVES

 

FUND

  PRIMARY RISK
EXPOSURE
  FUTURES
CONTRACTS
  OPTION
PURCHASED(g) 
  SWAP
AGREEMENTS
 

Limited Duration

 

Interest Rate Risk

 

$

46,092

   

$

   

$

   
   

Credit Risk

   

     

     

   
   

Total

 

$

46,092

   

$

   

$

   

Income Plus

 

Interest Rate Risk

 

$

15,776

   

$

   

$

(53,882

)

 
   

Credit Risk

   

     

     

(84,568

)

 
   

Currency Risk

   

     

     

   
   

Total

 

$

15,776

   

$

   

$

(138,450

)

 

Multi Cap Growth

 

Currency Risk

 

$

   

$

(109,344

)

 

$

   
   

CHANGE IN UNREALIZED APPRECIATION (DEPRECIATION) ON DERIVATIVES

 

FUND

  PRIMARY RISK
EXPOSURE
  FUTURES
CONTRACTS
  OPTIONS
PURCHASED(g) 
  SWAP
AGREEMENTS
 

Limited Duration

 

Interest Rate Risk

 

$

(7,875

)

 

$

   

$

   
   

Credit Risk

   

     

     

   
   

Total

 

$

(7,875

)

 

$

   

$

   

Income Plus

 

Interest Rate Risk

 

$

38,180

   

$

   

$

(56,417

)

 
   

Credit Risk

   

     

     

(10,428

)

 
   

Currency Risk

   

     

     

   
   

Total

 

$

38,180

   

$

   

$

(66,845

)

 

Multi Cap Growth

 

Currency Risk

 

$

   

$

(90,238

)

 

$

   

(g)  Amounts are included in Investments in the Statements of Operations.

At June 30, 2017, each Fund's derivative assets and liabilities are as follows:

    GROSS AMOUNTS OF ASSETS AND LIABILITIES PRESENTED
IN THE STATEMENTS OF ASSETS AND LIABILITIES
 

FUND

  DERIVATIVES(h)    ASSETS(i)    LIABILITIES(i)   

Income Plus

 

Swap Agreement

 

$

   

$

29,867

   

Multi Cap Growth

 

Option Purchased

 

$

22,526

(f)

 

$

   

(f)  Amounts are included in Investments in securities in the Statements of Assets and Liabilities.


65



Morgan Stanley Variable Investment Series

Notes to Financial Statements n June 30, 2017 (unaudited) continued

(h)  Excludes exchange traded derivatives.

(i)  Absent an event of default or early termination, OTC derivative assets and liabilities are presented gross and not offset in the Statements of Assets and Liabilities.

Certain Funds typically enter into International Swaps and Derivatives Association, Inc. Master Agreements ("ISDA Master Agreements") or similar master agreements (collectively, "Master Agreements") with their respective contract counterparties for certain OTC derivatives in order to, among other things, reduce its credit risk to counterparties. ISDA Master Agreements include provisions for general obligations, representations, collateral and events of default or termination. Under an ISDA Master Agreement, a Fund typically may offset with the counterparty certain OTC derivative financial instruments' payables and/or receivables with collateral held and/or posted and create one single net payment (close-out netting) in the event of default, termination and/or potential deterioration in the credit quality of the counterparty. Various Master Agreements govern the terms of certain transactions with counterparties, including transactions such as swap, forward, repurchase and reverse repurchase agreements. These Master Agreements typically attempt to reduce the counterparty risk associated with such transactions by specifying credit protection mechanisms and providing standardization that improves legal certainty. Cross-termination provisions under Master Agreements typically provide that a default in connection with one transaction between a Fund and a counterparty gives the non-defaulting party the right to terminate any other transactions in place with the defaulting party to create one single net payment due to/due from the defaulting party and may be a feature in certain Master Agreements. In the event a Fund exercises its right to terminate a Master Agreement after a counterparty experiences a termination event as defined in the Master Agreement, the return of collateral with market value in excess of a Fund's net liability may be delayed or denied.

The following tables present derivative financial instruments that are subject to enforceable netting arrangements as of June 30, 2017.

  GROSS AMOUNTS NOT OFFSET IN THE STATEMENTS OF ASSETS AND LIABILITIES

FUND

 

COUNTERPARTY

  GROSS
ASSET
DERIVATIVES
PRESENTED IN
STATEMENTS OF
ASSETS AND
LIABILITIES
  FINANCIAL
INSTRUMENT
  COLLATERAL
RECEIVED
  NET
AMOUNT
(NOT LESS
THAN $0)
 

Multi Cap Growth

 

Royal Bank of Scotland

 

$

22,526

   

$

   

$

   

$

22,526

   


66



Morgan Stanley Variable Investment Series

Notes to Financial Statements n June 30, 2017 (unaudited) continued

  GROSS AMOUNTS NOT OFFSET IN THE STATEMENTS OF ASSETS AND LIABILITIES

FUND

 

COUNTERPARTY

  GROSS
LIABILITIES
DERIVATIVES
PRESENTED IN
STATEMENTS OF
ASSETS AND
LIABILITIES
  FINANCIAL
INSTRUMENT
  COLLATERAL
PLEDGED
  NET
AMOUNT
(NOT LESS
THAN $0)
 

Income Plus

 

Barclays Bank PLC

 

$

29,867

   

$

   

$

   

$

29,867

   

For the six months ended June 30, 2017, the average monthly amount outstanding for each derivative type is as follows:

Limited Duration:

 

Futures Contracts:

 

Average monthly original value

 

$

7,278,022

   

Income Plus:

 

Future Contracts:

 

Average monthly original value

 

$

32,275,955

   

Swap Agreements:

 

Average monthly notional amount

 

$

13,183,499

   

Multi Cap Growth:

 

Options Purchased:

 
Average monthly notional amount    

29,964,215

   

4. Advisory/Administration and Sub-Advisory Agreements

Pursuant to an Investment Advisory Agreement with the Adviser and Sub-Adviser, the Trust pays an advisory fee, accrued daily and payable monthly, by applying the annual rates listed below to each Fund's net assets determined at the close of each business day.

Limited Duration — 0.30%.

Income Plus — 0.42% to the portion of the daily net assets not exceeding $500 million; 0.35% to the portion of the daily net assets exceeding $500 million but not exceeding $1.25 billion; and 0.22% to the portion of the daily net assets in excess of $1.25 billion. For the six months ended June 30, 2017, the advisory fee rate (net of rebate) was equivalent to an annual effective rate of 0.42% of the Fund's average daily net assets.

European Equity — 0.87% to the portion of the daily net assets not exceeding $500 million; 0.82% to the portion of the daily net assets exceeding $500 million but not exceeding $2 billion; 0.77% to the portion of


67



Morgan Stanley Variable Investment Series

Notes to Financial Statements n June 30, 2017 (unaudited) continued

the daily net assets exceeding $2 billion but not exceeding $3 billion; and 0.745% to the portion of the daily net assets in excess of $3 billion. For the six months ended June 30, 2017, the advisory fee rate (net of waivers/rebate) was equivalent to an annual effective rate of 0.45% of the Fund's average daily net assets.

Multi Cap Growth — 0.42% to the portion of the daily net assets not exceeding $1 billion; 0.395% to the portion of the daily net assets exceeding $1 billion but not exceeding $2 billion; and 0.37% to the portion of the daily net assets in excess of $2 billion. For the six months ended June 30, 2017, the advisory fee rate (net of waivers/rebate) was equivalent to an annual effective rate of 0.41% of the Fund's average daily net assets.

Under the Sub-Advisory Agreement between the Adviser and Sub-Adviser, the Sub-Adviser provides European Equity Portfolio with advisory services subject to the overall supervision of the Adviser and the Trust's Officers and Trustees. The Adviser pays the Sub-Adviser on a monthly basis a portion of the net advisory fees the Adviser receives from the Fund.

The Adviser also serves as the Administrator to the Trust and provides administrative services pursuant to an Administration Agreement for an annual fee, accrued daily and paid monthly, of 0.08% of each Fund's average daily net assets.

The Adviser/Administrator has agreed to reduce its advisory fee, its administration fee and/or reimburse European Equity Portfolio so that total annual Fund operating expenses, excluding certain investment related expenses, 12b-1 fees, taxes, interest and other extraordinary expenses (including litigation), will not exceed 1.00%. The fee waivers and/or expense reimbursements will continue for at least one year from the date of the Fund's prospectus(es) or until such time that the Trustees act to discontinue all or a portion of such waivers and/or reimbursements when they deem such action is appropriate. For the six months ended June 30, 2017, $63,910 of advisory fees were waived pursuant to this arrangement.

The Adviser/Administrator has agreed to reduce its advisory fee, its administration fee and/or reimburse Multi Cap Growth Portfolio so that total Fund operating expenses, excluding certain investment related expenses, 12b-1 fees, taxes, interest and other extraordinary expenses (including litigation), will not exceed 0.57%. The fee waivers and/or expense reimbursements will continue for at least one year from the date of the Fund's prospectus(es) or until such time that the Trustees act to discontinue all or a portion of such waivers and/or reimbursements when they deem such action is appropriate. For the six months ended June 30, 2017, $10,265 of other expenses were reimbursed by the Adviser pursuant to this arrangement.

Under a Sub-Administration agreement between the Administrator and State Street, State Street provides certain administrative services to the Trust. For such services, the Administrator pays State Street a portion of the fee the Administrator receives from each Fund.


68



Morgan Stanley Variable Investment Series

Notes to Financial Statements n June 30, 2017 (unaudited) continued

5. Plan of Distribution

Shares of the Trust are distributed by Morgan Stanley Distribution, Inc. (the "Distributor"), an affiliate of the Adviser/Administrator and Sub-Adviser. The Trust has adopted a Plan of Distribution (the "Plan") pursuant to Rule 12b-1 under the Act. Under the Plan, Class Y shares of each Fund bear a distribution fee which is accrued daily and paid monthly at the annual rate of 0.25% of the average daily net assets of the class.

6. Dividend Disbursing and Transfer Agent

The Trust's dividend disbursing and transfer agent is Boston Financial Data Services, Inc. ("BFDS"). Pursuant to a Transfer Agency Agreement, the Trust pays BFDS a fee based on the number of classes, accounts and transactions relating to the Funds of the Trust.

7. Custodian Fees

State Street (the "Custodian") serves as Custodian for the Trust in accordance with a Custodian Agreement. The Custodian holds cash, securities, and other assets of the Trust as required by the Act. Custody fees are payable monthly based on assets held in custody, investment purchases and sales activity and account maintenance fees, plus reimbursement for certain out-of-pocket expenses.

8. Security Transactions and Transactions with Affiliates

For the six months ended June 30, 2017, purchases and sales of investment securities, excluding short-term investments, were as follows:

   

U.S. GOVERNMENT SECURITIES

 

OTHER

 

FUND

 

PURCHASES

 

SALES

 

PURCHASES

 

SALES

 

Limited Duration

 

$

807,272

   

$

1,004,542

   

$

4,772,661

   

$

5,533,261

   

Income Plus

   

     

     

31,357,238

     

37,230,738

   

European Equity

   

     

     

2,180,713

     

3,513,792

   

Multi Cap Growth

   

     

     

38,885,447

     

58,663,026

   

Each Fund invests in the Institutional Class of the Morgan Stanley Institutional Liquidity Funds (the "Liquidity Funds"), an open-end management investment company managed by the Adviser, both directly and as a portion of the securities held as collateral on loaned securities. Advisory fees paid by each Fund are reduced by an amount equal to its pro-rata share of advisory and administrative fees paid by the Fund due to its investment in the Liquidity Funds.


69



Morgan Stanley Variable Investment Series

Notes to Financial Statements n June 30, 2017 (unaudited) continued

A summary of each Fund's transactions in shares of the Liquidity Funds during the six months ended June 30, 2017 is as follows:

FUND

  VALUE
DECEMBER 31, 2016
  PURCHASES
AT COST
 

SALES

  DIVIDEND
INCOME
  VALUE
JUNE 30, 2017
 

Limited Duration

 

$

479,800

   

$

4,334,603

   

$

4,584,575

   

$

708

   

$

229,828

   

Income Plus

   

2,416,859

     

16,591,169

     

17,346,137

     

3,386

     

1,661,891

   

European Equity

   

500,504

     

2,468,191

     

2,580,028

     

641

     

388,667

   

Multi Cap Growth

   

11,483,070

     

40,651,956

     

43,156,319

     

15,178

     

8,978,707

   

For the six months ended June 30, 2017, advisory fees paid were reduced by the following relating to each Fund's investment in the Liquidity Funds:

FUND

  ADVISORY FEE
REDUCTION
 

Limited Duration

 

$

201

   

Income Plus

   

924

   

European Equity

   

221

   

Multi Cap Growth

   

4,604

   

The Trust is permitted to purchase and sell securities ("cross-trade") from and to other Morgan Stanley Funds as well as other funds and client accounts for which the Adviser or an affiliate of the Adviser serves as investment adviser, pursuant to procedures approved by the Trustees in compliance with Rule 17a-7 under the Act (the "Rule"). Each cross-trade is executed at the current market price in compliance with provisions of the Rule. For the six months ended June 30, 2017, the Trust did not engage in any cross-trade transactions.

The following Funds had transactions with the following affiliates of the Trust:

FUND

 

ISSUER

  VALUE
DECEMBER 31,
2016
  PURCHASES
AT COST
 

SALES

  NET
REALIZED
GAIN (LOSS)
  INTEREST
INCOME
  VALUE
JUNE 30,
2017
 
Limited
Duration
  Metropolitan Life Global
Funding I
 

$

322,190

   

$

149,996

   

$

(149,513

)

 

$

(417

)

 

$

2,801

   

$

324,505

   
Income
Plus
 

MetLife, Inc.

   

589,376

     

     

     

     

14,250

     

617,428

   


70



Morgan Stanley Variable Investment Series

Notes to Financial Statements n June 30, 2017 (unaudited) continued

For the six months ended June 30, 2017, the Multi Cap Growth Portfolio incurred $5,117 in brokerage commissions with Morgan Stanley & Co., LLC, an affiliate of the Adviser/Administrator and Distributor, for portfolio transactions executed on behalf of the Fund.

The Trust has an unfunded noncontributory defined benefit pension plan covering certain independent Trustees of the Trust who will have served as independent Trustees for at least five years at the time of retirement. Benefits under this plan are based on factors which include years of service and compensation. The Trustees voted to close the plan to new participants and eliminate the future benefits growth due to increases to compensation after July 31, 2003.

At June 30, 2017, the accrued pension liability reflected as "Trustees' fees" in the Statements of Assets and Liabilities is as follows:

   

AGGREGATE PENSION LIABILITY

 
LIMITED
DURATION
  INCOME
PLUS
  EUROPEAN
EQUITY
  MULTI CAP
GROWTH
 
$

1,202

   

$

4,537

   

$

1,269

   

$

9,624

   

The Trust has an unfunded Deferred Compensation Plan (the "Compensation Plan"), which allows each independent Trustee to defer payment of all, or a portion, of the fees he or she receives for serving on the Board of Trustees. Each eligible Trustee generally may elect to have the deferred amounts credited with a return equal to the total return on one or more of the Morgan Stanley funds that are offered as investment options under the Compensation Plan. Appreciation/depreciation and distributions received from these investments are recorded with an offsetting increase/decrease in the deferred compensation obligation and do not affect the NAV of the Trust.

9. Federal Income Tax Status

It is the Funds' intention to continue to qualify as a regulated investment company and distribute all of its taxable and tax-exempt income. Accordingly, no provision for federal income taxes is required in the financial statements.

A Fund may be subject to taxes imposed by countries in which it invests. Such taxes are generally based on income and/or capital gains earned or repatriated. Taxes are accrued based on net investment income, net realized gains and net unrealized appreciation as such income and/or gains are earned. Taxes may also be based on transactions in foreign currency and are accrued based on the value of investments denominated in such currency.


71



Morgan Stanley Variable Investment Series

Notes to Financial Statements n June 30, 2017 (unaudited) continued

FASB ASC 740-10, "Income Taxes — Overall", sets forth a minimum threshold for financial statement recognition of the benefit of a tax position taken or expected to be taken in a tax return. Management has concluded there are no significant uncertain tax positions that would require recognition in the financial statements. If applicable, the Funds recognize interest accrued related to unrecognized tax benefits in "Interest Expense" and penalties in "Other Expenses" in the Statements of Operations. The Funds file tax returns with the U.S. Internal Revenue Service, New York and various states. Each of the tax years in the four-year period ended December 31, 2016 remains subject to examination by taxing authorities.

The tax character of distributions paid may differ from the character of distributions shown in the Statements of Changes in Net Assets due to short-term capital gains being treated as ordinary income for tax purposes. The tax character of distributions paid during fiscal years 2016 and 2015 was as follows:

   

2016 DISTRIBUTIONS PAID FROM:

 

2015 DISTRIBUTIONS PAID FROM:

 

FUND

  ORDINARY
INCOME
  LONG-TERM
CAPITAL GAIN
  ORDINARY
INCOME
  LONG-TERM
CAPITAL GAIN
 

Limited Duration

 

$

385,549

   

$

   

$

369,128

   

$

   

Income Plus

   

4,164,323

     

2,689,896

     

4,860,741

     

79,353

   

European Equity

   

904,460

     

     

2,049,674

     

   

Multi Cap Growth

   

     

35,643,300

     

1,218,034

     

42,696,379

   

The amount and character of income and gains to be distributed are determined in accordance with income tax regulations which may differ from GAAP. These book/tax differences are either considered temporary or permanent in nature.

Temporary differences are primarily due to differing book and tax treatments for the timing of the recognition of gains (losses) on certain investment transactions and the timing of the deductibility of certain expenses.

Permanent differences, primarily due to differing treatments of gains (losses) related to foreign currency transactions, swap transactions, paydown adjustments, expiring capital losses, a net operating losses, book amortization of premium on debt securities and nondeductible expenses, resulted in the following reclassifications among the Funds' components of net assets at December 31, 2016:

FUND

  ACCUMULATED UNDISTRIBUTED
NET INVESTMENT INCOME (LOSS)
  ACCUMULATED
NET REALIZED GAIN (LOSS)
 

PAID-IN-CAPITAL

 

Limited Duration

 

$

71,265

   

$

16,908,820

   

$

(16,980,085

)

 

Income Plus

   

(219,233

)

   

219,233

     

   

European Equity

   

(26,135

)

   

26,135

     

   

Multi Cap Growth

   

111,188

     

250,524

     

(361,712

)

 


72



Morgan Stanley Variable Investment Series

Notes to Financial Statements n June 30, 2017 (unaudited) continued

At December 31, 2016, the components of distributable earnings on a tax basis were as follows:

FUND

  UNDISTRIBUTED
ORDINARY
INCOME
  UNDISTRIBUTED
LONG-TERM
CAPITAL GAIN
 

Limited Duration

 

$

551,050

   

$

   

Income Plus

   

3,452,812

     

   

European Equity

   

882,962

     

   

Multi Cap Growth

   

     

24,057,579

   

At December 31, 2016, the following Funds had available for federal income tax purposes unused short term and/or long term capital losses that will not expire:

FUND

  SHORT TERM LOSSES
(NO EXPIRATION)
  LONG TERM LOSSES
(NO EXPIRATION)
 

Income Plus

 

$

7,544

   

$

   

European Equity

   

767,923

     

   

In addition, at December 31, 2016, the following Funds had available capital loss carryforwards to offset future net capital gains, to the extent provided by regulations, through the indicated expiration dates:

   

AMOUNTS IN THOUSANDS AVAILABLE THROUGH DECEMBER 31,

 

FUND

 

2017

 

2018

 

TOTAL

 

Limited Duration

 

$

8,980

   

$

   

$

8,980

   

European Equity

   

4,122

     

3,315

     

7,437

   

During the year ended December 31, 2016, the following Funds expired capital loss carryforwards for U.S. federal income tax purposes of:

FUND

  EXPIRED CAPITAL
LOSS CARRYFORWARDS
 

Limited Duration

 

$

16,980,085

   

To the extent that capital loss carryforwards are used to offset any future capital gains realized during the carryover period as provided by U.S. federal income tax regulations, no capital gains tax liability will be incurred by a Fund for gains realized and not distributed. To the extent that capital gains are offset, such gains will not be distributed to the shareholders.


73



Morgan Stanley Variable Investment Series

Notes to Financial Statements n June 30, 2017 (unaudited) continued

During the year ended December 31, 2016, the following Funds utilized capital loss carryforwards for U.S. federal income tax purposes of:

FUND

  UTILIZED CAPITAL
LOSS CARRYFORWARDS
 

Limited Duration

 

$

622,822

   

European Equity

   

6,478

   

10. Purposes of and Risks Relating to Certain Financial Instruments

Certain Funds may lend securities to qualified financial institutions, such as broker-dealers, to earn additional income. Risks in securities lending transactions are that a borrower may not provide additional collateral when required or return the securities when due, and that the value of the short-term investments will be less than the amount of cash collateral plus any rebate that is required to be returned to the borrower.

Certain Funds may invest in mortgage securities, including securities issued by the Federal National Mortgage Association ("FNMA") and Federal Home Loan Mortgage Corporation ("FHLMC"). These are fixed income securities that derive their value from or represent interests in a pool of mortgages or mortgage securities. An unexpectedly high rate of defaults on the mortgages held by a mortgage pool may adversely affect the value of a mortgage-backed security and could result in losses to the Funds. The risk of such defaults is generally higher in the case of mortgage pools that include sub-prime mortgages. Sub-prime mortgages refer to loans made to borrowers with weakened credit histories or with a lower capacity to make timely payments on their mortgages. The securities issued by FNMA and FHLMC that are held by the Funds are not backed by sub-prime mortgages.

Additionally, securities issued by FNMA and FHLMC are not backed by or entitled to the full faith and credit of the United States; rather, they are supported by the right of the issuer to borrow from the U.S. Department of the Treasury.

The Federal Housing Finance Agency ("FHFA") serves as conservator of FNMA and FHLMC and the U.S. Department of the Treasury has agreed to provide capital as needed to ensure FNMA and FHLMC continue to provide liquidity to the housing and mortgage markets.

Foreign security and currency transactions may involve certain considerations and risks not typically associated with those of U.S. dollar denominated transactions as a result of, among other factors, fluctuations of exchange rates in relation to the U.S. dollar, the possibility of lower levels of governmental supervision and regulation of foreign securities markets and the possibility of political or economic instability.


74



Morgan Stanley Variable Investment Series

Notes to Financial Statements n June 30, 2017 (unaudited) continued

At June 30, 2017, European Equity Portfolio's investments in securities of issuers in the United Kingdom, Germany, France and Switzerland represented 28.4%, 16.6%, 16.6% and 15.8%, respectively, of the Fund's net assets. These investments, as well as other non-U.S. investments, which involve risks and considerations not present with respect to U.S. securities, may be affected by economic or political developments in these countries.

11. Credit Facility

The Trust and other Morgan Stanley funds participated in a $150,000,000 committed, unsecured revolving line of credit facility (the "facility") with State Street. This facility is to be used for temporary emergency purposes or funding of shareholder redemption requests. The interest rate on borrowings is based on the federal funds rate or one month libor rate plus a spread. The facility also has a commitment fee of 0.25% per annum based on the unused portion of the facility. During the six months ended June 30, 2017, the Funds did not have any borrowings under the facility.

12. Other

At June 30, 2017, certain Funds had record owners of 10% or greater. Investment activities of these shareholders could have a material impact on these Funds. These Funds and the aggregate percentage of such owners were as follows:

    PERCENTAGE OF
OWNERSHIP
 

Limited Duration

   

96.5

%

 

Income Plus

   

94.6

   

European Equity

   

93.1

   

Multi Cap Growth

   

95.2

   

13. Accounting Pronouncement

In October 2016, the SEC issued a new rule, Investment Company Reporting Modernization, which, among other provisions, amends Regulation S-X to require standardized, enhanced disclosures, particularly related to derivatives, in investment company financial statements. Compliance with the guidance is effective for financial statements with reports ending on or after August 1, 2017; adoption will have no effect on the Funds' net assets or results of operations. Although still evaluating the potential impact of the Investment Company Reporting Modernization to the Funds, management expects that the impact of the Funds' adoption will be limited to additional financial statement disclosures.


75




Morgan Stanley Variable Investment Series

Financial Highlights

                             
FOR THE YEAR
ENDED
DECEMBER 31
  NET ASSET
VALUE
BEGINNING
OF PERIOD
  NET
INVESTMENT
INCOME(1)
  NET REALIZED
AND
UNREALIZED
GAIN (LOSS)
  TOTAL FROM
INVESTMENT
OPERATIONS
  DIVIDENDS
TO
SHAREHOLDERS
  DISTRIBUTIONS
TO
SHAREHOLDERS
  TOTAL
DIVIDENDS
AND
DISTRIBUTIONS
 
LIMITED DURATION
CLASS X SHARES
     
 

2012

   

$

7.69

   

$

0.12

   

$

0.13

   

$

0.25

   

$

(0.23

)

   

   

$

(0.23

)

 
 

2013

     

7.71

     

0.10

     

(0.07

)

   

0.03

     

(0.20

)

   

     

(0.20

)

 
 

2014

     

7.54

     

0.08

     

0.01

     

0.09

     

(0.14

)

   

     

(0.14

)

 
 

2015

     

7.49

     

0.10

     

(0.11

)

   

(0.01

)

   

(0.10

)

   

     

(0.10

)

 
 

2016

(2)

   

7.38

     

0.13

     

0.24

     

0.37

     

(0.11

)

   

     

(0.11

)

 
 

2017

(3)

   

7.64

     

0.06

     

0.04

     

0.10

     

     

     

   

CLASS Y SHARES

     
 

2012

     

7.67

     

0.10

     

0.13

     

0.23

     

(0.21

)

   

     

(0.21

)

 
 

2013

     

7.69

     

0.08

     

(0.07

)

   

0.01

     

(0.18

)

   

     

(0.18

)

 
 

2014

     

7.52

     

0.06

     

     

0.06

     

(0.11

)

   

     

(0.11

)

 
 

2015

     

7.47

     

0.08

     

(0.10

)

   

(0.02

)

   

(0.08

)

   

     

(0.08

)

 
 

2016

(2)

   

7.37

     

0.11

     

0.24

     

0.35

     

(0.09

)

   

     

(0.09

)

 
 

2017

(3)

   

7.63

     

0.05

     

0.04

     

0.09

     

     

     

   
INCOME PLUS
CLASS X SHARES
     
 

2012

     

11.13

     

0.48

     

1.04

     

1.52

     

(0.68

)

   

     

(0.68

)

 
 

2013

     

11.97

     

0.45

     

(0.35

)

   

0.10

     

(0.59

)

   

     

(0.59

)

 
 

2014

     

11.48

     

0.42

     

0.47

     

0.89

     

(0.51

)

   

     

(0.51

)

 
 

2015

     

11.86

     

0.42

     

(0.66

)

   

(0.24

)

   

(0.47

)

 

$

(0.01

)

   

(0.48

)

 
 

2016

(2)

   

11.14

     

0.42

     

0.37

     

0.79

     

(0.46

)

   

(0.28

)

   

(0.74

)

 
 

2017

(3)

   

11.19

     

0.18

     

0.28

     

0.46

     

     

     

   

CLASS Y SHARES

     
 

2012

     

11.09

     

0.45

     

1.04

     

1.49

     

(0.65

)

   

     

(0.65

)

 
 

2013

     

11.93

     

0.41

     

(0.33

)

   

0.08

     

(0.56

)

   

     

(0.56

)

 
 

2014

     

11.45

     

0.39

     

0.45

     

0.84

     

(0.47

)

   

     

(0.47

)

 
 

2015

     

11.82

     

0.39

     

(0.64

)

   

(0.25

)

   

(0.44

)

   

(0.01

)

   

(0.45

)

 
 

2016

(2)

   

11.12

     

0.39

     

0.35

     

0.74

     

(0.42

)

   

(0.28

)

   

(0.70

)

 
 

2017

(3)

   

11.16

     

0.17

     

0.28

     

0.45

     

     

     

   

See Notes to Financial Statements
76



                RATIO TO AVERAGE
NET ASSETS
         
FOR THE YEAR
ENDED
DECEMBER 31
  NET ASSET
VALUE
END OF
PERIOD
  TOTAL
RETURN(7)
  NET ASSETS
END OF
PERIOD
(000'S)
 

EXPENSES

  NET
INVESTMENT
INCOME
  REBATE FROM
MORGAN STANLEY
AFFILIATE
  PORTFOLIO
TURNOVER
RATE
 
LIMITED DURATION
CLASS X SHARES
 
 

2012

   

$

7.71

     

3.34

%

 

$

10,628

     

0.63

%(8)

   

1.52

%(8)

   

0.00

%(6)

   

58

%

 
 

2013

     

7.54

     

0.39

     

9,346

     

0.75

(8)

   

1.27

(8)

   

0.00

(6)

   

53

   
 

2014

     

7.49

     

1.13

     

7,986

     

0.80

(8)

   

1.09

(8)

   

0.00

(6)

   

51

   
 

2015

     

7.38

     

(0.16

)

   

6,773

     

0.94

(8)

   

1.38

(8)

   

0.00

(6)

   

39

   
 

2016

(2)

   

7.64

     

5.09

(13)

   

5,935

     

0.75

(8)(9)

   

1.77

(8)(9)

   

0.00

(6)

   

22

   
 

2017

(3)

   

7.74

     

1.31

(14)

   

5,727

     

1.01

(8)(15)

   

1.60

(8)(15)

   

0.00

(6)(15)

   

21

(14)

 

CLASS Y SHARES

 
 

2012

     

7.69

     

3.05

     

38,736

     

0.88

(8)

   

1.27

(8)

   

0.00

(6)

   

58

   
 

2013

     

7.52

     

0.09

     

32,974

     

1.00

(8)

   

1.02

(8)

   

0.00

(6)

   

53

   
 

2014

     

7.47

     

0.84

     

28,244

     

1.05

(8)

   

0.84

(8)

   

0.00

(6)

   

51

   
 

2015

     

7.37

     

(0.32

)

   

24,445

     

1.19

(8)

   

1.13

(8)

   

0.00

(6)

   

39

   
 

2016

(2)

   

7.63

     

4.80

(13)

   

22,112

     

1.00

(8)(9)

   

1.52

(8)(9)

   

0.00

(6)

   

22

   
 

2017

(3)

   

7.72

     

1.18

(14)

   

21,175

     

1.26

(8)(15)

   

1.35

(8)(15)

   

0.00

(6)(15)

   

21

(14)

 
INCOME PLUS
CLASS X SHARES
 
 

2012

     

11.97

     

14.09

     

86,765

     

0.61

(8)

   

4.14

(8)

   

0.00

(6)

   

68

   
 

2013

     

11.48

     

1.03

     

73,998

     

0.62

(8)

   

3.82

(8)

   

0.00

(6)

   

55

   
 

2014

     

11.86

     

7.79

     

68,129

     

0.64

(8)

   

3.52

(8)

   

0.00

(6)

   

43

   
 

2015

     

11.14

     

(2.09

)

   

57,579

     

0.68

(8)

   

3.56

(8)

   

0.00

(6)

   

44

   
 

2016

(2)

   

11.19

     

7.08

     

53,539

     

0.63

(8)(10)

   

3.67

(8)(10)

   

0.00

(6)

   

39

   
 

2017

(3)

   

11.65

     

4.11

(14)

   

51,158

     

0.70

(8)(15)

   

3.22

(8)(15)

   

0.00

(6)(15)

   

31

(14)

 

CLASS Y SHARES

 
 

2012

     

11.93

     

13.82

     

97,579

     

0.86

(8)

   

3.89

(8)

   

0.00

(6)

   

68

   
 

2013

     

11.45

     

0.81

     

82,429

     

0.87

(8)

   

3.57

(8)

   

0.00

(6)

   

55

   
 

2014

     

11.82

     

7.40

     

69,491

     

0.89

(8)

   

3.27

(8)

   

0.00

(6)

   

43

   
 

2015

     

11.12

     

(2.22

)

   

56,969

     

0.93

(8)

   

3.31

(8)

   

0.00

(6)

   

44

   
 

2016

(2)

   

11.16

     

6.68

     

52,595

     

0.88

(8)(10)

   

3.42

(8)(10)

   

0.00

(6)

   

39

   
 

2017

(3)

   

11.61

     

4.03

(14)

   

49,900

     

0.95

(8)(15)

   

2.97

(8)(15)

   

0.00

(6)(15)

   

31

(14)

 


77



Morgan Stanley Variable Investment Series

Financial Highlights continued

                               
FOR THE YEAR
ENDED
DECEMBER 31
  NET ASSET
VALUE
BEGINNING
OF PERIOD
  NET
INVESTMENT
INCOME
(LOSS)(1)
  NET REALIZED
AND
UNREALIZED
GAIN (LOSS)
  TOTAL FROM
INVESTMENT
OPERATIONS
  DIVIDENDS
TO
SHAREHOLDERS
  DISTRIBUTIONS
TO
SHAREHOLDERS
  TOTAL
DIVIDENDS
AND
DISTRIBUTIONS
 
EUROPEAN EQUITY
CLASS X SHARES
     
 

2012

   

$

14.19

   

$

0.53

   

$

2.03

   

$

2.56

   

$

(0.43

)

   

   

$

(0.43

)

 
 

2013

     

16.32

     

0.42

     

3.95

     

4.37

     

(0.53

)

   

     

(0.53

)

 
 

2014

     

20.16

     

0.82

     

(2.61

)

   

(1.79

)

   

(0.48

)

   

     

(0.48

)

 
 

2015

     

17.89

     

0.41

     

(1.24

)

   

(0.83

)

   

(0.94

)

   

     

(0.94

)

 
 

2016

(4)

   

16.12

     

0.45

     

(0.87

)

   

(0.42

)

   

(0.45

)

   

     

(0.45

)

 
 

2017

(3)

   

15.25

     

0.33

     

1.95

     

2.28

     

     

     

   

CLASS Y SHARES

     
 

2012

     

14.12

     

0.49

     

2.03

     

2.52

     

(0.38

)

   

     

(0.38

)

 
 

2013

     

16.26

     

0.33

     

3.98

     

4.31

     

(0.48

)

   

     

(0.48

)

 
 

2014

     

20.09

     

0.77

     

(2.60

)

   

(1.83

)

   

(0.43

)

   

     

(0.43

)

 
 

2015

     

17.83

     

0.37

     

(1.24

)

   

(0.87

)

   

(0.88

)

   

     

(0.88

)

 
 

2016

(4)

   

16.08

     

0.41

     

(0.87

)

   

(0.46

)

   

(0.40

)

   

     

(0.40

)

 
 

2017

(3)

   

15.22

     

0.31

     

1.95

     

2.26

     

     

     

   
MULTI CAP GROWTH
CLASS X SHARES
     
 

2012

     

37.31

     

0.20

     

4.40

     

4.60

     

   

$

(0.90

)

   

(0.90

)

 
 

2013

     

41.01

     

(0.03

)

   

20.55

     

20.52

     

(0.20

)

   

(0.66

)

   

(0.86

)

 
 

2014

     

60.67

     

(0.06

)

   

3.23

     

3.17

     

     

(7.79

)

   

(7.79

)

 
 

2015

     

56.05

     

(0.15

)

   

4.86

     

4.71

     

     

(10.37

)

   

(10.37

)

 
 

2016

(4)

   

50.39

     

0.00

(5)

   

(1.85

)

   

(1.85

)

   

     

(7.91

)

   

(7.91

)

 
 

2017

(3)

   

40.63

     

(0.08

)

   

11.74

     

11.66

     

     

     

   

CLASS Y SHARES

     
 

2012

     

37.00

     

0.09

     

4.37

     

4.46

     

     

(0.90

)

   

(0.90

)

 
 

2013

     

40.56

     

(0.15

)

   

20.32

     

20.17

     

(0.11

)

   

(0.66

)

   

(0.77

)

 
 

2014

     

59.96

     

(0.20

)

   

3.18

     

2.98

     

     

(7.79

)

   

(7.79

)

 
 

2015

     

55.15

     

(0.28

)

   

4.78

     

4.50

     

     

(10.37

)

   

(10.37

)

 
 

2016

(4)

   

49.28

     

(0.11

)

   

(1.81

)

   

(1.92

)

   

     

(7.91

)

   

(7.91

)

 
 

2017

(3)

   

39.45

     

(0.13

)

   

11.39

     

11.26

     

     

     

   

See Notes to Financial Statements
78



                RATIO TO AVERAGE
NET ASSETS
         
FOR THE YEAR
ENDED
DECEMBER 31
  NET ASSET
VALUE
END OF
PERIOD
  TOTAL
RETURN(7)
  NET ASSETS
END OF
PERIOD
(000'S)
 

EXPENSES

  NET
INVESTMENT
INCOME (LOSS)
  REBATE FROM
MORGAN STANLEY
AFFILIATE
  PORTFOLIO
TURNOVER
RATE
 
EUROPEAN EQUITY
CLASS X SHARES
 
 

2012

   

$

16.32

     

18.51

%

 

$

40,141

     

1.00

%(8)(11)

   

3.50

%(8)(11)

   

0.00

%(6)

   

11

%

 
 

2013

     

20.16

     

27.50

     

43,414

     

1.00

(8)(11)

   

2.32

(8)(11)

   

0.00

(6)

   

10

   
 

2014

     

17.89

     

(9.14

)

   

33,884

     

1.00

(8)(11)

   

4.17

(8)(11)

   

0.00

(6)

   

21

   
 

2015

     

16.12

     

(5.17

)

   

28,348

     

1.00

(8)(11)

   

2.29

(8)(11)

   

0.00

(6)

   

21

   
 

2016

(4)

   

15.25

     

(2.54

)

   

23,472

     

1.00

(8)(11)

   

2.94

(8)(11)

   

0.00

(6)

   

22

   
 

2017

(3)

   

17.53

     

14.95

(14)

   

25,275

     

1.00

(8)(11)(15)

   

4.06

(8)(11)(15)

   

0.00

(6)(15)

   

7

(14)

 

CLASS Y SHARES

 
 

2012

     

16.26

     

18.16

     

11,773

     

1.25

(8)(11)

   

3.25

(8)(11)

   

0.00

(6)

   

11

   
 

2013

     

20.09

     

27.20

     

11,807

     

1.25

(8)(11)

   

2.07

(8)(11)

   

0.00

(6)

   

10

   
 

2014

     

17.83

     

(9.37

)

   

8,518

     

1.25

(8)(11)

   

3.92

(8)(11)

   

0.00

(6)

   

21

   
 

2015

     

16.08

     

(5.39

)

   

6,776

     

1.25

(8)(11)

   

2.04

(8)(11)

   

0.00

(6)

   

21

   
 

2016

(4)

   

15.22

     

(2.75

)

   

5,819

     

1.25

(8)(11)

   

2.69

(8)(11)

   

0.00

(6)

   

22

   
 

2017

(3)

   

17.48

     

14.77

(14)

   

6,292

     

1.25

(8)(11)(15)

   

3.81

(8)(11)(15)

   

0.00

(6)(15)

   

7

(14)

 
MULTI CAP GROWTH
CLASS X SHARES
 
 

2012

     

41.01

     

12.37

     

164,917

     

0.58

(8)

   

0.48

(8)

   

0.00

(6)

   

44

   
 

2013

     

60.67

     

50.76

     

223,689

     

0.57

(8)

   

(0.06

)(8)

   

0.00

(6)

   

34

   
 

2014

     

56.05

     

5.71

     

200,910

     

0.54

(8)

   

(0.11

)(8)

   

0.00

(6)

   

29

   
 

2015

     

50.39

     

8.60

     

188,317

     

0.57

(8)(12)

   

(0.27

)(8)(12)

   

0.00

(6)

   

34

   
 

2016

(4)

   

40.63

     

(3.41

)

   

160,229

     

0.56

(8)(12)

   

0.01

(8)(12)

   

0.00

(6)

   

42

   
 

2017

(3)

   

52.29

     

28.70

(14)

   

190,768

     

0.57

(8)(12)(15)

   

(0.33

)(8)(12)(15)

   

0.00

(6)(15)

   

18

(14)

 

CLASS Y SHARES

 
 

2012

     

40.56

     

12.09

     

45,556

     

0.83

(8)

   

0.23

(8)

   

0.00

(6)

   

44

   
 

2013

     

59.96

     

50.37

     

72,135

     

0.82

(8)

   

(0.31

)(8)

   

0.00

(6)

   

34

   
 

2014

     

55.15

     

5.44

     

56,027

     

0.79

(8)

   

(0.36

)(8)

   

0.00

(6)

   

29

   
 

2015

     

49.28

     

8.34

     

51,882

     

0.82

(8)(12)

   

(0.52

)(8)(12)

   

0.00

(6)

   

34

   
 

2016

(4)

   

39.45

     

(3.65

)

   

42,909

     

0.81

(8)(12)

   

(0.24

)(8)(12)

   

0.00

(6)

   

42

   
 

2017

(3)

   

50.71

     

28.54

(14)

   

50,357

     

0.82

(8)(12)(15)

   

(0.58

)(8)(12)(15)

   

0.00

(6)(15)

   

18

(14)

 


79



Morgan Stanley Variable Investment Series

Financial Highlights continued

  (1)  The per share amounts were computed using an average number of shares outstanding during the period.

  (2)  Reflects prior period custodian out-of-pocket expenses that were reimbursed in September 2016. The amount of the reimbursement was immaterial on a per share basis and did not impact the total return of the Fund.

  (3)  For the six months ended June 30, 2017 (unaudited).

  (4)  Reflects prior period custodian out-of-pocket expenses that were reimbursed in September 2016. The amount of the reimbursement was immaterial on a per share basis and did not impact the total return of the Fund. The annualized expense and net investment income (loss) ratios would be unchanged as the reimbursement of custodian fees was offset against expense waivers/reimbursements with no impact to net expenses or net investment income (loss).

  (5)  Amount is less than $0.001.

  (6)  Amount is less than 0.005%.

  (7)  Calculated based on the net asset value as of the last business day of the period. Performance shown does not reflect fees and expenses imposed by your insurance company. If performance information included the effect of these additional charges, the total returns would be lower.

  (8)  The ratios reflect the rebate of certain Fund expenses in connection with investments in a Morgan Stanley affiliate during the period. The effect of the rebate on the ratios is disclosed in the above table as "Rebate from Morgan Stanley affiliate."

  (9)  If the Fund had not received the reimbursement from the custodian, the annualized expense and net investment income ratios would have been as follows:

PERIOD ENDED

  EXPENSE
RATIO
  NET INVESTMENT INCOME
RATIO
 

December 31, 2016

                 

Class X

   

0.92

%

   

1.60

%

 

Class Y

   

1.17

     

1.35

   

  (10)  If the Fund had not received the reimbursement from the custodian, the annualized expense and net investment income ratios would have been as follows:

PERIOD ENDED

  EXPENSE
RATIO
  NET INVESTMENT INCOME
RATIO
 

December 31, 2016

                 

Class X

   

0.68

%

   

3.62

%

 

Class Y

   

0.93

     

3.37

   

See Notes to Financial Statements
80



  (11)  If the Fund had borne all of its expenses that were reimbursed or waived by the Adviser/Administrator, the annualized expense and net investment income ratios, would have been as follows:

PERIOD ENDED

  EXPENSE
RATIO
  NET INVESTMENT INCOME
RATIO
 

June 30, 2017

                 

Class X

   

1.42

%

   

3.64

%

 

Class Y

   

1.67

     

3.39

   

December 31, 2016

                 

Class X

   

1.42

     

2.52

   

Class Y

   

1.67

     

2.27

   

December 31, 2015

                 

Class X

   

1.32

     

1.97

   

Class Y

   

1.57

     

1.72

   

December 31, 2014

                 

Class X

   

1.26

     

3.91

   

Class Y

   

1.51

     

3.66

   

December 31, 2013

                 

Class X

   

1.22

     

2.10

   

Class Y

   

1.47

     

1.85

   

December 31, 2012

                 

Class X

   

1.22

     

3.28

   

Class Y

   

1.47

     

3.03

   

  (12)  If the Fund had borne all of its expenses that were reimbursed or waived by the Adviser/Administrator, the annualized expense and net investment loss ratios, would have been as follows:

PERIOD ENDED

  EXPENSE
RATIO
  NET INVESTMENT LOSS
RATIO
 

June 30, 2017

                 

Class X

   

0.58

%

   

(0.34

)%

 

Class Y

   

0.83

     

(0.59

)

 

December 31, 2016

                 

Class X

   

0.58

     

(0.01

)

 

Class Y

   

0.83

     

(0.26

)

 

December 31, 2015

                 

Class X

   

0.58

     

(0.28

)

 

Class Y

   

0.83

     

(0.53

)

 

  (13)  Performance was positively impacted for Class X and Class Y Shares due to the receipt of proceeds from the settlement of a class action suit involving the Fund's past holdings by approximately 3.28% and 3.40%, respectively. This was a one time settlement, and as a result, the impact on the NAV and consequently the performance will not likely be repeated in the future. Had this settlement not occurred, the total return for Class X and Class Y shares would have been approximately 1.81% and 1.40%, respectively.

  (14)  Not Annualized.

(15)  Annualized.


81




Morgan Stanley Variable Investment Series

Investment Advisory Agreement Approval n June 30, 2017 (unaudited)

Nature, Extent and Quality of Services

The Board reviewed and considered the nature and extent of the investment advisory services provided by the Adviser (as defined herein) under the advisory agreement, including portfolio management, investment research and equity and fixed income securities trading. The Board reviewed similar information and factors regarding the Sub-Adviser (as defined herein) for the European Equity Portfolio. The Board also reviewed and considered the nature and extent of the non-advisory, administrative services provided by the Adviser under the administration agreement, including accounting, operations, clerical, bookkeeping, compliance, business management and planning, legal services and the provision of supplies, office space and utilities at the Adviser's expense. The Board also considered the Adviser's investment in personnel and infrastructure that benefits the Funds. (The Adviser and Sub-Adviser together are referred to as the "Adviser" and the advisory, sub-advisory and administration agreements together are referred to as the "Management Agreement.") The Board also considered that the Adviser serves a variety of other investment advisory clients and has experience overseeing service providers. The Board also compared the nature of the services provided by the Adviser with similar services provided by non-affiliated advisers as presented to the Board by Broadridge Financial Solutions, Inc. ("Broadridge").

The Board reviewed and considered the qualifications of the portfolio managers, the senior administrative managers and other key personnel of the Adviser who provide the administrative and advisory services to the Funds. The Board determined that the Adviser's portfolio managers and key personnel are well qualified by education and/or training and experience to perform the services in an efficient and professional manner. The Board concluded that the nature and extent of the advisory and administrative services provided were necessary and appropriate for the conduct of the business and investment activities of the Funds and supported its decision to approve the Management Agreement.

Performance, Fees and Expenses of the Funds

The Board reviewed the performance, fees and expenses of the Funds compared to their peers, as presented by Broadridge, and to appropriate benchmarks where applicable. The Board discussed with the Adviser the performance goals and the actual results achieved in managing the Funds. When considering a fund's performance, the Board and the Adviser place emphasis on trends and longer-term returns (focusing on one-year, three-year and five-year performance, as of December 31, 2016, or since inception, as applicable). When a fund underperforms its benchmark and/or its peer group average, the Board and the Adviser discuss the causes of such underperformance and, where necessary, they discuss specific changes to investment strategy or investment personnel.

Performance

The Board noted that the performance of the Multi Cap Growth Portfolio was below its peer group average for the one- and three-year periods but better than its peer group average for the five-year period.


82



Morgan Stanley Variable Investment Series

Investment Advisory Agreement Approval n June 30, 2017 (unaudited) continued

The Board noted that the performance of the European Equity Portfolio was below its peer group average for the one-, three- and five-year periods.

The Board noted that the performance of each of the Income Plus and Limited Duration Portfolios was better than its respective peer group averages for the one-, three- and five-year periods.

Performance Conclusions

With respect to the Income Plus and Limited Duration Portfolios, after discussion, the Board concluded that performance was competitive with their respective peer group averages.

With respect to the Multi Cap Growth and European Equity Portfolios, after discussion, the Board concluded that performance was acceptable.

Fees and Expenses

The Board members discussed with the Adviser the level of the advisory and administration fees (together, the "management fee") for the Funds relative to comparable funds and/or other accounts advised by the Adviser and/or compared to their respective peers as presented by Broadridge. In addition to the management fee, the Board also reviewed the Funds' total expense ratios. When a fund's management fee and/or its total expense ratio are higher than its peers, the Board and the Adviser discuss the reasons for this and, where appropriate, they discuss possible waivers and/or caps.

The Board noted that the contractual management fee for the European Equity Portfolio was higher than but close to its peer group average, the actual management fee was lower than its peer group average and the total expense ratio was higher than but close to its peer group average.

The Board noted that the management fee and total expense ratio for the Multi Cap Growth Portfolio were lower than its peer group averages.

The Board noted that while the management fees for the Income Plus and Limited Duration Portfolios were lower than their respective peer group averages, the total expense ratios were higher than their respective peer group averages.

Fee and Expense Conclusions

With respect to the European Equity and Multi Cap Growth Portfolios, after discussion, the Board concluded that the management fees and total expense ratios were competitive with their respective peer group averages.


83



Morgan Stanley Variable Investment Series

Investment Advisory Agreement Approval n June 30, 2017 (unaudited) continued

With respect to the Income Plus and Limited Duration Portfolios, after discussion, the Board concluded that (i) the management fees were competitive with their respective peer group averages and (ii) the total expense ratios were acceptable.

Economies of Scale

The Board considered the size and growth prospects of the Funds and how that relates to the Funds' total expense ratios and particularly the Funds' management fee rates (which, for all of the Funds except the Limited Duration Portfolio, include one or more breakpoints). In conjunction with its review of the Adviser's profitability, the Board discussed with the Adviser how a change in assets can affect the efficiency or effectiveness of managing the Funds and whether the management fee level is appropriate relative to current and projected asset levels and/or whether the management fee structure reflects economies of scale as asset levels change. The Board has determined that its review of the actual and/or potential economies of scale of each Fund supports its decision to approve the Management Agreement.

Profitability of the Adviser and Affiliates

The Board considered information concerning the costs incurred and profits realized by the Adviser and its affiliates during the last year from their relationship with the Funds and during the last two years from their relationship with the Morgan Stanley Fund Complex and reviewed with the Adviser the cost allocation methodology used to determine the profitability of the Adviser and affiliates. The Board has determined that its review of the analysis of the Adviser's expenses and profitability supports its decision to approve the Management Agreement.

Other Benefits of the Relationship

The Board considered other direct and indirect benefits to the Adviser and/or its affiliates derived from their relationship with the Funds and other funds advised by the Adviser. These benefits may include, among other things, fees for trading, distribution and/or shareholder servicing and for transaction processing and reporting platforms used by securities lending agents, and research received by the Adviser generated from commission dollars spent on funds' portfolio trading. The Board reviewed with the Adviser these arrangements and the reasonableness of the Adviser's costs relative to the services performed. The Board has determined that its review of the other benefits received by the Adviser or its affiliates supports its decision to approve the Management Agreement.

Resources of the Adviser and Historical Relationship Between the Funds and the Adviser

The Board considered whether the Adviser is financially sound and has the resources necessary to perform its obligations under the Management Agreement. The Board also reviewed and considered the historical relationship between the Funds and the Adviser, including the organizational structure of the Adviser, the policies and procedures formulated and adopted by the Adviser for managing the Funds' operations and the Board's confidence in the


84



Morgan Stanley Variable Investment Series

Investment Advisory Agreement Approval n June 30, 2017 (unaudited) continued

competence and integrity of the senior managers and key personnel of the Adviser. The Board concluded that the Adviser has the financial resources necessary to fulfill its obligations under the Management Agreement and that it is beneficial for the Funds to continue their relationship with the Adviser.

Other Factors and Current Trends

The Board considered the controls and procedures adopted and implemented by the Adviser and monitored by the Fund's Chief Compliance Officer and concluded that the conduct of business by the Adviser indicates a good faith effort on its part to adhere to high ethical standards in the conduct of the Funds' business.

General Conclusion

After considering and weighing all of the above factors, with various written materials and verbal information presented by the Adviser, the Board concluded that it would be in the best interest of the Funds and their shareholders to approve renewal of the Management Agreement for another year. In reaching this conclusion the Board did not give particular weight to any single piece of information or factor referenced above. The Board considered these factors and information over the course of the year and in numerous meetings, some of which were in executive session with only the independent Board members and their counsel present. It is possible that individual Board members may have weighed these factors, and the information presented, differently in reaching their individual decisions to approve the Management Agreement.


85



(This page has been intentionally left blank.)



(This page has been intentionally left blank.)



(This page has been intentionally left blank.)




Trustees

 
Frank L. Bowman  

Joseph J. Kearns

 
Kathleen A. Dennis  

Michael F. Klein

 
Nancy C. Everett  

Patricia Maleski

 
Jakki L. Haussler  

Michael E. Nugent

 
Dr. Manuel H. Johnson  

Chair of the Board

 
   

W. Allen Reed

 
   

Fergus Reid

 

Officers

John H. Gernon
President and Principal Executive Officer

Timothy J. Knierim
Chief Compliance Officer

Francis J. Smith
Treasurer and Principal Financial Officer

Mary E. Mullin
Secretary

Michael J. Key
Vice President

Transfer Agent  

Custodian

 
Boston Financial Data Services, Inc.
2000 Crown Colony Drive
Quincy, Massachusetts 02169
  State Street Bank and Trust Company
One Lincoln Street
Boston, Massachusetts 02111
 
Independent Registered Public Accounting Firm  

Legal Counsel

 
Ernst & Young LLP
200 Clarendon Street
Boston, Massachusetts 02116
  Dechert LLP
1095 Avenue of the Americas
New York, New York 10036
 
Counsel to the Independent Trustees  

Adviser and Administrator

 
Perkins Coie LLP
30 Rockefeller Plaza
New York, New York 10112
  Morgan Stanley Investment Management Inc.
522 Fifth Avenue
New York, New York 10036
 

Sub-Adviser (solely with respect to European Equity Portfolio)

 

Morgan Stanley Investment Management Limited
25 Cabot Square, Canary Wharf
London, E14 4QA, England

This report is submitted for the general information of shareholders of the Trust. For more detailed information about the Trust, its fees and expenses and other pertinent information, please read its Prospectus. The Trust's Statement of Additional Information contains additional information about the Trust, including its trustees. It is available without charge, by calling (800) 548-7786.

This report is not authorized for distribution to prospective investors in the Trust unless preceded or accompanied by an effective Prospectus. Read the Prospectus carefully before investing.

Morgan Stanley Distribution, Inc., member FINRA.



VARINSAN
1857760 EXP 08.31.18

#40113A




 

Item 2.  Code of Ethics.

 

Not applicable for semiannual reports.

 

Item 3.  Audit Committee Financial Expert.

 

Not applicable for semiannual reports.

 

Item 4. Principal Accountant Fees and Services

 

Not applicable for semiannual reports.

 

Item 5. Audit Committee of Listed Registrants.

 

Not applicable for semiannual reports.

 

Item 6.

 

(a) Refer to Item 1.

 

(b) Not applicable.

 

Item 7. Disclosure of Proxy Voting Policies and Procedures for Closed-End Management Investment Companies.

 

Not applicable for semiannual reports.

 

Item 8. Portfolio Managers of Closed-End Management Investment Companies

 

Applicable only to annual reports filed by closed-end funds.

 

Item 9. Closed-End Fund Repurchases

 

Applicable to reports filed by closed-end funds.

 

Item 10. Submission of Matters to a Vote of Security Holders

 

Not applicable.

 



 

Item 11. Controls and Procedures

 

(a)  The Fund’s principal executive officer and principal financial officer have concluded that the Fund’s disclosure controls and procedures are sufficient to ensure that information required to be disclosed by the Fund in this Form N-CSR was recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission’s rules and forms, based upon such officers’ evaluation of these controls and procedures as of a date within 90 days of the filing date of the report.

 

(b)  There were no changes in the registrant’s internal control over financial reporting that occurred during the second fiscal quarter of the period covered by this report that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting.

 

Item 12. Exhibits

 

(a) Code of Ethics – Not applicable for semiannual reports.

 

(b) A separate certification for each principal executive officer and principal financial officer of the registrant are attached hereto as part of EX-99.CERT.

 



 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

Morgan Stanley Variable Investment Series

 

/s/ John H. Gernon

 

John H. Gernon

 

Principal Executive Officer

 

August 17, 2017

 

Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, this report has been signed by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

 

/s/ John H. Gernon

 

John H. Gernon

 

Principal Executive Officer

 

August 17, 2017

 

 

 

/s/ Francis Smith

 

Francis Smith

 

Principal Financial Officer

 

August 17, 2017